UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-Q

(Mark One)

x
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 2011

¨
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ___________________ to ___________________

Commission file no. 001-33143

AmTrust Financial Services, Inc.
(Exact name of registrant as specified in its charter)

Delaware
 
04-3106389
(State or other jurisdiction of
 
(IRS Employer Identification No.)
incorporation or organization)
   
     
59 Maiden Lane, 6th  Floor, New York, New York
 
10038
(Address of principal executive offices)
 
(Zip Code)

(212) 220-7120
(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes   x     No   ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  Yes   x    No   ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company.  See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company" in Rule 12b-2 of the Exchange Act:

Large accelerated filer     ¨
 
Accelerated filer      x
     
Non-accelerated filer     ¨
 
Smaller reporting company      ¨
(Do not check if a smaller reporting company)
   

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Securities Exchange Act). Yes   ¨    No   x

As of November 1, 2011, the Registrant had one class of Common Stock ($.01 par value), of which 59,990,443 shares were issued and outstanding.

 
 

 

INDEX

     
Page
PART I
FINANCIAL INFORMATION
  3
       
Item 1.
Unaudited Financial Statements:
  3
       
 
Condensed Consolidated Balance Sheets as of September 30, 2011 and December 31, 2010 (audited)
  3
       
 
Condensed Consolidated Statements of Income — Three and nine months ended September 30, 2011 and 2010
  4
       
 
Condensed Consolidated Statements of Cash Flows — Three and nine months ended September 30, 2011 and 2010
  5
       
 
Notes to Condensed Consolidated Financial Statements
  6
       
Item 2.
Management’s Discussion and Analysis of Financial Condition and Results of Operations
  32
       
Item 3.
Quantitative and Qualitative Disclosures About Market Risk
  56
       
Item 4.
Controls and Procedures
  58
       
PART II
OTHER INFORMATION
  58
       
Item 1.
Legal Proceedings
  58
       
Item 1A.     
Risk Factors
  59
       
Item 2.
Unregistered Sales of Equity Securities and Use of Proceeds
  59
       
Item 3.
Defaults Upon Senior Securities
  59
       
Item 4.
(Removed and Reserved)
  59
       
Item 5.
Other Information
  59
       
Item 6.
Exhibits
  60
       
 
Signatures
  61
 
 
2

 

PART 1 - FINANCIAL INFORMATION

Item 1. Financial Statements

AMTRUST FINANCIAL SERVICES, INC. AND SUBSIDIARIES
Condensed Consolidated Balance Sheets
(in thousands, except par value)

   
September 30,
2011
   
December 31,
2010
 
(Amounts in Thousands)
 
(Unaudited)
   
(Audited)
 
ASSETS
           
Investments:
           
Fixed maturities, available-for-sale, at market value (amortized cost $1,391,104; $1,192,844)
  $ 1,412,164     $ 1,208,813  
Equity securities, available-for-sale, at market value (cost $38,409; $18,577)
    32,119       17,412  
Short-term investments
    164,815       32,137  
Equity investment in unconsolidated subsidiary – related party
    86,165       77,136  
Other investments
    21,204       21,514  
Total investments
    1,716,467       1,357,012  
Cash and cash equivalents
    320,863       201,949  
Accrued interest and dividends
    10,997       7,979  
Premiums receivable, net
    847,410       727,561  
Reinsurance recoverable (related party $458,855; $386,932)
    1,043,065       775,432  
Prepaid reinsurance premium (related party $346,586; $283,899)
    541,125       484,960  
Prepaid expenses and other assets
    289,707       163,905  
Federal income tax receivable
    22,394       10,269  
Deferred policy acquisition costs
    277,520       224,671  
Property and equipment, net
    57,071       30,889  
Goodwill
    142,547       106,220  
Intangible assets
    150,183       91,606  
    $ 5,419,349     $ 4,182,453  
LIABILITIES AND STOCKHOLDERS’ EQUITY
               
Liabilities:
               
Loss and loss expense reserves
  $ 1,782,953     $ 1,263,537  
Unearned premiums
    1,274,562       1,024,965  
Ceded reinsurance premiums payable (related party $147,171; $95,629)
    296,593       266,314  
Reinsurance payable on paid losses
    16,145       11,343  
Funds held under reinsurance treaties
    50,149       3,217  
Securities sold but not yet purchased, at market
    55,620       8,847  
Securities sold under agreements to repurchase, at contract value
    343,905       347,617  
Accrued expenses and other current liabilities
    263,563       195,060  
Deferred income taxes
    85,106       9,883  
Note payable on collateral loan – related party
    167,975       167,975  
Revolving credit facility
    33,200        
Secured term loan
    10,256        
Non-interest bearing note payable – net of unamortized discount of $221; $600
    7,279       14,400  
Term loan
          6,667  
Junior subordinated debt
    123,714       123,714  
Total liabilities
    4,511,020       3,443,539  
Commitments and contingencies
               
Redeemable non-controlling interest
    600       600  
Stockholders’ equity:
               
Common stock, $.01 par value; 100,000 shares authorized, 84,768 and 84,381 issued in 2011 and 2010, respectively; 59,968 and 59,565 outstanding in 2011 and 2010, respectively
    848       844  
Preferred stock, $.01 par value; 10,000 shares authorized
           
Additional paid-in capital
    556,465       548,731  
Treasury stock at cost; 24,800 and 24,816 shares in 2011 and 2010, respectively
    (300,365 )     (300,489 )
Accumulated other comprehensive income (loss)
    (2,207 )     (266 )
Retained earnings
    583,175       467,694  
Total AmTrust Financial Services, Inc. equity
    837,916       716,514  
Non-controlling interest
    69,813       21,800  
Total stockholders’ equity
    907,729       738,314  
    $ 5,419,349     $ 4,182,453  

See accompanying notes to unaudited condensed consolidated statements.

 
3

 

AmTrust Financial Services, Inc.
Condensed Consolidated Statements of Income
(Unaudited)
(in thousands, except per share data)

   
Three Months Ended September 30,
   
Nine Months Ended September 30,
 
   
2011
   
2010
   
2011
   
2010
 
Revenues:
                       
Premium income:
                       
Net written premium
  $ 321,903     $ 182,837     $ 931,603     $ 568,644  
Change in unearned premium
    (33,055 )     8,048       (194,135 )     (33,398 )
Net earned premium
    288,848       190,885       737,468       535,246  
Ceding commission – primarily related party
    40,732       37,903       111,830       103,109  
Service and fee income (related parties – three months $4,189; $3,323 and nine months $12,089; $8,871)
    28,815       22,418       78,546       39,505  
Net investment income
    14,456       10,952       41,815       39,237  
Net realized gain (loss) on investments
    550       7,460       1,581       2,701  
Total revenues
    373,401       269,618       971,240       719,798  
Expenses:
                               
Loss and loss adjustment expense
    185,352       120,432       484,056       331,763  
Acquisition costs and other underwriting expenses
    113,270       82,152       284,084       223,077  
Other
    24,045       20,210       62,805       35,780  
Total expenses
    322,667       222,794       830,945       590,620  
Income before other income (expense), income taxes and equity in earnings of unconsolidated subsidiaries
    50,734       46,824       140,295       129,178  
Other income (expense):
                               
Foreign currency loss
    (4,063 )     (141 )     (1,827 )     (103 )
Interest expense
    (3,946 )     (3,410 )     (12,034 )     (10,045 )
Bargain purchase on Majestic transaction
    2,665             2,665        
Net gain on investment in life settlement contracts
    6,822       11,855       48,346       11,855  
Total other income (expense)
    1,478       8,304       37,150       1,707  
Income before income taxes and equity in earnings of unconsolidated subsidiaries
    52,212       55,128       177,445       130,885  
Provision for income taxes
    13,182       13,935       29,508       37,942  
Income before equity earnings of unconsolidated subsidiaries and non-controlling interest
    39,030       41,193       147,937       92,943  
Equity in earnings (loss) of unconsolidated subsidiaries – related parties
    (447 )     4,030       6,753       21,803  
Net income
    38,583       45,223       154,690       114,746  
Net income attributable to non-controlling interest of subsidiaries
    3,487       (5,927 )     24,249       5,927  
Net income attributable to AmTrust Financial Services, Inc.
    35,096       39,296       130,441       108,819  
                                 
Earnings per common share:
                               
Basic earnings per common share
  $ 0.59     $ 0.65     $ 2.18     $ 1.82  
Diluted earnings per common share
  $ 0.57     $ 0.64     $ 2.12     $ 1.80  
Dividends declared per common share
  $ 0.09     $ 0.07     $ 0.25     $ 0.21  
                                 
Net realized gain (loss) on investments:
                               
Total other-than-temporary impairment loss
  $     $ (4,051 )   $ (345 )   $ (21,196 )
Portion of loss recognized in other comprehensive income
                       
Net impairment losses recognized in earnings
          (4,051 )     (345 )     (21,196 )
Other net realized gain on investments
    550       11,511       1,926       23,897  
Net realized investment gain (loss)
  $ 550     $ 7,460     $ 1,581     $ 2,701  

See accompanying notes to unaudited condensed consolidated financial statements.

 
4

 
 
AmTrust Financial Services, Inc.
Consolidated Statements of Cash Flows
(Unaudited)

   
Nine Months Ended September 30,
 
(in thousands)
 
2011
   
2010
 
Cash flows from operating activities:
           
Net income
  $ 154,690     $ 114,746  
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
               
Depreciation and amortization
    40,151       12,632  
Equity earnings and gain on investment in unconsolidated subsidiaries
    (6,753 )     (21,803 )
Gain on investment in life settlement contracts
    (48,346 )     (11,855 )
Realized gain marketable securities
    (1,926 )     (23,897 )
Acquisition gain on Majestic renewal rights transaction
    (2,665 )      
Non-cash write-down of marketable securities
    345       21,196  
Discount on notes payable
    379       610  
Stock compensation expense
    4,182       2,682  
Bad debt expense
    4,717       4,532  
Foreign currency (gain) loss
    1,827       103  
Changes in assets - (increase) decrease:
               
Premiums and note receivables
    (98,569 )     (98,621 )
Reinsurance recoverable
    (120,897 )     (123,012 )
Deferred policy acquisition costs, net
    (52,849 )     (32,710 )
Prepaid reinsurance premiums
    (56,165 )     (18,268 )
Prepaid expenses and other assets
    (64,722 )     (32,712 )
Deferred tax asset
          6,631  
Changes in liabilities - increase (decrease):
               
Reinsurance premium payable
    30,279       85,165  
Loss and loss expense reserve
    204,265       118,672  
Unearned premiums
    223,600       68,211  
Funds held under reinsurance treaties
    (4,783 )     799  
Deferred tax liability, net
    (42,207 )      
Accrued expenses and other current liabilities
    67,770       (76,767 )
Net cash provided by(used in) in operating activities
    232,323       (3,666 )
Cash flows from investing activities:
               
Net (purchases) sales of securities with fixed maturities and short term investments
    (88,449 )     96,429  
Net (purchases) sales of equity securities
    (18,852 )     23,654  
Net (purchases) sales of other investments
    (544 )     (1,646 )
Acquisition of Majestic, net of cash obtained
    27,314        
Investment in ACAC
          (53,055 )
Acquisition of and capitalized premiums for life settlement contracts
    (43,847 )     (12,510 )
Acquisition of  intangible assets and subsidiaries, net of cash obtained
    (4,535 )     (11,125 )
Receipt of life settlement contract proceeds
    10,530        
Purchase of property and equipment
    (33,055 )     (9,315 )
Net cash (used in) provided by investing activities
    (151,438 )     32,432  
Cash flows from financing activities:
               
Repurchase agreements, net
    (3,712 )     65,682  
Revolving credit facility borrowings
    123,200        
Revolving credit facility payment
    (90,000 )      
Secured loan agreement borrowings
    10,800        
Secured loan agreement payment
    (544 )      
Term loan payment
    (6,667 )     (10,000 )
Capital contributions to subsidiaries
    23,764       6,255  
Stock option exercise and other
    3,680       1,124  
Dividends distributed on common stock
    (14,327 )     (11,879 )
Non-interest bearing note payment
    (7,500 )     (7,500 )
Debt financing fees
    (1,368 )      
Net cash provided by financing activities
    37,326       43,682  
Effect of exchange rate changes on cash
    703       (2,730 )
Net increase  in cash and cash equivalents
    118,914       69,718  
Cash and cash equivalents, beginning of the period
    201,949       233,810  
Cash and cash equivalents, end of the period
  $ 320,863     $ 303,528  
Supplemental Cash Flow Information
               
Income tax payments
  $ 13,792     $ 24,457  
Interest payments on debt
    10,098       8,672  

See accompanying notes to unaudited condensed consolidated financial statements.

 
5

 
 
Notes to Unaudited Condensed Consolidated Financial Statements
(Unaudited)
(dollars in thousands, except share data)

 
1.
Basis of Reporting
 
The accompanying unaudited interim consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial statements and with the instructions to Form 10-Q and Article 10 of Regulation S-X and, therefore, do not include all of the information and footnotes required by GAAP for complete financial statements. These interim statements should be read in conjunction with the financial statements and notes thereto included in the AmTrust Financial Services, Inc. (“AmTrust” or the “Company”) Annual Report on Form 10-K for the year ended December 31, 2010, previously filed with the Securities and Exchange Commission (“SEC”) on March 15, 2011. The balance sheet at December 31, 2010 has been derived from the audited consolidated financial statements at that date but does not include all of the information and footnotes required by GAAP for complete financial statements.
 
These interim consolidated financial statements reflect all adjustments that are, in the opinion of management, necessary for a fair presentation of the results for the interim period and all such adjustments are of a normal recurring nature. The results of operations for the interim period are not necessarily indicative, if annualized, of those to be expected for the full year.   The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.
 
A detailed description of the Company’s significant accounting policies and management judgments is located in the audited consolidated financial statements for the year ended December 31, 2010, included in the Company’s Form 10-K filed with the SEC.
 
All significant inter-company transactions and accounts have been eliminated in the consolidated financial statements.   To facilitate period-to-period comparisons, certain reclassifications have been made to prior period consolidated financial statement amounts to conform to current period presentation.  Included on these reclassifications are the following:
 
 
a)
The non-controlling interest related to income on life settlement contracts is now presented on a pre-tax basis and the provision for income taxes has been reduced by an equivalent amount;
 
 
b)
The Company made a purchase price adjustment to goodwill in the amount of approximately $36,000 related to its purchase accounting for Warrantech, which was acquired during the three months ended September 30, 2010.  The adjustment related to an increase in deferred tax and other liabilities due to non-deductibility of certain goodwill and intangible assets.
 
There was no effect on net income from the changes in presentation.

 
2.
Recent Accounting Pronouncements
 
With the exception of those discussed below, there have been no recent accounting pronouncements or changes in accounting pronouncements during the nine months ended September 30, 2011, as compared to those described in our Annual Report on Form 10-K for the fiscal year ended December 31, 2010, that are of significance, or potential significance, to the Company.
 
In September 2011, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2011-08 Intangibles-Goodwill and Other (Topic 350) .  The updated guidance is intended to reduce complexity and costs by allowing an entity the option to make a qualitative evaluation about the likelihood of goodwill impairment, using factors such as changes in management, key personnel, business strategy, technology or customers, to determine whether it should calculate the fair value of a reporting unit.  Previous accounting literature required an entity to test goodwill for impairment by comparing the fair value of a reporting unit with its carrying amount, including goodwill.  If the fair value of a reporting unit is less than its carrying amount, then the second step of the test must be performed to measure the amount of the impairment loss, if any.  In the second step, the implied fair value of the reporting unit’s goodwill is determined in the same manner as goodwill is measured in a business combination (by measuring the fair value of the reporting unit’s assets, liabilities and unrecognized intangible assets and determining the remaining amount ascribed to goodwill) and comparing the amount of the implied goodwill to the carrying amount of the goodwill.  Under the updated guidance, an entity is not required to calculate the fair value of a reporting unit unless the entity determines that is more likely than not that its fair value is less than its carrying amount.  This update is effective for annual and interim goodwill impairment tests performed for fiscal years beginning after December 31, 2011.  Early adoption is permitted, including for annual and interim goodwill impairment tests performed for fiscal years beginning after September 15, 2011 if an entity’s financial statements for the most recent annual or interim period have not yet been issued.  The Company is currently assessing the impact of the adoption of this guidance, but does not anticipate any material impact on its results of operations, financial position or liquidity.

 
6

 
 
In June 2011, the FASB issued ASU No. 2011-05 Comprehensive Income (Topic 220) .  This update requires that all non-owner charges in stockholders’ equity be presented either in a single continuous statement of comprehensive income or in two separate but consecutive statements.  In the two-step approach, the first statement should present total net income and its components followed consecutively by a second statement that should present total other comprehensive income, the components of other comprehensive income, and the total of comprehensive income.  The updated guidance is effective for fiscal years and interim periods beginning on or after December 15, 2011 and is to be applied on a retrospective basis to the beginning of the annual period of adoption. Early adoption is permitted and the amendment does not require any transition disclosure.  The Company is currently assessing the impact of the adoption of this guidance, but does not anticipate any material impact on its results of operations, financial position or liquidity.
 
In May 2011, the FASB issued ASU No. 2011-04, Fair Value Measurement (Topic 820) .  The ASU generally aligns the principles for fair value measurements and the related disclosure requirements under GAAP and International Financial Reporting Standards (“IFRS”).  ASU 2011-04 changes certain fair value measurement principles and enhances the disclosure requirements, particularly for Level 3 fair value measurements.  The amendment is effective on a prospective basis for interim and annual reporting periods beginning after December 15, 2011 and early adoption is not permitted.  The Company is currently assessing the impact of the adoption of this guidance, but does not anticipate any material impact on its results of operations, financial position or liquidity.
 
On April 29, 2011, the FASB amended its guidance on accounting for repurchase agreements. The amendments eliminate the criteria to assess whether a transferor must have the ability to repurchase or redeem the financial assets in order to demonstrate effective control over the transferred asset. Under the amended guidance, a transferor maintains effective control over transferred financial assets (and thus accounts for the transfer as a secured borrowing) if there is an agreement that both entitles and obligates the transferor to repurchase the financial assets before maturity and if all of the following conditions previously required are met: (i) financial assets to be repurchased or redeemed are the same or substantially the same as those transferred; (ii) repurchase or redemption date before maturity at a fixed or determinable price; and (iii) the agreement is entered into contemporaneously with, or in contemplation of, the transfer.  As a result, more arrangements could be accounted for as secured borrowings rather than sales.  The updated guidance is effective on a prospective basis for interim and annual reporting periods beginning on or after December 15, 2011, and early adoption is prohibited. The Company is currently evaluating the impact of the adoption of this new guidance on its consolidated results of operations and financial condition.
 
In April 2011, the FASB issued updated guidance to clarify whether a modification or restructuring of a receivable is considered a troubled debt restructuring, i.e., whether the creditor has granted a concession and whether the debtor is experiencing financial difficulties. A modification or restructuring that is considered a troubled debt restructuring will result in the creditor having to account for the receivable as being impaired and will also result in additional disclosure of the creditors’ troubled debt restructuring activities. The updated guidance is effective for the first interim period beginning on or after June 15, 2011 and is to be applied on a retrospective basis to the beginning of the annual period of adoption. The adoption of this guidance did not have a material impact on the Company’s results of operations, financial position or liquidity.
 
In December 2010, the FASB issued authoritative guidance on disclosure of supplementary pro forma information for business combinations. The new guidance specifies that if a public entity presents comparative financial statements, the entity should disclose revenue and earnings of the combined entity as though the business combination that occurred during the current year had occurred as of the beginning of the comparable prior annual reporting period. The new guidance became effective for the Company on January 1, 2011. The adoption of this guidance did not have a material impact on the Company’s results of operations, financial position or liquidity.
 
In October 2010, the FASB issued updated guidance to address the diversity in practice for the accounting for costs associated with acquiring or renewing insurance contracts. This guidance modifies the definition of acquisition costs to specify that a cost must be directly related to the successful acquisition of a new or renewal insurance contract in order to be deferred. If application of this guidance would result in the capitalization of acquisition costs that had not previously been capitalized by a reporting entity, the entity may elect not to capitalize those costs. The updated guidance is effective on either a retrospective or prospective basis for interim and annual reporting periods beginning after December 15, 2011, with early adoption permitted as of the beginning of a company’s annual period. The Company is currently evaluating the impact of the adoption of this new guidance on its consolidated results of operations and financial condition.

 
7

 

3.     Investments

(a) Available-for-Sale Securities
 
The original cost, estimated market value and gross unrealized appreciation and depreciation of available-for-sale securities as of September 30, 2011, are presented in the table below:

(Amounts in Thousands)
 
Original or
amortized
cost
   
Gross
unrealized
gains
   
Gross
unrealized
losses
   
Market
value
 
Preferred stock
  $ 6,029     $ -     $ (1,605 )   $ 4,424  
Common stock
    32,380       1,019       (5,704 )     27,695  
U.S. treasury securities
    37,828       2,586       -       40,414  
U.S. government agencies
    27,695       2,146       (1 )     29,840  
Municipal bonds
    272,883       6,219       (743 )     278,359  
Corporate bonds:
                               
Finance
    493,020       8,901       (25,423 )     476,498  
Industrial
    99,132       3,971       (2,284 )     100,819  
Utilities
    38,537       1,732       (1,142 )     39,127  
Commercial mortgage backed securities
    1,541       98       -       1,639  
Residential mortgage backed securities:
                               
Agency backed
    408,124       24,603       (48 )     432,679  
Non-agency backed
    11,633       463       (34 )     12,062  
Asset-backed securities
    711       16       -       727  
    $ 1,429,513     $ 51,754     $ (36,984 )   $ 1,444,283  
 
In June 2011, the Company, through a subsidiary, purchased $12,500 of an aggregate $107,500 principal amount of 8.25% Senior Notes issued by Maiden Holdings North America, Ltd. that are fully guaranteed by Maiden Holdings, Ltd. (“Maiden”), both related parties. The Company has classified this fixed security in corporate finance bonds and its market value at September 30, 2011 was $12,500.  For a further description of this transaction see Note 11. “Related Party Transactions”.
 
Proceeds from the sale of investments in available-for-sale securities during the nine months ended September 30, 2011 and 2010 were approximately $1,827,485 and $2,826,479, respectively.
 
A summary of the Company’s available-for-sale fixed securities as of September 30, 2011, by contractual maturity, is shown below. Expected maturities may differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties.

(Amounts in Thousands)
 
Amortized
Cost
   
Fair Value
 
Due in one year or less
  $ 18,763     $ 18,767  
Due after one through five years
    251,196       243,955  
Due after five through ten years
    467,721       470,272  
Due after ten years
    231,415       232,064  
Mortgage backed securities
    422,009       447,106  
Total fixed maturities
  $ 1,391,104     $ 1,412,164  
 
 
8

 

(b) Investment Income
 
Net investment income for the three and nine months ended September 30, 2011 and 2010 was derived from the following sources:

   
Three Months Ended September 30,
   
Nine Months Ended September 30,
 
(Amounts in Thousands)
 
2011
   
2010
   
2011
   
2010
 
Fixed maturities
  $ 13,601     $ 9,462     $ 39,577     $ 32,832  
Equity maturities
    141       51       427       410  
Cash and cash equivalents
    1,075       1,102       2,647       3,857  
Note receivable – related party
    -       563       -       2,612  
      14,817       11,178       42,651       39,711  
Less: Investment expenses and interest expense on securities sold under agreements to repurchase
    361       226       836       474  
    $ 14,456     $ 10,952     $ 41,815     $ 39,237  

(c) Other-Than-Temporary Impairment
 
Other-than-temporary impairment (“OTTI”) charges of our fixed-maturities and equity securities for the three and nine months ended September 30, 2011 and 2010 are presented in the table below:

   
Three Months Ended September 30,
   
Nine Months Ended September 30,
 
(Amounts in Thousands)
 
2011
   
2010
   
2011
   
2010
 
Equity securities
  $     $ 4,051     $ 345     $ 10,656  
Fixed maturities
                      10,540  
    $     $ 4,051     $ 345     $ 21,196  
 
The table below summarizes the gross unrealized losses of our fixed maturity and equity securities by length of time the securities have continuously been in an unrealized position as of September 30, 2011:

   
Less Than 12 Months
   
12 Months or More
   
Total
 
(Amounts in Thousands)
 
Fair
Market
Value
   
Unrealized
Losses
   
No. of
Positions
Held
   
Fair
Market
Value
   
Unrealized
Losses
   
No. of
Positions
Held
   
Fair
Market
Value
   
Unrealized
Losses
 
Common and preferred stock
  $ 20,971     $ (4,831 )     41     $ 6,714     $ (2,478 )     6     $ 27,685     $ (7,309 )
U.S. treasury securities
    805       (1 )     2       -       -       -       805       (1 )
Municipal bonds
    100,313       (743 )     25       -       -       -       100,313       (743 )
Corporate bonds:
                                                               
Finance
    230,145       (11,606 )     86       86,720       (13,817 )     11       316,865       (25,423 )
Industrial
    35,146       (2,284 )     16       -       -       -       35,146       (2,284 )
Utilities
    27,893       (1,142 )     4       -       -       -       27,893       (1,142 )
Residential mortgage backed securities:
                                                               
Agency backed
    25,889       (48 )     10       -       -       -       25,889       (48 )
Non-agency backed
  $ 3,749     $ (28 )     2     $ 22     $ (6 )     1     $ 3,771     $ (34 )
Total temporarily impaired securities
  $ 444,911     $ (20,683 )     186     $ 93,456     $ (16,301 )     18     $ 538,367     $ (36,984 )
 
 
9

 
 
There are 204 securities at September 30, 2011 that account for the gross unrealized loss, none of which is deemed by the Company to be OTTI. Significant factors influencing the Company’s determination that unrealized losses were temporary included the magnitude of the unrealized losses in relation to each security’s cost, the nature of the investment and management’s intent not to sell these securities and it being not more likely than not that the Company will be required to sell these investments before anticipated recovery of fair value to the Company’s cost basis.
 
(d) Derivatives
 
The Company from time to time invests in a limited amount of derivatives and other financial instruments as part of its investment portfolio to manage interest rate changes or other exposures to a particular financial market. The Company records changes in valuation on its derivative positions not designated as a hedge as a component of net realized gains and losses. The Company records changes in valuation on its hedge positions as a component of other comprehensive income. As of September 30, 2011, the Company has two interest rate swaps designated as a hedge that were entered into in June 2011 related to the Company’s trust preferred securities, one of which became effective in September 2011 and the second that will take effect in June 2012.

The following   table presents the notional amounts by remaining maturity of the Company’s interest rate swaps as of September 30, 2011:

   
Remaining Life of Notional Amount (1)
 
(Amounts in Thousands)
 
One
Year
   
Two Through
Five Years
   
Six Through
Ten Years
   
After Ten
years
   
Total
 
Interest rate swaps
  $     $ 30,000     $ 40,000     $     $ 70,000  

(1)     Notional amount is not representative of either market risk or credit risk and is not recorded in the consolidated balance sheet.

(e) Other
 
Securities sold but not yet purchased represent obligations of the Company to deliver the specified security at the contracted price and, thereby, create a liability to purchase the security in the market at prevailing prices. The Company’s liability for securities to be delivered is measured at their fair value and as of September 30, 2011 was $55,496 for U.S. treasury securities and $124 related to equity securities. These transactions result in off-balance sheet risk, as the Company’s ultimate cost to satisfy the delivery of securities sold but not yet purchased may exceed the amount reflected at September 30, 2011. Subject to certain limitations, all securities owned, to the extent required to cover the Company’s obligations to sell or repledge the securities to others, are pledged to the clearing broker.
 
The Company enters into repurchase agreements, which are accounted for as collateralized borrowing transactions and are recorded at contract amounts. The Company receives cash or securities that it invests or holds in short term or fixed income securities. As of September 30, 2011, there were $343,905 principal amount outstanding at interest rates between .30% and .35%. Interest expense associated with these repurchase agreements for the three months ended September 30, 2011 and 2010 was $361 and $226, respectively, of which $0 was accrued as of September 30, 2011. Interest expense associated with the repurchase agreements for the nine months ended September 30, 2011 and 2010 was $836 and $474, respectively. The Company has approximately $356,008 of collateral pledged in support of these agreements.

 
10

 

4.    Fair Value of Financial Instruments

The following table presents the level within the fair value hierarchy at which the Company’s financial assets and financial liabilities are measured on a recurring basis as of September 30, 2011:

(Amounts in Thousands)
 
Total
   
Level 1
   
Level 2
   
Level 3
 
Assets:
                       
U.S. treasury securities
  $ 40,414     $ 40,414     $     $  
U.S. government agencies
    29,840             29,840        
Municipal bonds
    278,359             278,359        
Corporate bonds:
                               
Finance
    476,498             476,498        
Industrial
    100,819             100,819        
Utilities
    39,127             39,127        
Commercial mortgage backed securities
    1,639             1,639        
Residential mortgage backed securities:
                               
Agency backed
    432,679             432,679        
Non-agency backed
    12,062             12,062        
Asset-backed securities
    727             727        
Equity securities
    32,119       32,119              
Short term investments
    164,815       164,815              
Other investments
    21,204                   21,204  
Life settlement contracts
    121,666                   121,666  
    $ 1,715,968     $ 237,348     $ 1,371,750     $ 142,870  
Liabilities:
                               
Equity securities sold but not yet purchased, market
  $ 124     $ 124     $     $  
U.S. treasury securities sold but not yet purchased , market
    55,496       55,496              
Securities sold under agreements to repurchase, at contract value
    343,905             343,905        
Life settlement contract profit commission
    12,636                   12,636  
      412,161       55,620       343,905       12,636  

The Company classifies its financial assets and liabilities in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.  This classification requires judgment in assessing the market and pricing methodologies for a particular security.  The fair value hierarchy includes the following three levels:
 
Level 1 – Valuations are based on unadjusted quoted market prices in active markets for identical financial assets or liabilities;
 
Level 2 – Valuations of financial assets and liabilities are based on prices obtained from third party pricing services, dealer quotations of the bid price using observable inputs, or through consensus pricing of a pricing service; and
 
Level 3 – Valuations are based on unobservable inputs for assets and liabilities where there is little or no market activity.  Management’s assumptions are used in internal valuation pricing models to determine the fair value of financial assets or liabilities.
 
For additional discussion regarding techniques used to value the Company’s investment portfolio, refer to Note 2. “Significant Accounting Policies” in Item 8. “Financial Statements and Supplementary Data” in its 2010 Form 10-K.

 
11

 
 
The following table provides a summary of changes in fair value of the Company’s Level 3 financial assets for the three and nine months ended September 30, 2011 and 2010:

(Amounts in
Thousands)
 
Balance as of
June 30,
2011
   
Net income
   
Other
comprehensive
income
   
Purchases
and
issuances
   
Sales and
settlements
   
Net
transfers
into (out of)
Level 3
   
Balance as of
September 30,
2011
 
Other investments
  $ 22,008     $     $ (1,348 )   $ 5,672     $ (5,128 )   $     $ 21,204  
Life settlement contracts
    108,710       17,188             6,298       (10,530 )           121,666  
Life settlement contract profit commission
    (9,267 )     (3,369 )                             (12,636 )
Total
  $ 121,451     $ 13,819     $ (1,348 )   $ 11,970     $ (15,658 )   $     $ 130,234  
 
(Amounts in
Thousands)
 
Balance as of
December 31,
2010
   
Net income
   
Other
comprehensive
income
   
Purchases
and
issuances
   
Sales and
settlements
   
Net
transfers
into (out of)
Level 3
   
Balance as of
September 30,
2011
 
Other investments
  $ 21,514     $ 661     $ (1,725 )   $ 6,538     $ (5,784 )   $     $ 21,204  
Life settlement contracts
    22,155       75,209             34,832       (10,530 )           121,666  
Life settlement contract profit commission
    (4,711 )     (7,925 )                             (12,636 )
Total
  $ 38,958     $ 67,945     $ (1,725 )   $ 41,370     $ (16,314 )   $     $ 130,234  
 
(Amounts in
Thousands)
 
Balance as of
June 30,
2010
   
Net income
   
Other
comprehensive
income
   
Purchases
and
issuances
   
Sales and
settlements
   
Net
transfers
into (out of)
Level 3
   
Balance as of
September 30,
2010
 
Other investments
  $ 13,323     $ 6     $     $ 2,432     $ (81 )   $     $ 15,680  
Life settlement contracts
          10,592             6,433                   17,025  
Life settlement contract profit commission
                                         
Derivatives
    (220 )     (64 )                             (284 )
Total
  $ 13,103     $ 10,534     $     $ 14,941     $ (81 )   $     $ 38,497  
 
(Amounts in
Thousands)
 
Balance as of
December 31,
2009
   
Net income
   
Other
comprehensive
income
   
Purchases
and
issuances
   
Sales and
settlements
   
Net
transfers
into (out of)
Level 3
   
Balance as of
September 30,
2010
 
Other investments
  $ 12,746     $ 283     $ 296     $ 2,555     $ (200 )   $     $ 15,680  
Life settlement contracts
          10,592             6,433                   17,025  
Life settlement contract profit commission
          (4,711 )                             (4,711 )
Derivatives
    (1,893 )     1,609                               (284 )
Total
  $ 10,853     $ 12,484     $ 296     $ 15,064     $ (200 )   $     $ 27,710  
 
The Company had no transfers between levels during the three and nine months ended September 30, 2011 and 2010.
 
 
12

 
 
The Company uses the following methods and assumptions in estimating its fair value disclosures for financial instruments:

 
Equity and Fixed Income Investments:    Fair value disclosures for these investments are disclosed above in this note. The carrying values of cash, short term investments and investment income accrued approximate their fair values;

 
Premiums Receivable:    The carrying values reported in the accompanying balance sheets for these financial instruments approximate their fair values due to the short term nature of the asset;

 
Subordinated Debentures and Debt:    The carrying values reported in the accompanying balance sheets for these financial instruments approximate fair value. Fair value was estimated using projected cash flows, discounted at rates currently being offered for similar notes.

5.      Debt

Junior Subordinated Debt
 
The Company has established four special purpose trusts for the purpose of issuing trust preferred securities. The proceeds from such issuances, together with the proceeds of the related issuances of common securities of the trusts, were invested by the trusts in junior subordinated debentures issued by the Company. In accordance with FASB ASC 810-10-25, the Company does not consolidate such special purpose trusts, as the Company is not considered to be the primary beneficiary. The equity investment, totaling $3,714 as of September 30, 2011 on the Company’s consolidated balance sheet, represents the Company’s ownership of common securities issued by the trusts. The debentures require interest-only payments to be made on a quarterly basis, with principal due at maturity. The debentures contain covenants that restrict declaration of dividends on the Company’s common stock under certain circumstances, including default of payment. The Company incurred $2,605 of placement fees in connection with these issuances, which is being amortized over thirty years. The Company recorded $2,552 and $2,553 of interest expense for the three months ended September 30, 2011 and 2010, respectively, and $7,657 of interest expense for the nine months ended September 30, 2011 and 2010, respectively, related to these trust preferred securities.
 
The table below summarizes the Company’s trust preferred securities as of September 30, 2011:

   
Aggregate
                     
   
Liquidation
   
Aggregate
           
Per
 
   
Amount of
   
Liquidation
   
Aggregate
     
Annum
 
(Amounts in Thousands)
 
Trust
   
Amount of
   
Principal
 
Stated
 
Interest
 
   
Preferred
   
Common
   
Amount
 
Maturity
 
Rate of
 
Name of Trust
 
Securities
   
Securities
   
of Notes
 
of Notes
 
Notes
 
AmTrust Capital Financing Trust I
  $ 25,000     $ 774     $ 25,774  
3/17/2035
    8.275 %(1)
AmTrust Capital Financing Trust II
    25,000       774       25,774  
6/15/2035
    7.710 (1)
AmTrust Capital Financing Trust III
    30,000       928       30,928  
9/15/2036
    3.647 (2)
AmTrust Capital Financing Trust IV
    40,000       1,238       41,238  
3/15/2037
    7.930 (3)
Total trust preferred securities
  $ 120,000     $ 3,714     $ 123,714            

 
(1)
The interest rate will change to three-month LIBOR plus 3.40% after the tenth anniversary in 2015.
 
(2)
The interest rate will change to LIBOR plus 3.30% after the fifth anniversary in 2011.
 
(3)
The interest rate will change to LIBOR plus 3.00% after the fifth anniversary in 2012.
 
The Company entered into two interest rate swap agreements related to these junior subordinated debentures, which effectively convert the interest rate on the trust preferred securities from a variable rate to a fixed rate.  Each agreement is for a period of five years and commenced on September 15, 2011 for tranche III and will commence for tranche IV on its fifth anniversary in 2012.

 
13

 

Revolving Credit Agreement
 
On January 28, 2011, the Company entered into a three-year, $150,000 credit agreement (the “Credit Agreement”), among JPMorgan Chase Bank, N.A., as Administrative Agent, The Bank of Nova Scotia, as Syndication Agent, SunTrust Bank, as Documentation Agent, and the various lending institutions party thereto. The credit facility is a revolving credit facility with a letter of credit sublimit of $50,000 and an expansion feature not to exceed $50,000. Proceeds of borrowings under the Credit Agreement may be used for working capital, acquisitions and general corporate purposes. In connection with entering into the Credit Agreement, the Company terminated the then existing Term Loan and Uncommitted Line of Credit Letter Agreement with JPMorgan Chase Bank, N.A.  The Company did not record a gain or loss on the extinguishment of its previous term loan.
 
ABR borrowings (which are borrowings bearing interest at a rate determined by reference to the Alternate Base Rate) under the Credit Agreement will bear interest at (x) the greatest of (a) the Administrative Agent’s prime rate, (b) the federal funds effective rate plus 0.5 percent or (c) the adjusted LIBO rate for a one month interest period on such day plus 1 percent, plus (y) a margin that is adjusted on the basis of the Company’s consolidated leverage ratio. Eurodollar borrowings under the credit agreement will bear interest at the adjusted LIBO rate for the interest period in effect plus a margin that is adjusted on the basis of the Company’s consolidated leverage ratio.
 
The Credit Agreement contains certain restrictive covenants customary for facilities of this type (subject to negotiated exceptions and baskets), including restrictions on indebtedness, liens, acquisitions and investments, restricted payments and dispositions. There are also financial covenants that require the Company to maintain a minimum consolidated net worth, a maximum consolidated leverage ratio, a minimum fixed charge coverage ratio, a minimum risk-based capital and a minimum statutory surplus.  The Company was in compliance with all covenants as of September 30, 2011.

As of September 30, 2011, the Company had outstanding borrowings of $33,200 under this Credit Agreement. The Company had outstanding letters of credit in place under this Credit Agreement at September 30, 2011 for $50,633, which reduced the availability under the facility to $66,167 as of September 30, 2011.  The Company’s outstanding letters of credit of $50,633 exceeded the availability for letters of credit by $633 as of September 30, 2011. The Company corrected this on October 27, 2011, bringing the Company’s outstanding letters of credit in place under this Credit Agreement to $49,972.  This did not require an amendment or waiver to the Credit Agreement, nor did the Company incur any fees as a result.
 
The Company recorded approximately $1,030 of deferred financing costs related to the Credit Agreement.  Fees payable by the Company under the Credit Agreement include a letter of credit participation fee (which is the margin applicable to Eurodollar borrowings and was 2.25% at September 30, 2011), a letter of credit fronting fee with respect to each letter of credit (.125%) and a commitment fee on the available commitments of the lenders (a range of .35% to .45% based on the Company’s consolidated leverage ratio and was .40% at September 30, 2011).
 
The interest rate on the credit facility as of September 30, 2011 was 2.5%. The Company recorded interest expense of approximately $595 and $2,013 for the three and nine months ended September 30, 2011, respectively, under the Credit Agreement.  The Company recorded interest expense of approximately $0 and $167 for the three months ended September 30, 2011 and 2010, respectively, and $72 and $630 for the nine months ended September 30, 2011 and 2010, respectively, related to the terminated term loan.
 
Secured Loan Agreement
 
During February 2011, the Company, through a wholly-owned subsidiary, entered into a seven-year secured loan agreement with Bank of America Leasing & Capital, LLC in the aggregate amount of $10,800 to finance the purchase of an aircraft. The loan bears interest at a fixed rate of 4.45%, requires monthly installment payments of approximately $117 commencing on March 25, 2011 and ending on February 25, 2018, and a balloon payment of $3,240 at the maturity date. The Company recorded approximately $44 of deferred financing costs related to this agreement.  The Company recorded interest expense of approximately $117 and $288 for the three and nine months ended September 30, 2011, respectively, related to this agreement. The loan is secured by an aircraft that the subsidiary acquired in February 2011.
 
The agreement contains certain covenants that are similar to the Company’s revolving credit facility. Additionally, subsequent to February 25, 2012, but prior to payment in full, if the outstanding balance of this loan exceeds 90% of the fair value of the aircraft, the Company is required to pay the lender the entire amount necessary to reduce the outstanding principal balance to be equal to or less than 90% of the fair value of the aircraft.  The agreement allows the Company, under certain conditions, to repay the entire outstanding principal balance of this loan without penalty.

 
14

 
 
Promissory Note
 
In connection with the stock and asset purchase agreement with a subsidiary of Unitrin, Inc. (now called Kemper Corporation), the Company, on June 1, 2008, issued a promissory note to Unitrin, Inc. in the amount of $30,000. The note is non-interest bearing and requires four annual principal payments of $7,500. The first three annual principal payments were paid between 2009 and 2011, and the remaining principal payment is due on June 1, 2012. Upon entering into the promissory note, the Company calculated imputed interest of $3,155 based on interest rates available to the Company, which was 4.5%. Accordingly, the note’s carrying balance was adjusted to $26,845 at the acquisition. The note is required to be paid in full, immediately, under certain circumstances including a default of payment or change of control of the Company. The Company included $82 and $160 of amortized discount on the note in its results of operations for the three months ended September 30, 2011 and 2010, respectively, and $379 and $610 for the nine months ended September 30, 2011 and 2010, respectively. The note’s carrying value at September 30, 2011 was $7,279.
 
Comerica Letter of Credit Facility
 
The Company, through one of its subsidiaries, entered into a secured letter of credit facility with Comerica Bank during the three months ended September 30, 2011.  The credit limit is for $75,000 and was utilized for $49,968 as of September 30, 2011.  The Company is required to pay a letter of credit participation fee for each letter of credit in the amount of 0.40%.
 
Other Letters of Credit
 
The Company, through certain subsidiaries, has additional existing stand-by letters of credit as of September 30, 2011 in the amount of $1,321.
 
Maturities of Debt
 
Maturities of the Company’s debt subsequent to September 30, 2011 are as follows:

(Amounts in Thousands)
 
2011
   
2012
   
2013
   
2014
   
2015
   
Thereafter
 
Junior subordinated debt
  $     $     $     $     $     $ 123,714  
Revolving credit facility
                      33,200              
Secured loan
    238       977       1,021       1,068       1,116       5,836  
Promissory note
          7,279                          
Total
  $ 238     $ 8,256     $ 1,021     $ 34,268     $ 1,116     $ 129,550  

 
6.
Acquisition Costs and Other Underwriting Expenses
 
The following table summarizes the components of acquisition costs and other underwriting expenses for the three and nine months ended September 30, 2011 and 2010:

   
Three Months Ended
September 30,
   
Nine Months Ended
September 30,
 
(Amounts in Thousands)
 
2011
   
2010
   
2011
   
2010
 
Policy acquisition expenses
  $ 76,944     $ 52,761     $ 180,260     $ 128,174  
Salaries and benefits
    27,418       24,956       87,309       73,371  
Other insurance general and administrative expenses
    8,908       4,435       16,515       21,532  
    $ 113,270     $ 82,152     $ 284,084     $ 223,077  

 
7.
Earnings Per Share
 
Effective January 1, 2009, the Company adopted ASC subtopic 260-10, Determining Whether Instruments Granted in Share-Based Payments Transactions Are Participating Securitie s. ASC 260-10 provides that unvested share-based payment awards that contain nonforfeitable rights to dividends or dividend equivalents, whether paid or unpaid, are participating securities and are to be included in the computation of earnings per share under the two-class method. The Company’s unvested restricted shares contain rights to receive nonforfeitable dividends and are participating securities, requiring the two-class method of computing earnings per share.

 
15

 
 
The following table is a summary of the elements used in calculating basic and diluted earnings per share for the three and nine months ended September 30, 2011 and 2010:

   
Three Months Ended September 30,
   
Nine Months Ended September 30,
 
(Amounts in Thousands except per share)
 
2011
   
2010
   
2011
   
2010
 
Basic earnings per share:
                       
Net income attributable to AmTrust Financial Services, Inc. shareholders
  $ 35,096     $ 39,296     $ 130,441     $ 108,819  
Less: Net income allocated to participating securities and redeemable non-controlling interest
    16       427       80       454  
Net income allocated to AmTrust Financial Services, Inc. common  shareholders
  $ 35,080     $ 38,869     $ 130,361     $ 108,365  
                                 
Weighted average common shares outstanding – basic
    59,987       59,540       59,842       59,455  
Less: Weighted average participating shares outstanding
    32       50       40       35  
Weighted average common shares outstanding - basic
    59,955       59,490       59,802       59,420  
Net income per AmTrust Financial Services, Inc. common share - basic
  $ 0.59     $ 0.65     $ 2.18     $ 1.82  
                                 
Diluted earnings per share:
                               
Net income attributable to AmTrust Financial Services, Inc. shareholders
  $ 35,096     $ 39,296     $ 130,441     $ 108,819  
Less: Net income allocated to participating securities and redeemable non-controlling interest
    16       427       80       454  
Net income allocated to AmTrust Financial Services, Inc. common shareholders
  $ 35,080     $ 38,869     $ 130,361     $ 108,365  
                                 
Weighted average common shares outstanding – basic
    59,955       59,490       59,802       59,420  
Plus: Dilutive effect of stock options, other
    1,929       885       1,703       850  
Weighted average common shares outstanding – dilutive
    61,884       60,375       61,505       60,270  
Net income per AmTrust Financial Services, Inc. common shares – diluted
  $ 0.57     $ 0.64     $ 2.12     $ 1.80  

As of September 30, 2011, there were less than 100,000 anti-dilutive securities excluded from diluted earnings per share.

 
8.
Share Based Compensation
 
During 2010, the Company adopted the 2010 Omnibus Incentive Plan (the “Plan”), which permits the Company to grant to officers, employees and non-employee directors of the Company incentive compensation directly linked to the price of the Company’s stock. The Plan authorizes up to an aggregate of 6,045,511 shares of Company stock for awards of options to purchase shares of the Company’s common stock, restricted stock, restricted stock units (“RSU”) or appreciation rights. Shares used may be either newly issued shares or treasury shares or both. The aggregate number of shares of common stock for which awards may be issued may not exceed 6,045,511 shares, subject to the authority of the Company’s board of directors (“Board”) to adjust this amount in the event of a consolidation, reorganization, stock dividend, stock split, recapitalization or similar transaction affecting the Company’s common stock. All remaining unissued shares related to the Company’s previously existing 2005 Equity Incentive Plan were absorbed into the Plan. As of September 30, 2011, approximately 5,500,000 shares of Company common stock remained available for grants under the Plan.

 
16

 
 
The Company recognizes compensation expense under FASB ASC 718-10-25 for its share-based payments based on the fair value of the awards. The Company grants stock options at prices equal to the closing stock price of the Company’s stock on the dates the options are granted. The options have a term of ten years from the date of grant and vest primarily in equal annual installments over the four-year period following the date of grant for employee options. Employees have three months after the employment relationship ends to exercise all vested options. The fair value of each option grant is separately estimated for each vesting date. The fair value of each option is amortized into compensation expense on a straight-line basis between the grant date for the award and each vesting date. The Company has estimated the fair value of all stock option awards as of the date of the grant by applying the Black-Scholes-Merton multiple-option pricing valuation model. The application of this valuation model involves assumptions that are judgmental and highly sensitive in the determination of compensation expense.
 
The following schedule shows all options granted, exercised, and expired under the Plan for the nine months ended September 30, 2011 and 2010:

   
2011
   
2010
 
(Amounts in thousands except per share)
 
Shares
   
Weighted
Average
Exercise Price
   
Shares
   
Weighted
Average
Exercise Price
 
Outstanding at beginning of period
    4,127     $ 10.46       4,168     $ 10.12  
Granted
    235       16.84       241       13.76  
Exercised
    (388 )     9.61       (135 )     7.71  
Cancelled or terminated
    (65 )     16.48       (96 )     10.45  
Outstanding end of period
    3,909     $ 10.86       4,178     $ 10.40  
 
The weighted average grant date fair value of options granted during the nine months ended September 30, 2011 and 2010 was approximately $6.97 and $3.69, respectively.
 
The Company issued 50,000 shares of restricted stock with a market value of approximately $700 during the nine months ended September 30, 2010. The Board set a four-year vesting period for the outstanding restricted shares. The fair value of each restricted share grant is equal to the market price of the Company’s common stock at the date of grant. Expense relating to restricted shares is amortized ratably over the vesting period. The Company recorded compensation expense of approximately $44 and $44 during the three months ended September 30, 2011 and 2010, respectively,  and approximately $133 and $93 during the nine months ended September 30, 2011 and 2010, respectively, related to this grant.
 
The Company issued 203,096 and 90,828 restricted stock units (“RSUs”) with a market value of approximately $4,139 and $1,250 during the nine months ended September 30, 2011 and 2010, respectively. The Board set a four-year vesting period for RSUs. The fair value of each RSU is equal to the market price of the Company’s common stock at the date of grant. Expense relating to all RSU grants is amortized ratably over the vesting period. The Company recorded compensation expense of approximately $336 and $78 during the three months ended September  30, 2011 and 2010, respectively, and approximately $696 and $117 during the nine months ended September 30, 2011 and 2010, respectively, related to all existing RSU grants.
 
Compensation expense for all share-based payments under ASC 718-10-30 was approximately $906 and $822 for the three months ended September 30, 2011 and 2010, respectively, and $4,182 and $2,682 for the nine months ended September 30, 2011 and 2010.
 
As of September 30, 2011, there was approximately $7,042 of total unrecognized compensation cost related to non-vested share-based compensation arrangements.

 
17

 

 
9.
Comprehensive Income and Shareholder Equity

The following table summarizes the components of comprehensive income for the three and nine months ended September 30, 2011 and 2010:

   
Three Months Ended
September 30,
   
Nine Months Ended
September 30,
 
(Amounts in thousands)
 
2011
   
2010
   
2011
   
2010
 
Net income attributable to AmTrust
  $ 35,096     $ 39,296     $ 130,441     $ 108,819  
Unrealized holding gain (loss)
    (7,917     7,649       2,483       9,882  
Reclassification adjustment
    (5,667 )     7,521       (3,916 )     19,439  
Foreign currency translation
    (5,027     7,348       (508 )     (1,499 )
Comprehensive income
  $ 16,485     $ 61,404     $ 128,500     $ 136,231  

The following table summarizes the ownership components of total equity for the nine months ended September 30, 2011:

(Amounts in thousands)
 
AmTrust
   
Non-Controlling
Interests
   
Total
 
Beginning Balance, January 1, 2011
  $ 716,514     $ 21,800     $ 738,314  
Net income
    130,441       24,249       154,690  
Unrealized holding gains  and reclassification
    (1,433     -       (1,433
Foreign currency translation
    (508 )     -       (508
Comprehensive income
    128,500       24,249       152,749  
Capital contribution
    -       23,764       23,764  
Dividends
    (14,960 )     -       (14,960 )
Share exercises and compensation, other
    7,862       -       7,862  
Ending Balance, September 30, 2011
  $ 837,916     $ 69,813     $ 907,729  
 
There were no distributions to non-controlling interests or changes in ownership percentages during the nine months ended September 30, 2011.

 
10.
Income Taxes
 
Income tax expense for the three months ended September 30, 2011 and 2010 was $13,182 and $13,935, respectively, and $29,508 and $37,942 for the nine months ended September 30, 2011 and 2010, respectively. The following table reconciles the Company’s statutory federal income tax rate to its effective tax rate.

   
Three Months Ended
September 30,
   
Nine Months Ended
September 30,
 
(Amounts in Thousands)
 
2011
   
2010
   
2011
   
2010
 
Income before provision for income taxes, equity in earnings of unconsolidated subsidiaries
  $ 52,212     $ 55,128     $ 177,445     $ 130,885  
Equity in earnings (loss) of unconsolidated subsidiaries
    (447 )     4,030       6,753       21,803  
Non-controlling interest
    (3,487 )     (5,927 )     (24,249 )     (5,927 )
    $ 48,278     $ 53,231     $ 159,949     $ 146,761  
                                 
Income taxes at statutory rates
  $ 16,897     $ 18,631     $ 55,982     $ 51,366  
Effect of income not subject to U.S. taxation
    (5,471 )     (3,703 )     (28,100 )     (12,672 )
Other, net
    1,756       (993 )     1,626       (752 )
Provision for income taxes as shown on the Condensed Consolidated Statements of Income
  $ 13,182     $ 13,935     $ 29,508     $ 37,942  
GAAP effective tax rate
    27.3 %     26.2 %     18.4 %     26.1 %
 
18

 
 
The Company’s management believes that it will realize the benefits of its deferred tax assets, which is included as a component of the Company’s net deferred tax liability, and, accordingly, no valuation allowance has been recorded for the periods presented. The Company does not provide for income taxes on the unremitted earnings of foreign subsidiaries where, in management’s opinion, such earnings have been indefinitely reinvested. It is not practical to determine the amount of unrecognized deferred tax liabilities for temporary differences related to these investments.
 
The Company’s major taxing jurisdictions include the U.S. (federal and state), the United Kingdom and Ireland. The years subject to potential audit vary depending on the tax jurisdiction. Generally, the Company’s statute of limitation is open for tax years ended December 31, 2006 and forward. As permitted by FASB ASC 740-10, the Company's accounting policy is to prospectively classify accrued interest and penalties related to any unrecognized tax benefits in its income tax provision. At September 30, 2011, the Company has no accrued interest and penalties related to unrecognized tax benefits in accordance with FASB ASC 740-10.

 
11.
Related Party Transactions

Maiden
 
The Company has various reinsurance and service agreements with Maiden Holdings, Ltd. (“Maiden”).  Maiden is a publicly-held Bermuda insurance holding company (Nasdaq: MHLD) formed by Michael Karfunkel, George Karfunkel and Barry Zyskind, the principal shareholders, and, respectively, the chairman of the board of directors, a director, and the chief executive officer and director of the Company. As of September 30, 2011, Michael Karfunkel owns or controls approximately 13.9% of the issued and outstanding capital stock of Maiden, George Karfunkel owns or controls approximately 9.4% of the issued and outstanding capital stock of Maiden and Mr. Zyskind owns or controls approximately 5.1% of the issued and outstanding stock of Maiden. Mr. Zyskind serves as the non-executive chairman of the board of Maiden’s board of directors. Maiden Insurance Company, Ltd (“Maiden Insurance”), a wholly-owned subsidiary of Maiden, is a Bermuda reinsurer.  The following section describes the agreements in place between the Company and its subsidiaries and Maiden and its subsidiaries.
 
Reinsurance Agreements
 
During the third quarter of 2007, the Company and Maiden entered into a master agreement, as amended, by which the parties caused the Company’s Bermuda subsidiary, AmTrust International Insurance, Ltd. (“AII”) and Maiden Insurance to enter into a quota share reinsurance agreement (the “Maiden Quota Share”), as amended, by which AII retrocedes to Maiden Insurance an amount equal to 40% of the premium written by the Company’s U.S., Irish and U.K. insurance companies (the “AmTrust Ceding Insurers”), net of the cost of unaffiliated inuring reinsurance (and in the case of the Company’s U.K. insurance subsidiary, AmTrust Europe Ltd., net of commissions) and 40% of losses, excluding certain specialty risk programs that the Company commenced writing after the effective date and risks, other than workers’ compensation risks and certain business written by the Company’s Irish subsidiary, AmTrust International Underwriters Limited (“AIU”), for which the AmTrust Ceding Insurers’ net retention exceeds $5,000 (“Covered Business”).
 
The Maiden Quota Share, which had an initial term of three years, was renewed through June 30, 2014 and will automatically renew for successive three-year terms unless either AII or Maiden Insurance notifies the other of its election not to renew not less than nine months prior to the end of any such three-year term. In addition, either party is entitled to terminate on thirty days’ notice or less upon the occurrence of certain early termination events, which include a default in payment, insolvency, change in control of AII or Maiden Insurance, run-off, or a reduction of 50% or more of the shareholders’ equity of Maiden Insurance or the combined shareholders’ equity of AII and the AmTrust Ceding Insurers.
 
Effective April 1, 2011, the Maiden Quota Share, as amended, further provides that AII receives a ceding commission of 30% of ceded written premiums with respect to all Covered Business, except retail commercial package business, for which the ceding commission remains 34.375%. Commencing January 1, 2012, the ceding commission, excluding the retail package business ceding commission (which remains at 34.375%), will be adjusted to (a) 30% of ceded premium, if the Specialty Risk and Extended Warranty subject premium, excluding ceded premium related to our medical liability business discussed below, is greater than or equal to 42% of the total subject premium, (b) 30.5% of ceded premium, if the Specialty Risk and Extended Warranty subject premium is less than 42% but greater than or equal to 38%, or (c) 31% of ceded premium, if the Specialty Risk and Extended Warranty subject premium is less than 38% of the total subject premium. Prior to April 1, 2011, AII received a ceding commission of 31% of ceded premiums with respect to all Covered Business, except retail commercial package business, for which the ceding commission was 34.375%.

 
19

 
 
Effective April 1, 2011, the Company, through its subsidiaries AEL and AIU, entered into a reinsurance agreement with Maiden Insurance by which the Company cedes to Maiden Insurance 40% of its European medical liability business, including business in force at April 1, 2011. The quota share has an initial term of one year and can be terminated at April 1, 2012 or any April 1 thereafter by either party on four months’ notice.  Maiden Insurance pays the Company a 5% ceding commission, and the Company will earn a profit commission of 50% of the amount by which the ceded loss ratio is lower than 65%.
 
The following is the effect on the Company’s balance sheet as of September 30, 2011 and December 31, 2010 and the results of operations for the three and nine months ended September 30, 2011 and 2010 related to the above reinsurance agreements:

(Amounts in Thousands)
 
September 30,
2011
   
December 31,
2010
 
Assets and liabilities:
           
Reinsurance recoverable
  $ 458,855     $ 386,932  
Prepaid reinsurance premium
    346,586       283,899  
Ceded reinsurance premiums payable
    (147,171 )     (95,629 )
Note payable
    (167,975 )     (167,975 )

   
Three Months Ended
September 30,
   
Nine Months Ended
September 30,
 
(Amounts in Thousands)
 
2011
   
2010
   
2011
   
2010
 
Results of operations:
                       
Premium written – ceded
  $ (173,218 )   $ (109,457 )   $ (513,859 )   $ (336,014 )
Change in unearned premium – ceded
    13,008       (11,122 )     103,022       6,733  
Earned premium - ceded
  $ (160,210 )   $ (120,579 )   $ (410,838 )   $ (329,281 )
                                 
Ceding commission on premium written
  $ 48,339     $ 33,855     $ 132,224     $ 104,959  
Ceding commission – deferred
    (6,557 )     4,048       (20,269 )     (1,851 )
Ceding commission – earned
  $ 41,782     $ 37,903     $ 111,955     $ 103,108  
                                 
Incurred loss and loss adjustment expense – ceded
  $ 94,371     $ 78,694     $ 275,434     $ 214,140  
Interest expense on collateral loan
    473       475       1,431       982  
 
In conjunction with the Maiden Quota Share, AII entered into a loan agreement with Maiden Insurance during the fourth quarter of 2007, whereby Maiden Insurance loaned to AII the amount equal to its quota share of the obligations of the AmTrust Ceding Insurers that AII was then obligated to secure. The loan agreement provides for interest at a rate of LIBOR plus 90 basis points and is payable on a quarterly basis. Advances under the loan are secured by a promissory note and totaled $167,975 as of September 30, 2011. The Company recorded $1,431 and $982 of interest expense during the nine months ended September 30, 2011 and 2010, respectively.  Effective December 1, 2008, AII and Maiden Insurance entered into a Reinsurer Trust Assets Collateral agreement whereby Maiden Insurance is required to provide AII the assets required to secure Maiden’s proportionate share of the Company’s obligations to its U.S. subsidiaries. The amount of this collateral as of September 30, 2011 was approximately $434,000. Maiden retains ownership of the collateral in the trust account.
 
Effective September 1, 2010, the Company, through its subsidiary Technology Insurance Company, Inc.  (“TIC”), entered into a quota share reinsurance agreement with Maiden Specialty Insurance Company (“Maiden Specialty”) by which TIC assumes a portion (generally 90%) of premiums and losses with respect to certain surplus lines programs written by Maiden Specialty on behalf of the Company (the “Surplus Lines Facility”). The Surplus Lines Facility enables the Company to write business on a surplus lines basis throughout the United States in states in which it is otherwise unauthorized to write such business through its own insurance company subsidiaries. Currently, the Company is utilizing the Surplus Lines Facility for two programs for which Maiden Specialty receives a five percent ceding commission on all premiums ceded by Maiden Specialty to TIC. The Surplus Lines Facility shall remain continuously in force until terminated.  The Company is actively pursuing surplus lines authority for two of its insurance company subsidiaries, which would remove the need for the Surplus Lines Facility.  As a result of this agreement, the Company assumed approximately $12,800 of written premium for which it earned approximately $6,300 and incurred losses of approximately $3,900 for the nine months ended September 30, 2011.

 
20

 
 
Effective September 1, 2010, the Company, through its subsidiary, Security National Insurance Company (“SNIC”), entered into a reinsurance agreement with Maiden Reinsurance Company and an unrelated third party. Under the agreement, which has a term of one year, SNIC cedes 80% of the gross liabilities produced under the Southern General Agency program to Maiden Reinsurance Company and 20% of the gross liabilities produced to the unrelated third party. SNIC receives a five percent commission on ceded written premiums.  The Company ceded written premium of $333 and $448 for the three and nine months ended September 30, 2011 related to this agreement for which the Company earned ceding commission of $72 and $97 for the three and nine months ended September 30, 2011.
 
Reinsurance Brokerage Agreement
 
Effective July 1, 2007, the Company, through a subsidiary, entered into a reinsurance brokerage agreement with Maiden. Pursuant to the brokerage agreement, the Company provides brokerage services relating to the Maiden Quota Share for a fee equal to 1.25% of reinsured premium. Effective April 1, 2011, the Company also provides brokerage services to Maiden Insurance relating to the reinsurance agreement on the European medical liability business for a fee equal to 1.25% of reinsured premium.  The Company recorded $2,037 and $1,398 of brokerage commission (recorded as a component of service and fee income) during the three months ended September 30, 2011 and 2010, respectively and $6,295 and $4,253 during the nine months ended September 30, 2011 and 2010, respectively.
 
Asset Management Agreement
 
Effective July 1, 2007, the Company, through a subsidiary, entered into an asset management agreement with Maiden, pursuant to which the Company provides investment management services to Maiden and its affiliates. The investment management services fee is 0.20% per annum for periods in which average invested assets are $1,000,000 or less and 0.15% per annum for periods in which the average invested assets exceed $1,000,000. As a result of this agreement, the Company earned approximately $750 and $677 of investment management fees (recorded as a component of service and fee income) for the three months ended September 30, 2011 and 2010, respectively and $2,251 and $2,018 for the nine months ended September 30, 2011 and 2010, respectively.
 
Senior Notes
 
In June 2011, the Company, through a subsidiary, participated as a purchaser in a registered public offering by Maiden Holdings North America, Ltd., a subsidiary of Maiden, for $12,500 of an aggregate $107,500 principal amount of 8.25% Senior Notes due 2041 (the “Notes”) that are fully and unconditionally guaranteed by Maiden.  The Notes are redeemable for cash, in whole or in part, on or after June 15, 2016, at 100% of the principal amount of the Notes to be redeemed plus accrued and unpaid interest to, but not including, the redemption date.  Maiden Holdings North America, Ltd. issued the Notes to use the proceeds, together with cash on hand, to repurchase, at 114% of the principal amount, $107,500 of Maiden’s $260,000 outstanding trust preferred securities, on a pro rata basis, to all of its trust preferred securities holders. ACP Re, Ltd., an entity owned by a trust controlled by Michael Karfunkel, the Company's Chairman of the Board, accepted the offer to repurchase its $79,066 in principal amount of trust preferred securities. The Company’s Audit Committee reviewed and approved the Company’s participation in this offering.
 
American Capital Acquisition Corporation
 
During the three months ended March 31, 2010, the Company completed its strategic investment in American Capital Acquisition Corporation (“ACAC”). ACAC was formed by The Michael Karfunkel 2005 Grantor Retained Annuity Trust (the “Trust”) and the Company for the purpose of acquiring from GMAC Insurance Holdings, Inc. and Motor Insurance Corporation (“MIC”, together with GMAC Insurance Holdings, Inc., “GMACI”), GMACI’s U.S. consumer property and casualty insurance business (the “GMACI Business”), a writer of automobile coverages through independent agents in the United States. Its coverages include standard/preferred auto, RVs, non-standard auto and commercial auto. The acquisition included ten statutory insurance companies (the “GMACI Insurers”). Michael Karfunkel, individually, and the Trust, which is controlled by Michael Karfunkel, own 100% of ACAC’s common stock (subject to the Company’s conversion rights described below). Michael Karfunkel is the chairman of the board of directors of the Company and the father-in-law of Barry D. Zyskind, the chief executive officer of the Company. The ultimate beneficiaries of the Trust include Michael Karfunkel’s children, one of whom is married to Mr. Zyskind. In addition, Michael Karfunkel is the Chairman of the Board of Directors of ACAC.

 
21

 
 
Pursuant to the Amended Stock Purchase Agreement, ACAC issued and sold to the Company for an initial purchase price of approximately $53,000, which was equal to 25% of the capital initially required by ACAC, 53,054 shares of Series A Preferred Stock, which provides an 8% cumulative dividend, is non-redeemable and is convertible, at the Company’s option, into 21.25% of the issued and outstanding common stock of ACAC (the “Preferred Stock”). The Company has pre-emptive rights with respect to any future issuances of securities by ACAC and the Company’s conversion rights are subject to customary anti-dilution protections. The Company has the right to appoint two members of ACAC’s board of directors, which consists of six members. Subject to certain limitations, the board of directors of ACAC may not take any action in the absence of the Company’s appointees and ACAC may not take certain corporate actions without the unanimous prior approval of its board of directors (including the Company’s appointees).
 
The Company, the Trust and Michael Karfunkel, individually, each shall be required to make its or his proportionate share of deferred payments payable by ACAC to GMACI pursuant to the GMACI Securities Purchase Agreement, which are payable, annually on March 1 through March 1, 2013, to the extent that ACAC is unable to otherwise provide for such payments. The Company’s proportionate share of such deferred payments will not exceed $15,000.  In addition, in connection with the Company’s investment, ACAC will grant the Company a right of first refusal to purchase or to reinsure commercial auto insurance business acquired from GMACI.
 
In accordance with ASC 323-10-15, Investments-Equity Method and Joint Ventures , the Company accounts for its investment in ACAC under the equity method. The Company recorded $(447) and $4,172 of income (loss) during the three months ended September 30, 2011 and 2010, respectively and $6,753 and $12,641 during the nine months ended September 30, 2011 and 2010, respectively related to its equity investment in ACAC.
 
Personal Lines Quota Share
 
The Company, effective March 1, 2010, reinsures 10% of the net premiums of the GMACI Business, pursuant to a 50% quota share reinsurance agreement (“Personal Lines Quota Share”) among the GMACI Insurers, as cedents, and the Company, ACP Re, Ltd., a Bermuda reinsurer that is a wholly-owned indirect subsidiary of the Trust, and Maiden Insurance Company, Ltd., as reinsurers. The Personal Lines Quota Share provides that the reinsurers, severally, in accordance with their participation percentages, receive 50% of the net premium of the GMACI Insurers and assume 50% of the related net losses.  The Company has a 20% participation in the Personal Lines Quota Share, by which it receives 10% of the net premiums of the personal lines business and assumes 10% of the related net losses. The Personal Lines Quota Share has an initial term of three years and will renew automatically for successive three-year terms unless terminated by written notice not less than nine months prior to the expiration of the current term. In addition, either party is entitled to terminate on 60 days’ written notice or less upon the occurrence of certain early termination events, which include a default in payment, insolvency, change in control of the Company or the GMACI Insurers, run-off, or a reduction of 50% or more of the shareholders’ equity.  The GMACI Insurers also may terminate on nine months’ written notice following the effective date of an initial public offering or private placement of stock by ACAC or a subsidiary. The Personal Lines Quota Share provides that the reinsurers pay a provisional ceding commission equal to 32.5% of ceded earned premium, net of premiums ceded by the personal lines companies for inuring reinsurance, subject to adjustment to a maximum of 34.5% if the loss ratio for the reinsured business is 60.5% or less and a minimum of 30.5% if the loss ratio is 64.5% or higher. The Personal Lines Quota Share is subject to a premium cap that limits the premium that could be ceded by the GMACI Insurers to TIC to $121,000 during calendar year 2011 to the extent TIC was to determine, in good faith, that it could not assume additional premium. The premium cap increases by 10% per annum thereafter. As a result of this agreement, the Company assumed $26,690 and $24,523  of business from the GMACI Insurers during the three months ended September 30, 2011 and 2010, respectively, and $77,276 and $59,083 of business from the GMACI Insurers during the nine months ended September 30, 2011 and 2010, respectively.
 
Information Technology Services Agreement
 
The Company provides ACAC and its affiliates information technology development services at a price of cost plus 20%. In addition, as a new system developed by the Company is implemented and ACAC or its affiliates begin using the system in its operations, the Company is receiving a license fee for use of the systems in the amount of 1.25% of gross premiums of ACAC and its affiliates plus our costs for support services. The Company recorded approximately $1,007 and $685 of fee income for the three months ended September 30, 2011 and 2010, respectively, and $2,364 and $1,307 of fee income for the nine months ended September 30, 2011 and 2010, respectively, related to this agreement. The terms and conditions of this agreement are subject to regulatory approval.
 
Asset Management Agreement
 
The Company manages the assets of ACAC and its subsidiaries for an annual fee equal to 0.20% of the average aggregate value of the assets under management for the preceding quarter if the average aggregate value for the preceding quarter is $1,000,000 or less and 0.15% of the average aggregate value of the assets under management for the preceding quarter if the average aggregate value for that quarter is more than $1,000,000. As a result of this agreement, the Company earned approximately $389 and $438 of investment management fees for the three months ended September 30, 2011 and 2010, respectively, and $1,170 and $1,021 of investment management fees for the nine months ended September 30, 2011 and 2010, respectively.

 
22

 
 
As a result of the above service agreements with ACAC, the Company recorded fees totaling approximately $1,396 and $1,123 for the three months ended September 30, 2011 and 2010, and $3,534 and $2,328 for the nine months ended September 30, 2011 and 2010, respectively.  As of September 30, 2011, the outstanding balance payable by ACAC related to these service fees and reimbursable costs was approximately $1,406.
 
800 Superior LLC
 
During the third quarter of 2011, the Company formed 800 Superior, LLC with a subsidiary of ACAC for the purposes of acquiring an office building in Cleveland, Ohio. The Company and ACAC each have a fifty percent ownership interest in 800 Superior, LLC.  The cost of the building was approximately $7,500.  The Company has been appointed managing member of the LLC.  The Company’s Audit Committee reviewed and approved this joint purchase with ACAC.  Additionally in conjunction with the Company’s 21.25% ownership percentage of ACAC, the Company ultimately receives 60.6% of the profits and losses of the LLC.  As such, in accordance with ASC 810-10, Consolidation, the Company has been deemed the primary beneficiary and, therefore, consolidates this entity.  The results of operations of the LLC did not have a material impact on the Company’s results of operations for the three months ended September 30, 2011.
 
Diversified
 
Diversified Construction Management, LLC (“Diversified”) provided construction management and general contractor services for a Company subsidiary in 2011 and 2010. The Company recorded a total of $52 and $0 for the three months ended September 30, 2011 and 2010, respectively and $195 and $345 for the nine months ended September 30, 2011, for Diversified’s services in connection with the construction project. Robert A. Saxon, Jr., a principal of Diversified, is the brother of Michael J. Saxon, the Company’s Chief Operating Officer. During several prior years, Diversified provided similar services to the Company. In March 2010, the Audit Committee ratified our existing contractual relationship and approved the ongoing contractual relationship with Diversified, including a determination that the contracts were not less favorable to the Company than similar services provided at arm's length.
 
Office Lease Agreements
 
In January 2008, the Company entered into an amended agreement for its office space at 59 Maiden Lane in New York, New York from 59 Maiden Lane Associates, LLC, an entity that is wholly-owned by Michael Karfunkel and George Karfunkel.  The lease was amended such that it increased the leased space to 14,807 square feet and extended the lease through December 31, 2017.  The Company’s Audit Committee reviewed and approved the extension of the lease.  The Company paid approximately $184 and $226 for the lease for the three months ended September 30, 2011 and 2010, respectively and $529 and $554 for the nine months ended September 30, 2011 and 2010, respectively.
 
In January 2011, the Company entered into an amended agreement to lease office space in Chicago, Illinois from 33 West Monroe Associates, LLC, an entity that is wholly-owned by entities controlled by Michael Karfunkel and George Karfunkel.   The lease was amended to increase the leased space to 9,030 square feet and extend the lease through October 31, 2017.  The Company’s Audit Committee reviewed and approved this amended lease agreement.  The Company paid approximately $65 and $54 for the three months ended September 30, 2011 and 2010, respectively and $213 and $179 for the nine months ended September 30, 2011 and 2010, respectively.

Use of Company Aircraft
 
The Company’s wholly-owned subsidiary, AmTrust Underwriters, Inc. (“AUI”), is a party to an aircraft time share agreement with each of Maiden and ACAC.  The agreements provide for payment to AUI for usage of its company-owned aircraft and covers actual expenses incurred and permissible under federal aviation regulations, including travel and lodging expenses of the crew, in-flight catering, flight planning and weather contract services, ground transportation, fuel, landing and hanger fees, airport taxes, among others. AUI does not charge Maiden or ACAC for the fixed costs that would be incurred in any event to operate the aircraft (for example, aircraft purchase costs, insurance and flight crew salaries).  During the nine months ended September 30, 2011, Maiden and ACAC paid AUI $42 and $51, respectively, for the use of AUI’s aircraft under these agreements.
 
In addition, for personal travel, Mr. Zyskind, the Company’s President and Chief Executive Officer, entered into an aircraft reimbursement agreement with AUI and, since entering into such agreement, has fully reimbursed AUI for the incremental cost billed by AUI for his personal use of AUI’s aircraft, which for the nine months ended September 30, 2011 was $69.  The Company’s Audit Committee reviewed and approved the time share and reimbursement agreements.

 
23

 

 
12.
Acquisitions
 
Cardinal Comp
 
In September 2008, the Company entered into a managing general agency agreement with Cardinal Comp, LLC (“Cardinal Comp”), a workers’ compensation managing general agent.  The agency operates in eight states and primarily in the state of New York.  During the nine months ended September 30, 2011, Cardinal Comp placed approximately $84,000 of workers’ compensation premium that was included in the Company’s small commercial business segment.  In September 2011, the Company, through one of its subsidiaries, entered into a renewal rights and asset purchase agreement with Cardinal Comp and Cook Inlet Alternative Risk LLC.  The purchase price was approximately $30,000.  The existing managing general agency agreement entered into in 2008 was terminated as part of the new agreement and will enable the Company to reduce commissions on written premium generated from the renewal rights agreement.  In accordance with FASB ASC 805-10 “ Business Combinations ”, the Company recorded a provisional purchase price of $30,000, which consisted primarily of intangible assets of renewal rights, agency relationships, trademarks and non-compete agreements.  The transaction did not have a material impact on the Company’s results of operations, financial position or liquidity during the three months ended September 30, 2011.
 
Majestic
 
The Company, through certain of its subsidiaries and the Insurance Commissioner of the State of California acting solely in the capacity as the statutory conservator (the “Conservator”) of Majestic Insurance Company (“Majestic”), entered into a Rehabilitation Agreement that set forth a plan for the rehabilitation of Majestic (the “Rehabilitation Plan”) by which the Company acquired the business of Majestic through a Renewal Rights and Asset Purchase Agreement (the “Purchase Agreement”), and a Loss Portfolio Transfer and Quota Share Reinsurance Agreement (the “Reinsurance Agreement”).  On July 1, 2011, the Company, through one of its subsidiaries, entered into the Reinsurance Agreement, which was effective June 1, 2011, and assumed all of Majestic’s liability for losses and loss adjustment expenses under workers’ compensation insurance policies of approximately $315,151 on a gross basis (approximately $167,000 on a net basis), without any aggregate limit, and certain contracts related to Majestic's workers' compensation business, including leases for Majestic's California office space.  In addition, the Company assumed 100% of the unearned premium reserve of approximately $25,997 on all in-force Majestic policies.  In connection with this transaction, the Company received approximately $216,000 of cash and investments, which included $26,000 for a reserve deficiency and also included the assignment of Majestic’s reinsurance recoverables of approximately $51,715.  The Reinsurance Agreement also contains a profit sharing provision whereby the Company pays Majestic up to 3% of net earned premium related to current Majestic policies that are renewed by the Company in the three year period commencing on the closing date should the loss ratio on such policies for the three year period be 65% or less.  The insurance premiums, which are included in the Company’s Small Commercial Business segment, have been recorded since the acquisition date and were approximately $13,000 and $39,000 for the three and nine months ended September 30, 2011, respectively.

The Company is in the process of completing its purchase price accounting related to the Reinsurance Agreement.  In accordance with ASC 944-805 “Business Combinations”, the Company is required to adjust to fair value Majestic’s loss and LAE reserves by taking the acquired loss reserves recorded and discounting them based on expected reserve payout patterns using a current risk-free rate of interest.  This risk free interest rate will then be adjusted based on different cash flow scenarios that use different payout and ultimate reserve assumptions deemed to be reasonably possible based upon the inherent uncertainties present in determining the amount and timing of payment of such reserves.  The difference between the acquired loss and LAE reserves and the Company’s best estimate of the fair value of such reserves at acquisition date is amortized ratably over the payout period of the acquired loss and LAE reserves.  The Company expects to complete its analysis during the three months ended December 31, 2011 and anticipates the fair value of the acquired loss and LAE reserves will be less than its nominal reserves at acquisition.  Accordingly, the amortization will be recorded as an expense on the Company’s income statement until fully amortized.

In consideration for the Company’s assumption of (i) Majestic’s losses and loss adjustment expenses under its workers’ compensation insurance policies pursuant to the Reinsurance Agreement and (ii) Majestic’s leases for its California offices, a Company subsidiary,  pursuant to the Purchase Agreement, acquired the right to offer, quote and solicit the renewals of  in-force workers’ compensation policies written by Majestic, certain assets required to conduct such business, including intellectual property and information technology, certain fixed asets, and to offer employment to Majestic’s California-based employees.

As a result of entering into the Purchase Agreement, the Company, in accordance with FASB ASC 805 “Business Combinations” recorded $3,870 of intangible assets related to distribution networks and trademarks. The distribution networks have a life of 13 years and the trademarks have a life of two years.  Additionally, the Company recorded a liability for approximately $390 related to an unfavorable lease assumed in the transaction and a liability for approximately $815 related to the above mentioned profit sharing provision.  As a result, the Company recorded a preliminary bargain purchase gain of $2,665 during the three months ended September 30, 2011 related to the Majestic purchase.  The Company is still in process of finalizing it purchase price accounting related to the remainder of the Purchase Agreement and expects to finalize it during the three months ended December 31, 2011.
 
 
24

 

ICM Re
 
In June 2011, the Company, through its subsidiary AmTrust Holdings Luxembourg Limited (formerly called AmTrust Captive Holdings Limited, “AHLL”), acquired all the issued and outstanding stock of International Crédit Mutuel Reinsurance SA (“ICM Re”), a Luxembourg domiciled captive insurance company, from Assurance du Credit Mutuel IARD SA. The purchase price of ICM Re was approximately $315,000. The Company recorded approximately $347,000 of cash, intangible assets of $55,900 and a deferred tax liability of $87,800. The Company has classified the intangible assets as contractual use rights that will be amortized based on the actual use of the related equalization reserves.  ICM Re subsequently changed its name to AmTrust Re Alpha. AHLL is included in the Company’s Specialty Risk and Extended Warranty segment.
 
The ICM Re transaction allows the Company to obtain the benefit of the captive’s capital and utilization of its existing and future loss reserves through a series of reinsurance arrangements with a subsidiary of the Company.
 
Warrantech
 
In August 2010, the Company, through its wholly-owned subsidiary AMT Warranty Corp., acquired 100% of the issued and outstanding capital stock of Warrantech Corporation (“Warrantech”) from WT Acquisition Holdings, LLC for approximately $7,500 in cash and an earnout payment to the sellers of a minimum of $2,000 and a maximum and $3,000 based on AMT Warranty Corp.’s EBITDA over the three-year period from January 1, 2011 through December 31, 2013. At the time of the acquisition, the Company had a 27% equity interest (in the form of preferred units) in WT Acquisition Holdings, LLC and a $20,000 senior secured note due January 31, 2012 issued to it by Warrantech.  Interest on the note was payable monthly at a rate of 15% per annum and consisted of a cash component at 11% per annum and 4% per annum for the issuance of additional notes in principal amount equal to the interest not paid  in cash on such date. Warrantech is a developer, marketer and third party administrator of service contracts and aftermarket warranty products that largely serves the consumer products and automotive industries in the U.S. and Canada.
 
Immediately prior to the consummation of this transaction, WT Acquisition Holdings, LLC redeemed the Company’s preferred units that had represented the Company’s 27% equity interest in that entity. In addition, immediately following the transaction, AMT Warranty Corp. was recapitalized and the Company contributed its note receivable from Warrantech in the approximate amount of $24,100 to AMT Warranty Corp. in exchange for Series A preferred stock, par value $0.01 per share (the “Series A Preferred Stock”), of AMT Warranty Corp. valued at $24,100. The Company also received additional shares of Series A Preferred Stock such that the total value of its 100% preferred share ownership in AMT Warranty Corp. is equivalent to $50,700. Lastly, AMT Warranty Corp. issued 20% of its issued and outstanding common stock to the Chairman of Warrantech, which had a fair value of $6,900 as determined using both a market and an income approach. Given its preference position, absent the Company’s waiver, the Company will be paid distributions on its Series A Preferred Stock before any common shareholder would be entitled to a distribution on the common stock.
 
During the nine months ended September 30, 2011, the Company adjusted its purchase price accounting, largely to record additional deferred tax and other liabilities.  As a result, the ultimate acquisition price of Warrantech was adjusted to $78,586 and the Company has recorded goodwill and intangible assets of approximately $84,284 and $29,600, respectively. Acquisition related costs related to the deal were less than $100. The intangible assets consisted of trademarks, agency relationships and non-compete agreements, which had estimated lives of between 3 and 18 years. The Company recognizes the revenue from Warrantech as a component of service and fee income, which was approximately $14,130 and $38,772 for the three and nine months ended September 30, 2011, respectively, and includes the results of operations in its Specialty Risk and Extended Warranty segment.
 
 
13.
Investment in Life Settlements
 
During the third quarter of 2010, the Company formed Tiger Capital LLC (“Tiger”) with a subsidiary of ACAC for the purposes of acquiring certain life settlement contracts. A life settlement contract is a contract between the policy owner of a life insurance policy and a third-party investor who obtains the ownership and beneficiary rights of the underlying life insurance policy. Tiger also acquired premium finance loans made in connection with the borrower’s purchase of a life insurance policy that are secured by the policy. The premium finance loans are in default and Tiger is in the process of acquiring the underlying policies through the borrower’s agreement to surrender the policy in satisfaction of the loan or foreclosure. The Company and ACAC each have a fifty percent ownership interest in Tiger. Upon formation, the Company and ACAC each contributed approximately $6,000 to purchase a portfolio of life insurance policies and premium finance loans with a follow on contribution each of approximately $5,000 during the fourth quarter of 2010. Additionally, during the nine months ended September 30, 2011 each party contributed approximately $19,000 to Tiger.  A third party serves as the administrator of the life settlement contract portfolio, for which it receives an annual fee.  Under the terms of the agreement, the third party administrator is eligible to receive a percentage of profits after certain time and performance thresholds have been met.

 
25

 
 
During 2011, the Company formed AMT Capital Alpha, LLC (formerly called AMT Capital Holdings, LLC, “AMT Alpha”) with a subsidiary of ACAC for the purposes of acquiring additional life settlement contracts. The Company and ACAC each have a fifty percent ownership interest in AMT Alpha.  During 2011, each party contributed approximately $1,000 to AMT Alpha.
 
The Company provides for certain actuarial and finance functions related to Tiger and AMT Alpha.  Additionally, in conjunction with the Company’s 21.25% ownership percentage of ACAC, the Company ultimately receives 60.6% of the profits and losses of Tiger and AMT Alpha.  As such, in accordance with ASC 810-10, Consolidation, the Company has been deemed the primary beneficiary and, therefore, consolidates both entities.
 
During the three and nine months ended September 30, 2011, Tiger and AMT Alpha acquired certain life insurance policies for approximately $4,568 and $28,211 respectively.  Additionally the Company converted $1,730 and $6,621 of premium finance loans to life insurance policies for the three and nine months ended September 30, 2011 respectively. The Company accounts for investments in life settlements in accordance with ASC 325-30, Investments in Insurance Contracts , which states that an investor shall elect to account for its investments in life settlement contracts by using either the investment method or the fair value method.  The election is made on an instrument-by-instrument basis and is irrevocable.  The Company has elected to account for these policies using the fair value method.  The Company determines fair value on a discounted cash flow basis of anticipated death benefits, incorporating current life expectancy assumptions, premium payments, the credit exposure to the insurance company that issued the life settlement contracts and the rate of return that a buyer would require on the contracts as no comparable market pricing is available.  The Company recorded other income for the three and nine months ended September 30, 2011 of approximately $6,882 and $48,346, respectively, related to the life insurance policies.  The Company’s investments in life settlements and cash value loans were approximately $128,001 as of September 30, 2011 and are included in Prepaid expenses and other assets on the Consolidated Balance Sheet.
 
In addition to the 223 policies disclosed in the table below, Tiger owns 53 premium finance loans, which are secured by life insurance policies and are carried at a value of $6,334. The face value amount of the related 223 life insurance policies and 53 premium finance loans is approximately $1,441,993 and $305,700, respectively. All of the premium finance loans are in default and Tiger is enforcing its rights in the collateral.  Upon the voluntary surrender of the underlying life insurance policy in satisfaction of the loan or foreclosure, Tiger will become the owner of and beneficiary under the underlying life insurance policy and will have the option to continue to make premium payments on the policies or allow the policies to lapse.  If a policyholder wishes to cure his or her default and repay the loan, Tiger will be repaid the total amount due under the premium finance loans, including all premium payments made by Tiger to maintain the policy in force since its acquisition of the loan.
 
The following table describes the Company’s investment in life settlements as of September 30, 2011:

(Amounts in thousands, except Life Settlement Contracts)
Remaining life expectancy as of September 30, 2011
 
Number of Life
Settlement
Contracts
   
Fair Value
   
Face Value
 
0-1
        $     $  
1-2
                 
2-3
    1       6,487       10,000  
3-4
    1       2,579       5,000  
4-5
    4       14,431       30,000  
Thereafter
    217       98,170       1,396,933  
Total
    223     $ 121,667     $ 1,441,933  

Premiums to be paid for each of the five succeeding fiscal years to keep the life insurance policies in force as of September 30, 2011, are as follows:

(Amounts in thousands)
(Premiums due are between October 1 and September 30)
 
Premiums Due on
Life Settlement
Contracts
   
Premiums
Due
on Premium
Finance
Loans
   
Total
 
2011
  $ 19,525     $ 2,478     $ 22,003  
2012
    23,554       3,251       26,805  
2013
    24,942       3,421       28,363  
2014
    25,794       3,777       29,571  
2015
    29,006       4,584       33,590  
Thereafter
    519,561       132,121       651,682  
Total
  $ 642,382     $ 149,632     $ 792,014  
 
26

 

 
14.
Contingent Liabilities
 
The Company’s insurance subsidiaries are named as defendants in various legal actions arising principally from claims made under insurance policies and contracts. Those actions are considered by the Company in estimating the loss and LAE reserves. The Company’s management believes the resolution of those actions should not have a material adverse effect on the Company’s financial position or results of operations.
 
As a result of its equity investment in ACAC, the Company made an initial investment in ACAC in the amount of approximately $53,000.  In addition, the Company, the Trust and Michael Karfunkel, individually, each shall be required to make its or his proportionate share of the deferred payments payable by ACAC to GMACI pursuant to the GMACI Securities Purchase Agreement (See Note 11. “Related Party Transactions”), which are payable over a period of three years from the date of the closing of the Acquisition, to the extent that ACAC is unable to otherwise provide for such payments. As of September 30, 2011, the Company’s proportionate share of such deferred payments will not exceed $15,000.

 
15.
Segments
 
The Company currently operates four business segments, Small Commercial Business; Specialty Risk and Extended Warranty; Specialty Program and Personal Lines Reinsurance. The “Corporate & Other” segment represents the activities of the holding company as well as a portion of service and fee revenue. In determining total assets (excluding cash and invested assets) by segment, the Company identifies those assets that are attributable to a particular segment such as deferred acquisition cost, reinsurance recoverable, goodwill, intangible assets and prepaid reinsurance while the remaining assets are allocated based on net written premium by segment. In determining cash and invested assets by segment, the Company matches certain identifiable liabilities such as unearned premium and loss and loss adjustment expense reserves by segment. The remaining cash and invested assets are then allocated based on net written premium by segment. Investment income and realized gains (losses) are determined by calculating an overall annual return on cash and invested assets and applying that overall return to the cash and invested assets by segment. Ceding commission revenue is allocated to each segment based on that segment’s proportionate share of the Company’s overall acquisition costs. Interest expense is allocated based on net written premium by segment. Income taxes are allocated on a pro-rata basis based on the Company’s effective tax rate. Additionally, management reviews the performance of underwriting income in assessing the performance of and making decisions regarding the allocation of resources to the segments. Underwriting income excludes, primarily, service and fee revenue, investment income and other revenues, other expenses, interest expense and income taxes. Management believes that providing this information in this manner is essential to providing Company’s shareholders with an understanding of the Company’s business and operating performance.

 
27

 

The following tables summarize the results of operations of the business segments for the three and nine months ended September 30, 2011 and 2010:

(Amounts in Thousands)
 
Small
Commercial
Business
   
Specialty Risk
and Extended
Warranty
   
Specialty
Program
   
Personal
Lines
Reinsurance
   
Corporate
and Other
   
Total
 
Three months ended September 30, 2011:
                                   
Gross written premium
  $ 145,418     $ 256,493     $ 132,621     $ 26,690     $ -     $ 561,222  
                                                 
Net written premium
    79,070       149,238       66,905       26,690       -       321,903  
Change in unearned premium
    10,807       (22,454 )     (19,958 )     (1,450 )     -       (33,055 )
Net earned premium
    89,877       126,784       46,947       25,240       -       288,848  
                                                 
Ceding commission - primarily related party
    16,312       14,928       9,492       -       -       40,732  
                                                 
Loss and loss adjustment expense
    (55,721 )     (83,102 )     (30,376 )     (16,153 )     -       (185,352 )
Acquisition costs and other underwriting expenses
    (42,074 )     (39,187 )     (23,806 )     (8,203 )     -       (113,270 )
      (97,795 )     (122,289 )     (54,182 )     (24,356 )     -       (298,622 )
                                                 
Underwriting income
    8,394       19,423       2,257       884       -       30,958  
Service and fee income
    6,347       18,413       5       -       4,050       28,815  
Investment income and realized gain (loss)
    6,590       4,956       2,997       463       -       15,006  
Other expenses
    (7,432 )     (9,857 )     (6,386 )     (370 )     -       (24,045 )
Interest expense
    (1,219 )     (1,556 )     (1,136 )     (35 )     -       (3,946 )
Foreign currency loss
    -       (4,063 )     -       -       -       (4,063 )
Gain on life settlement contracts
    2,096       1,705       3,358       (337 )     -       6,822  
Bargain purchase on Majestic transaction
    2,665       -       -       -       -       2,665  
Provision for income taxes
    (4,205 )     (7,344 )     (488 )     (188 )     (957 )     (13,182 )
Equity in earnings (loss) of unconsolidated subsidiaries  – related party
    -       -       -       -       (447 )     (447 )
Non-controlling interest
    (1,072 )     (888 )     (1,693 )     166       -       (3,487 )
Net income attributable to AmTrust Financial Services, Inc.
  $ 12,164     $ 20,789     $ (1,086 )   $ 583     $ 2,646     $ 35,096  

 
28

 

(Amounts in Thousands)
 
Small
Commercial
Business
   
Specialty Risk
and Extended
Warranty
   
Specialty
Program
   
Personal
Lines
Reinsurance
   
Corporate
and Other
   
Total
 
Three months ended September 30, 2010:
                                   
Gross written premium
  $ 107,838     $ 146,155     $ 60,568     $ 24,523     $     $ 339,084  
                                                 
Net written premium
    56,386       78,377       23,551       24,523             182,837  
Change in unearned premium
    8,029       2,524       3,828       (6,333 )           8,048  
Net earned premium
    64,415       80,901       27,379       18,190             190,885  
                                                 
Ceding commission - primarily related party
    16,400       14,578       6,925                   37,903  
                                                 
Loss and loss adjustment expense
    (39,245 )     (50,584 )     (19,235 )     (11,368 )           (120,432 )
Acquisition costs and other underwriting expenses
    (32,899 )     (29,482 )     (13,860 )     (5,911 )           (82,152 )
      (72,144 )     (80,066 )     (33,095 )     (17,279 )           (202,584 )
                                                 
Underwriting income
    8,671       15,413       1,209       911             26,204  
Service and fee income
    9,124       9,971                   3,323       22,418  
Investment income and realized gain (loss)
    7,390       6,356       3,645       1,021             18,412  
Other expenses
    (6,515 )     (8,456 )     (3,781 )     (1,458 )           (20,210 )
Interest expense
    (1,083 )     (1,417 )     (628 )     (282 )           (3,410 )
Foreign currency loss
          (141 )                       (141 )
Gain on life settlement contracts
    3,857       4,983       2,241       774             11,855  
Provision for income taxes
    (5,463 )     (6,813 )     (565 )     (280 )     (814 )     (13,935 )
Equity in earnings of unconsolidated subsidiaries  – related party
                            4,030       4,030  
Non-controlling interest
    (1,928 )     (2,491 )     (1,121 )     (387 )           (5,927 )
Net income attributable to AmTrust Financial Services, Inc.
  $ 14,053     $ 17,405     $ 1,000     $ 299     $ 6,539     $ 39,296  
 
 
29

 

(Amounts in Thousands)
 
Small
Commercial
Business
   
Specialty Risk
and Extended
Warranty
   
Specialty
Program
   
Personal
Lines
Reinsurance
   
Corporate
and Other
   
Total
 
Nine months ended September  30, 2011:
                                   
Gross written premium
  $ 460,741     $ 749,743     $ 275,951     $ 77,276     $ -     $ 1,563,711  
                                                 
Net written premium
    269,942       438,963       145,422       77,276       -       931,603  
Change in unearned premium
    (44,170 )     (117,971 )     (27,567 )     (4,427 )     -       (194,135 )
Net earned premium
    225,772       320,992       117,855       72,849       -       737,468  
                                                 
Ceding commission - primarily related party
    48,207       41,614       22,009       -       -       111,830  
                                                 
Loss and loss adjustment expense
    (142,411 )     (216,579 )     (78,443 )     (46,623 )     -       (484,056 )
Acquisition costs and other underwriting expenses
    (108,483 )     (97,493 )     (54,432 )     (23,676 )     -       (284,084 )
      (250,894 )     (314,072 )     (132,875 )     (70,299 )     -       (768,140 )
                                                 
Underwriting income
    23,085       48,534       6,989       2,550       -       81,158  
Service and fee income
    16,765       49,823       10       -       11,948       78,546  
Investment income and realized gain (loss)
    19,399       14,962       7,502       1,533       -       43,396  
Other expenses
    (19,457 )     (29,366 )     (11,549 )     (2,433 )     -       (62,805 )
Interest expense
    (3,728 )     (5,627 )     (2,213 )     (466 )     -       (12,034 )
Foreign currency loss
    -       (1,827 )     -       -       -       (1,827 )
Gain on life settlement contracts
    14,978       22,605       8,890       1,873       -       48,346  
Bargain purchase on Majestic transaction
    2,665       -       -       -       -       2,665  
Provision for income taxes
    (8,932 )     (16,480 )     (1,601 )     (508 )     (1,987 )     (29,508 )
Equity in earnings of unconsolidated investment – related party
                                    6,753       6,753  
Non-controlling interest
    (7,513 )     (11,338 )     (4,459 )     (939 )     -       (24,249 )
Net income attributable to AmTrust Financial Services, Inc.
  $ 37,262     $ 71,286     $ 3,569     $ 1,610     $ 16,714     $ 130,441  

 
30

 

(Amounts in Thousands)
 
Small
Commercial
Business
   
Specialty Risk
and Extended
Warranty
   
Specialty
Program
   
Personal
Lines
Reinsurance
   
Corporate
and Other
   
Total
 
Nine months ended September 30, 2010:
                                   
Gross written premium
  $ 338,140     $ 495,799     $ 192,935     $ 59,083     $     $ 1,085,957  
                                                 
Net written premium
    173,875       238,642       97,044       59,083             568,644  
Change in unearned premium
    15,404       (19,390 )     2,128       (31,540 )           (33,398 )
Net earned premium
    189,279       219,252       99,172       27,543             535,246  
                                                 
Ceding commission - primarily related party
    50,580       35,408       17,121                   103,109  
                                                 
Loss and loss adjustment expense
    (113,680 )     (135,808 )     (65,061 )     (17,214 )           (331,763 )
Acquisition costs and other underwriting expenses
    (97,621 )     (73,531 )     (42,974 )     (8,951 )           (223,077 )
      (211,301 )     (209,339 )     (108,035 )     (26,165 )           (554,840 )
                                                 
Underwriting income
    28,558       45,321       8,258       1,378             83,515  
                                                 
Service and fee income
    14,676       15,958                   8,871       39,505  
Investment income and realized gain (loss)
    17,142       14,223       8,747       1,826             41,938  
Other expenses
    (11,640 )     (15,039 )     (6,764 )     (2,337 )           (35,780 )
Interest expense
    (3,268 )     (4,222 )     (1,899 )     (656 )           (10,045 )
Foreign currency loss
          (103 )                       (103 )
Gain on life settlement contracts
    3,857       4,983       2,241       774             11,855  
Provision for income taxes
    (14,298 )     (17,718 )     (3,068 )     (286 )     (2,572 )     (37,942 )
Equity in earnings of unconsolidated investment – related party
                            21,803       21,803  
Non-controlling interest
    (1,928 )     (2,491 )     (1,121 )     (387 )           (5,927 )
Net income attributable to AmTrust Financial Services, Inc.
  $ 33,099     $ 40,912     $ 6,394     $ 312     $ 28,102     $ 108,819  

The following tables summarize long lived assets and total assets of the business segments as of September 30, 2011 and December 31, 2010:

(Amounts in Thousands)
 
Small
Commercial
Business
   
Specialty Risk
and Extended
Warranty
   
Specialty
Program
   
Personal
Lines
Reinsurance
   
Corporate
and   other
   
Total
 
As of September  30, 2011:
                                   
Fixed assets
  $ 17,681     $ 26,685     $ 10,494     $ 2,211     $     $ 57,071  
Goodwill and intangible assets
    118,363       159,676       14,691       -             292,730  
Total assets
    2,131,828       2,286,620       868,081       132,820             5,419,349  
                                                 
As of December 31, 2010:
                                               
Fixed assets
  $ 9,839     $ 13,386     $ 5,694     $ 1,970     $     $ 30,889  
Goodwill and intangible assets
    87,001       95,737       15,088                   197,826  
Total assets
    1,581,946       1,716,980       741,835       141,692             4,182,453  
    
 
31

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
 
The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our condensed consolidated financial statements and related notes included elsewhere in this Form 10-Q.

Note on Forward-Looking Statements
 
This Form 10-Q contains certain forward-looking statements that are intended to be covered by the safe harbors created by The Private Securities Litigation Reform Act of 1995. When we use words such as “anticipate,” “intend,” “plan,” “believe,” “estimate,” “expect,” or similar expressions, we do so to identify forward-looking statements. Examples of forward-looking statements include the plans and objectives of management for future operations, including those relating to future growth of our business activities and availability of funds, and are based on current expectations that involve assumptions that are difficult or impossible to predict accurately and many of which are beyond our control. There can be no assurance that actual developments will be those anticipated by us. Actual results may differ materially from those expressed or implied in these statements as a result of significant risks and uncertainties, including, but not limited to, non-receipt of expected payments from insureds or reinsurers, changes in interest rates, a downgrade in the financial strength ratings of our insurance subsidiaries, the effect of the performance of financial markets on our investment portfolio, development of claims and the effect on loss reserves, accuracy in projecting loss reserves, the cost and availability of reinsurance coverage, the effects of emerging claim and coverage issues, changes in the demand for our products, successful integration of acquired businesses, the effect of general economic conditions, adverse state and federal legislation, regulations and regulatory investigations into industry practices, risks associated with conducting business outside the United States, developments relating to existing agreements, disruptions to our business relationships with Maiden Holdings, Ltd., American Capital Acquisition Corporation, or third party agencies and warranty administrators, difficulties with technology, heightened competition, changes in pricing environments, and changes in asset valuations. Additional information about these risks and uncertainties, as well as others that may cause actual results to differ materially from those projected, is contained in our filings with the SEC, including our Annual Report on Form 10-K for the year ended December 31, 2010, and our quarterly reports on Form 10-Q. The projections and statements in this report speak only as of the date of this report and we undertake no obligation to update or revise an forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law.

Overview

We are a multinational specialty property and casualty insurer focused on generating consistent underwriting profits. We provide insurance coverage for small businesses and products with high volumes of insureds and loss profiles that we believe are predictable. We target lines of insurance that we believe generally are underserved by the market. We have grown by hiring teams of underwriters with expertise in our specialty lines and acquiring companies and assets that, in each case, provide access to distribution networks and renewal rights to established books of specialty insurance business. We have operations in four business segments:

 
·
Small Commercial Business.  We provide workers’ compensation, commercial package and other commercial insurance lines produced by wholesale agents, retail agents and brokers in the United States.

 
·
Specialty Risk and Extended Warranty. We provide coverage for consumer and commercial goods and custom designed coverages, such as accidental damage plans and payment protection plans offered in connection with the sale of consumer and commercial goods, in the United States, United Kingdom and Europe, and certain property, casualty and specialty liability risks in the United States and Europe, including general liability, employers’ liability and professional and medical liability.

 
·
Specialty Program. We write commercial insurance for homogeneous, narrowly defined classes of insureds, requiring an in-depth knowledge of the insured’s industry segment, through general and other wholesale agents.

 
·
Personal Lines Reinsurance. We reinsure 10% of the net premiums of the GMACI personal lines business, pursuant to a quota share reinsurance agreement (“Personal Lines Quota Share”) with the GMACI personal lines insurance companies.

 
32

 

We transact business primarily through eleven insurance company subsidiaries:

Company
 
A.M.
Best Rated
 
Coverage Type Offered
 
Coverage
Market
 
Domiciled
Technology Insurance Company, Inc. (“TIC”)
 
A (Excellent)
 
Small commercial, middle market property & casualty, specialty risk & extended warranty and reinsurance for GMACI
 
United States
 
New Hampshire
Rochdale Insurance Company (“RIC”)
 
A (Excellent)
 
Small commercial, middle market property & casualty and specialty risk & extended warranty
 
United States
 
New York
Wesco Insurance Company (“WIC”)
 
A (Excellent)
 
Small commercial, middle market property & casualty and specialty risk & extended warranty
 
United States
 
Delaware
Associated Industries Insurance Company, Inc. (“AIIC”)
 
A (Excellent)
 
Workers’ compensation
 
United States
 
Florida
Milwaukee Casualty Insurance Company (“MCIC”)
 
A (Excellent)
 
Small Commercial Business
 
United States
 
Wisconsin
Security National Insurance Company (“SNIC”)
 
A (Excellent)
 
Small Commercial Business
 
United States
 
Texas
AmTrust Insurance Company of Kansas, Inc. (“AICK”)
 
A (Excellent)
 
Small Commercial Business
 
United States
 
Kansas
AmTrust Lloyd’s Insurance Company (“ALIC”)
 
A (Excellent)
 
Small Commercial Business
 
United States
 
Texas
AmTrust International Underwriters Limited (“AIU”)
 
A (Excellent)
 
Specialty Risk and Extended Warranty
 
European Union
 
Ireland
AmTrust Europe, Ltd. (“AEL”)
 
A (Excellent)
 
Specialty Risk and Extended Warranty
 
European Union
 
England
AmTrust International Insurance Ltd. (“AII”)
 
A (Excellent)
 
Reinsurance for consolidated subsidiaries
 
United States and European Union
 
Bermuda
 
Insurance, particularly workers’ compensation, is generally affected by seasonality. The first quarter generally produces greater premiums than subsequent quarters. Nevertheless, the impact of seasonality on our Small Commercial Business and Specialty Program segments has not been significant. We believe that this is because we serve many small businesses in different geographic locations. In addition, we believe seasonality is muted by our acquisition activity.
 
We evaluate our operations by monitoring key measures of growth and profitability. We measure our growth by examining our net income, return on average equity, and our loss, expense and combined ratios. The following summary provides further explanation of the key measures that we use to evaluate our results:
 
Gross Written Premium. Gross written premium represents estimated premiums from each insurance policy that we write during a reporting period based on the effective date of the individual policy. Certain policies that we underwrite are subject to premium audit at that policy’s cancellation or expiration. The final actual gross premiums written may vary from the original estimate based on changes to the final rating parameters or classifications of the policy.
 
Net Written Premium. Net written premium is gross written premium less that portion of premium that is ceded to third party reinsurers under reinsurance agreements. The amount ceded under these reinsurance agreements is based on a contractual formula contained in the individual reinsurance agreements.

 
33

 
 
Net Earned Premium. Net earned premium is the earned portion of our net written premiums. We earn insurance premiums on a pro-rata basis over the term of the policy. At the end of each reporting period, premiums written that are not earned are classified as unearned premiums and are earned in subsequent periods over the remaining term of the policy. Our workers’ compensation insurance and commercial package policies typically have a term of one year. Thus, for a one-year policy written on July 1, 2011 for an employer with a constant payroll during the term of the policy, we would earn half of the premiums in 2011 and the other half in 2012. We earn our specialty risk and extended warranty coverages over the estimated exposure time period. The terms vary depending on the risk and have an average duration of approximately 25 months, but range in duration from one month to 120 months.
 
Ceding Commission Revenues.   Ceding commission is a commission we receive from ceding gross written premium to third-party reinsurers. In connection with the Maiden Quota Share, which is our primary source of ceding commission, effective April 1, 2011 we receive a ceding commission of 30% or 34.375%, based on the business ceded.  Prior to April 1, 2011, we received a ceding commission of 31% or 34.375%, based on the business ceded. We allocate earned ceding commissions to our segments based on each segment's direct share of total acquisition costs and other underwriting expenses recognized during the period as well as the indirect share of the above expenses based on the proportionate share of earned premium recognized during the period.
 
Service and Fee Income.   We currently generate service and fee income from the following sources:

 
Product warranty registration and service — Our Specialty Risk and Extended Warranty business generates fee revenue for product warranty registration and claims handling services provided to unaffiliated third parties.

 
Servicing carrier — We act as a servicing carrier for the Alabama, Arkansas, Illinois, Indiana, Georgia and Kansas workers’ compensation assigned risk plans. In addition, we also offer claims adjusting and loss control services for fees to unaffiliated third parties.

 
Management services — We provide services to insurance consumers, traditional insurers and insurance producers by offering flexible and cost effective alternatives to traditional insurance tools in the form of various risk retention groups and captive management companies, as well as management of workers’ compensation and commercial property programs.

 
Installment and reinstatement fees — We recognize fee income associated with the issuance of workers’ compensation policies for which premium is payable in installments, in jurisdictions where it is permitted and approved, and reinstatement fees, which are fees charged to reinstate a policy after it has been cancelled for non-payment, in jurisdictions where it is permitted and approved.

 
Broker services — We provide brokerage services to Maiden in connection with our reinsurance agreements for which we receive a fee.

 
Asset management services — We currently manage the investment portfolios of Maiden and ACAC for which we receive a management fee.

 
Information technology services — We provide information technology services to ACAC and its affiliates for a fee.
 
Loss and Loss Adjustment Expenses Incurred.   Loss and loss adjustment expenses (“LAE”) incurred represent our largest expense item and, for any given reporting period, include estimates of future claim payments, changes in those estimates from prior reporting periods and costs associated with investigating, defending and servicing claims. These expenses fluctuate based on the amount and types of risks we insure. We record loss and loss adjustment expenses related to estimates of future claim payments based on case-by-case valuations and statistical analyses. We seek to establish all reserves at the most likely ultimate exposure based on our historical claims experience. It is typical for our more serious bodily injury claims to take several years to settle and we revise our estimates as we receive additional information about the condition of injured employees and claimants and the costs of their medical treatment. Our ability to estimate loss and loss adjustment expenses accurately at the time of pricing our insurance policies is a critical factor in our profitability.

 
34

 
 
Acquisition Costs and Other Underwriting Expenses.   Acquisition costs and other underwriting expenses consist of policy acquisition expenses, salaries and benefits and general and administrative expenses. These items are described below:

 
Policy acquisition expenses comprise commissions directly attributable to those agents, wholesalers or brokers that produce premiums written on our behalf. In most instances, we pay commissions based on collected premium, which reduces our credit risk exposure associated with producers in case a policyholder does not pay a premium. We pay state and local taxes, licenses and fees, assessments and contributions to various state guaranty funds based on our premiums or losses in each state. Surcharges that we may be required to charge and collect from insureds in certain jurisdictions are recorded as accrued liabilities, rather than expense.
 
Salaries and benefits expenses are those salaries and benefits expenses for employees that are directly involved in the origination, issuance and maintenance of policies, claims adjustment and accounting for insurance transactions. We classify salaries and benefits associated with employees that are involved in fee generating activities as other expenses.
 
General and administrative expenses are comprised of other costs associated with our insurance activities, such as federal excise tax, postage, telephones and internet access charges, as well as legal and auditing fees and board and bureau charges.
 
Gain on Investment in Life Settlement Contracts .  The gain on investment in life settlement contracts includes both the gain on acquisition of life settlement contracts and the gain realized upon a mortality event. The gain on acquisition of life settlement contracts represents the change in fair value of the investments in life settlements as evaluated at the end of each reporting period.  We determine fair value based upon the dis counted cash flow of the ‎anticipated death benefits, incorporating a number of factors, such as current life expectancy assumptions, expected premium payment ‎obligations and increased cost assumptions, credit exposure to the insurance companies that issued the life insurance policies and the ‎rate of return that a buyer would require on the policies.   The gain realized upon a mortality event is the difference between the death benefit received and the recorded fair value of that particular policy. We allocate gain on life settlement contracts to our segments based on net written premium by segment.
 
Net Loss Ratio. The net loss ratio is a measure of the underwriting profitability of an insurance company's business. Expressed as a percentage, this is the ratio of net losses and loss adjustment expense incurred to net premiums earned.
 
Net Expense Ratio. The net expense ratio is a measure of an insurance company’s operational efficiency in administering its business. Expressed as a percentage, this is the ratio of the sum of acquisition costs and other underwriting expenses less ceding commission revenue to net premiums earned. As we allocate certain acquisition costs and other underwriting expenses based on premium volume to our segments, net loss ratio on a segment basis may be impacted period over period by a shift in the mix of net written premium.
 
Net Combined Ratio. The net combined ratio is a measure of an insurance company's overall underwriting profit. This is the sum of the net loss and net expense ratios. If the net combined ratio is at or above 100%, an insurance company cannot be profitable without investment income, and may not be profitable if investment income is insufficient.
 
Net Premiums Earned less Expenses Included in Combined Ratio (Underwriting Income).   Underwriting income is a measure of an insurance company’s overall operating profitability before items such as investment income, interest expense and income taxes.
 
Net Investment Income and Realized Gains and (Losses).   We invest our statutory surplus funds and the funds supporting our insurance liabilities primarily in cash and cash equivalents, fixed maturity and equity securities. Our net investment income includes interest and dividends earned on our invested assets. We report net realized gains and losses on our investments separately from our net investment income. Net realized gains occur when we sell our investment securities for more than their costs or amortized costs, as applicable. Net realized losses occur when we sell our investment securities for less than their costs or amortized costs, as applicable, or we write down the investment securities as a result of other-than-temporary impairment. We classify equity securities and our fixed maturity securities as available-for-sale. We report net unrealized gains (losses) on those securities classified as available-for-sale separately within accumulated other comprehensive income on our balance sheet.
 
Return on Equity. We calculate return on equity by dividing net income by the average of shareholders’ equity.
 
One of the key financial measures that we use to evaluate our operating performance is return on average equity. Our return on annualized average equity was 16.9% and 23.3% for the three months ended September 30, 2011 and 2010, respectively and 22.4% and 21.7% for the nine months ended September 30, 2011 and 2010, respectively. In addition, we target a net combined ratio of 95.0% or lower over the long term, while seeking to maintain optimal operating leverage in our insurance subsidiaries commensurate with our A.M. Best rating objectives. Our net combined ratio was 89.3% and 86.3% for the three months ended September 30, 2011 and 2010, respectively and 89.0% and 84.4% for the nine months ended September 30, 2011 and 2010, respectively.

 
35

 
 
Critical Accounting Policies
 
Our discussion and analysis of our results of operations, financial condition and liquidity are based upon our consolidated financial statements, which have been prepared in accordance with U.S. generally accepted accounting principles. The preparation of these financial statements requires us to make estimates and judgments that affect the amounts of assets and liabilities, revenues and expenses and disclosure of contingent assets and liabilities as of the date of the financial statements. As more information becomes known, these estimates and assumptions could change, which would have an impact on actual results that may differ materially from these estimates and judgments under different assumptions. We have not made any changes in estimates or judgments that have had a significant effect on the reported amounts as previously disclosed in our Annual Report on Form 10-K for the fiscal period ended December 31, 2010.
 
Life Settlement profit commission
 
Investments in life settlements are accounted for in accordance with ASC 325-30, Investments in Insurance Contracts , and we have elected to account for our investment in life settlements using the fair value method.  We retain a third party service provider to perform certain administration functions to effectively manage these life settlement contracts and a portion of their fee is contingent on the overall profitability of the life settlement contracts.  We accrue the related profit commission on life settlements at fair value, in relation to life settlements purchased prior to December 31, 2010. This profit commission is calculated based on the discounted anticipated cash flows and the provisions of the underlying contract.  In addition, we accrue a best estimate in relation to profit commission due on the life settlement contracts acquired subsequent to December 31, 2010 as no contractual relationship currently exists.
 
Material Transactions
 
The following section is a summary of material transactions that occurred during the three and nine month periods ended September 30, 2011:
 
Majestic
 
We, through certain of our subsidiaries and the Insurance Commissioner of the State of California acting solely in the capacity as the statutory conservator (the “Conservator”) of Majestic Insurance Company (“Majestic”), entered into a Rehabilitation Agreement that set forth a plan for the rehabilitation of Majestic (the “Rehabilitation Plan”) by which we acquired the business of Majestic through a Renewal Rights and Asset Purchase Agreement (the “Purchase Agreement”), and a Loss Portfolio Transfer and Quota Share Reinsurance Agreement (the “Reinsurance Agreement”). In consideration, on July 1, 2011, we entered into the Purchase Agreement with the Conservator, whereby our subsidiary, AmTrust North America, Inc. (“ANA”), acquired the right to offer, quote and solicit the renewals of in-force workers’ compensation policies written by Majestic and certain assets required by Majestic to conduct its business, including intellectual property and information technology, and furniture, fixtures and equipment.  In addition, ANA hired most of Majestic’s California-based employees.  Additionally, one of our subsidiaries entered into the Reinsurance Agreement, which was effective June 1, 2011, and assumed all of Majestic’s liability for losses and loss adjustment expenses under workers’ compensation insurance policies of approximately $315 million on a gross basis ($167 million on a net basis), without any aggregate limit, and certain contracts related to Majestic's workers' compensation business, including leases for Majestic's California office space.  In addition, we assumed 100% of the unearned premium reserve of approximately $26 million on all in-force Majestic policies.   In connection with this transaction, we received from Majestic approximately $216 million related of cash and invested assets, including assignment of Majestic’s reinsurance recoverables of approximately $52 million, equal to Majestic’s loss and loss adjustment expense reserves and unearned premium reserves as of June 1, 2011, plus an additional $26 million related to a reserve deficiency. The Reinsurance Agreement also contains a profit sharing provision whereby we pay Majestic up to 3% of net earned premium related to current Majestic policies that we renew in the three year period commencing on the closing date should the loss ratio on such policies for the three year period be 65% or less.  Majestic is included in our Small Commercial Business segment.  As a result of this transaction, we included in our Small Commercial Business segment and consolidated results of operations approximately $13 million and $31 million in gross written premium for the three and nine months ended September 30, 2011.
 
 
36

 
 
ICM Re
 
In June 2011, we, through our subsidiary AmTrust Holdings Luxembourg Limited (formerly AmTrust Captive Holdings Limited, “AHLL”), acquired all the issued and outstanding stock of International Crédit Mutuel Reinsurance SA (“ICM Re”), a Luxembourg domiciled captive insurance company, from Assurance du Credit Mutuel IARD SA. The purchase price of ICM Re was approximately $315 million. We recorded approximately $347 million of cash, $55.9 million of intangibles and $87.8 million of deferred tax liabilities. We classified the intangible assets as contractual use rights and will be amortized based on the actual use of the related equalization reserves.  ICM Re subsequently changed its name to AmTrust Re Alpha. AHLL is included in our Specialty Risk and Extended Warranty segment. The ICM Re transaction allows us to obtain the benefit of the captive’s capital and utilization of its existing and future loss reserves through a series of reinsurance arrangements with one of our subsidiaries.
 
Maiden Quota Share
 
As described in more detail in the “Reinsurance” section of our Management’s Discussion and Analysis of Financial Condition and Results of Operations, we amended the Maiden Quota Share agreement effective April 1, 2011 such that we now receive a ceding commission of 30% of ceded written premiums (instead of 31%) with respect to all covered business, except retail commercial package business, for which the ceding commission remains 34.375%.

 
37

 

Results of Operations

Consolidated Results of Operations for the Three and Nine Months Ended September 30, 2011 and 2010 (Unaudited)

   
Three Months Ended
September 30,
   
Nine Months Ended
September 30,
 
(Amounts in Thousands)
 
2011
   
2010
   
2011
   
2010
 
Gross written premium
  $ 561,222     $ 339,084     $ 1,563,711     $ 1,085,957  
                                 
Net written premium
  $ 321,903     $ 182,837     $ 931,603     $ 568,644  
Change in unearned premium
    (33,055 )     8,048       (194,135 )     (33,398 )
Net earned premium
    288,848       190,885       737,468       535,246  
Ceding commission – primarily related party
    40,732       37,903       111,830       103,109  
Service and fee income (related parties – three months $4,191; $3,323 and nine months $12,809; $8,871)
    28,815       22,418       78,546       39,505  
Net investment income
    14,456       10,952       41,815       39,237  
Net realized gain (loss) on investments
    550       7,460       1,581       2,701  
Total revenues
    373,401       269,618       971,240       719,798  
                                 
Loss and loss adjustment expense
    185,352       120,432       484,056       331,763  
Acquisition costs and other underwriting expenses
    113,270       82,152       284,084       223,077  
Other
    24,045       20,210       62,805       35,780  
Total expenses
    322,667       222,794       830,945       590,620  
Income before other income (expense), income taxes and equity in earnings of unconsolidated subsidiaries
    50,734       46,824       140,295       129,178  
                                 
Other income (expense):
                               
Foreign currency (loss) gain
    (4,063 )     (141 )     (1,827 )     (103 )
Interest expense
    (3,946 )     (3,410 )     (12,034 )     (10,045 )
Bargain purchase on Majestic transaction
    2,665             2,665        
Gain on investment in life settlement contracts
    6,822       11,855       48,346       11,855  
Total other income (expense)
    1,487       8,304       37,150       1,707  
Income before income taxes and equity in earnings of unconsolidated subsidiaries
    52,212       55,128       177,445       130,885  
                                 
Provision for income taxes
    13,182       13,935       29,508       37,942  
Income before equity earnings of unconsolidated subsidiaries and non-controlling interest
    39,030       41,193       147,937       92,943  
Equity in earnings of unconsolidated subsidiaries – related parties
    (447 )     4,030       6,753       21,803  
Net income
    38,583       45,223       154,690       114,746  
Non-controlling interest
    (3,487 )     (5,927 )     (24,249 )     (5,927 )
Net income attributable to AmTrust Financial Services, Inc.
  $ 35,096     $ 39,296     $ 130,441     $ 108,819  
                                 
Key measures:
                               
Net loss ratio
    64.2 %     63.1 %     65.6 %     62.0 %
Net expense ratio
    25.1 %     23.2 %     23.4 %     22.4 %
Net combined ratio
    89.3 %     86.3 %     89.0 %     84.4 %
                                 
Net realized loss on investments:
                               
Total other-than-temporary impairment loss
  $     $ (4,051 )   $ (345 )   $ (21,196 )
Portion of loss recognized in other comprehensive income
                       
Net impairment losses recognized in earnings
          (4,051 )     (345 )     (21,196 )
Other net realized gain on investments
    550       11,511       1,926       23,897  
Net realized investment gain (loss)
  $ 550     $ 7,460     $ 1,581     $ 2,701  
 
 
38

 

Consolidated Result of Operations for the Three Months Ended September 30, 2011 and 2010
 
Gross Written Premium. Gross written premium increased $222.1 million, or 65.5%, to $561.2 million from $339.1 million for the three months ended September 30, 2011 and 2010, respectively. The increase of $222.1 million was attributable to growth in our Small Commercial Business, Specialty Risk and Extended Warranty and Specialty Program segments.  The increase in our Small Commercial Business segment of $37.6 million resulted primarily from increases in policy counts, the full quarter impact of the Majestic acquisition and new product offerings. The increase in Specialty Risk and Extended Warranty business of $110.3 million resulted primarily from growth in new programs in the U.S. and Europe, as well as our European medical liability business.  The majority of the increase in our Specialty Program segment of $72.0 million resulted from new program additions in 2011.
 
Net Written Premium . Net written premium increased $139.1 million, or 76.1%, to $321.9 million from $182.8 million for the three months ended September 30, 2011 and 2010, respectively. The increase by segment was: Small Commercial Business - $22.7 million, Specialty Risk and Extended Warranty - $70.9 million, Specialty Program – $43.3 million and Personal Lines – $2.2 million. Net written premium increased for the three months ended September 30, 2011 compared to the same period in 2010 due to the increase in gross written premium in 2011 compared to 2010.
 
Net Earned Premium. Net earned premium increased $97.9 million, or 51.3%, to $288.8 million from $190.9 million for the three months ended September 30, 2011 and 2010. The increase by segment was: Small Commercial Business — $25.5 million, Specialty Risk and Extended Warranty — $45.9 million, Specialty Program — $19.5 million, and Personal Lines — $7.0 million.
 
Ceding Commission . Ceding commission represents commission earned primarily through the Maiden Quota Share, whereby AmTrust receives a 30% or 34.375% ceding commission, depending on the business ceded, on ceded written premiums to Maiden.  The ceding commission earned during the three months ended September 30, 2011 and 2010 was $40.7 million and $37.9 million, respectively. Ceding commission increased period over period as a result of increased premium writings.  Additionally, we ceded our European medical liability business to Maiden during the third quarter of 2011 for which we received a five percent commission.  In 2010, this business was ceded to another reinsurer.
 
Service and Fee Income. Service and fee income increased $6.4 million, or 28.5%, to $28.8 million from $22.4 million for the three months ended September 30, 2011 and 2010, respectively.  The increase was attributable primarily to fees of approximately $7 million generated by Warrantech, which was acquired in the third quarter of 2010.
 
Net Investment Income. Net investment income increased $3.5 million, or 31.8%, to $14.5 million from $11.0 million for the three months ended September 30, 2011 and 2010, respectively.  Investment income increased primarily from an increase in the average invested assets during the three months ended September 30, 2011, which included the cash and investments acquired in the Majestic transaction, compared to the equivalent period in the prior year.
 
Net Realized Gain (Losses) on Investments. Net realized gains on investments were $0.6 million, compared to net realized gains of $7.5 million for the three months ended September 30, 2011 and 2010, respectively.  The decrease related primarily to a decline in overall trading activity as our equity portfolio now represents less than two percent of our overall investment portfolio.
 
Loss and Loss Adjustment Expenses; Loss Ratio.   Loss and loss adjustment expenses increased $65.0 million, or 54.0%, to $185.4 million from $120.4 million for the three months ended September 30, 2011 and 2010, respectively.  Our loss ratio for the three months ended September 30, 2011 and 2010 was 64.2% and 63.1%, respectively.  The increase in the loss ratio in 2011 resulted from higher current accident year selected ultimate losses as compared to selected ultimate losses from the prior accident years.
 
Acquisition Costs and Other Underwriting Expenses.   Acquisition costs and other underwriting expenses increased $31.1 million, or 37.8%, to $113.3 million from $82.2 million for the three months ended September 30, 2011 and 2010, respectively.  The expense ratio for the same periods increased to 25.1% from 23.2%, respectively, and impacted all segments.  The increase resulted from the amendment to the Maiden Quota Share, effective April 1, 2011, which lowered the ceding commission.
 
Income Before Other Income (Expense), Income Taxes and Equity Earnings of Unconsolidated Subsidiaries . Income before other income (expense), income taxes and equity earnings of unconsolidated subsidiaries increased $3.9 million, or 8.3%, to $50.7 million from $46.8 million for the three months ended September 30, 2011 and 2010, respectively.  The increase from 2010 to 2011 resulted primarily from higher net earned premium and increased service and fee income offset, partially, by higher loss and loss adjustment expenses and other insurance general and administrative expense.
 
Interest Expense. Interest expense for the three months ended September 30, 2011 was $3.9 million, compared to $3.4 million for the same period in 2010.  The increase was attributable to interest expense related to the revolving credit facility we entered into during January 2011 and a secured loan agreement we entered into in February 2011 that had higher outstanding balances than our previous debt facilities in the comparative periods in 2010.

 
39

 
 
Bargain Purchase on Majestic transaction.  We recorded a gain of $2.7 million in 2011 related to the acquisition of Majestic’s workers’ compensation renewal rights entered into in July 2011.
 
Gain on Investment in Life Settlement Contracts.   Gain on investment in life settlement contracts decreased $5.1 million, or 42.9%, to $6.8 million from $11.9 million for the three months ended September 30, 2011 and 2010, respectively.  The 2011 amount consisted of a $7.1 million gain realized upon a mortality event and a $0.3 million loss on acquisition of life settlement contracts.  The 2010 amount related entirely to gain on acquisition of life settlement contracts.  The life settlement contracts were acquired by Tiger Capital, LLC, and AMT Alpha, a company we formed in 2011 with ACAC.
 
Income Tax Expense. Income tax expense for the three months ended September 30, 2011 was $13.2 million, which resulted in an effective tax rate of 27.3%. Income tax expense for the three months ended September 30, 2010 was $13.9 million, which resulted in an effective tax rate of 26.2%.  The increase in our effective rate for the three months ended September 30, 2011 resulted primarily from earning a higher percentage of pretax income in countries of domicile with higher effective rates.
 
Equity in Earnings (Loss) of Unconsolidated Subsidiaries - Related Party . Equity in earnings (loss) of unconsolidated subsidiaries - related parties decreased by $4.4 million for the three months ended September 30, 2011 to a loss of $0.4 million compared to earnings of $4.0 million for the three months ended September 30, 2010.  The decrease related to lower equity earnings from ACAC in 2011 as well as a downward adjustment to ACAC’s purchase price gain from its 2010 acquisition of GMACI’s consumer property and casualty business for which our proportionate share was $3.6 million.

Consolidated Result of Operations for the Nine Months Ended September 30, 2011 and 2010
 
Gross Written Premium. Gross written premium increased $477.8 million, or 44%, to $1,563.7 million from $1,086.0 million for the nine months ended September 30, 2011 and 2010, respectively. The increase of $477.8 million was attributable to growth in our Small Commercial Business, Specialty Risk and Extended Warranty and Specialty Program segments.  Gross written premium increased in our Small Commercial Business segment by $122.6 million, resulting primarily from increases in policy counts, new product offerings and the Majestic acquisition. The increase in Specialty Risk and Extended Warranty business of $253.9 million resulted primarily from growth in new programs in the U.S. and Europe, as well as our European medical liability business.  Additionally, the increase in our Specialty Program segment of $83.1 million was largely the result of new program additions.  We also benefited from participating in the Personal Lines Quota share with the GMACI Insurers for all nine months in 2011 compared to four months in 2010, which resulted in an additional $18.2 million of assumed gross written premium.
 
Net Written Premium . Net written premium increased $363.0 million, or 63.8%, to $931.6 million from $568.6 million for the nine months ended September 30, 2011 and 2010, respectively. The increase (decrease) by segment was: Small Commercial Business - $96.0 million, Specialty Risk and Extended Warranty - $200.4 million, Specialty Program – $48.4 million and Personal Lines - $18.2 million. Net written premium increased for the nine months ended September 30, 2011 compared to the same period in 2010 due to the increase in gross written premium in 2011 compared to 2010.
 
Net Earned Premium. Net earned premium increased $202.3 million, or 37.8%, to $737.5 million from $535.2 million for the nine months ended September 30, 2011 and 2010. The increase by segment was: Small Commercial Business — $36.5 million, Specialty Risk and Extended Warranty — $101.7 million, Specialty Program — $18.7 million, and Personal Lines — $45.4 million.
 
Ceding Commission . Ceding commission represents commission earned primarily through the Maiden Quota Share, whereby AmTrust receives a 30% or 34.375% ceding commission, depending on the business ceded, on ceded written premiums to Maiden.  The ceding commission earned during the nine months ended September 30, 2011 and 2010 was $111.8 million and $103.1 million, respectively.  Ceding commission increased period over period as a result of increased premium writings.  Additionally, effective April 1, 2011, we began ceding our European medical liability business to Maiden and receiving a five percent commission.  Prior to April 1, 2011, this business was ceded to another reinsurer.
 
Service and Fee Income. Service and fee income increased $39.0 million, or 98.8%, to $78.5 million from $39.5 million for the nine months ended September 30, 2011 and 2010, respectively.  The increase was attributable primarily to incremental fees of approximately $32.0 million generated by Warrantech, which was acquired during the third quarter of 2010 as well as an increase of $2.4 million in fees derived by services we provide to ACAC and Maiden.
 
Net Investment Income. Net investment income increased $2.6 million, or 6.6%, to $41.8 million from $39.2 million for the nine months ended September 30, 2011 and 2010, respectively.  In the nine months ended September 30, 2010, investment income benefited from the inclusion of $2.6 million of interest income related to a note receivable due from Warrantech before it was acquired during the third quarter of 2010.  Absent this item, investment income increased $5.2 million as a result of a higher amount of invested assets period over period, which included the cash and investments acquired in the Majestic transaction.

 
40

 
 
Net Realized Gain (Losses) on Investments . Net realized gains on investments were $1.6 million, compared to net realized gains of $2.7 million for the nine months ended September 30, 2011 and 2010, respectively.  The decrease in realized gains related to the decline in our equity portfolio in 2011 to approximately two percent of our total investment portfolio, thereby causing a decline in our trading activity on our equity portfolio.
 
Loss and Loss Adjustment Expenses; Loss Ratio.   Loss and loss adjustment expenses increased $152.3 million, or 45.9%, to $484.1 million from $331.8 million for the nine months ended September 30, 2011 and 2010, respectively.  Our loss ratio for the nine months ended September 30, 2011 and 2010 was 65.6% and 62.0%, respectively.  The increase in the loss ratio in 2011 resulted from higher current year accident selected ultimate losses as compared to selected ultimate losses from the prior year, and was also impacted by U.S. storms in the nine months ended September 30, 2011 that contributed an additional 1.0% to the loss ratio.
 
Acquisition Costs and Other Underwriting Expenses.   Acquisition costs and other underwriting expenses increased $61.0 million, or 27.3%, to $284.1 million from $223.1 million for the nine months ended September 30, 2011 and 2010, respectively.  The expense ratio for the same periods increased to 23.4% from 22.4%, respectively. The reduction in the Maiden ceding commission percentage was the largest contributor to the increase in the expense ratio during the nine months ended September 30, 2011.
 
Income Before Other Income (Expense), Income Taxes and Equity Earnings of Unconsolidated Subsidiaries . Income before other income (expense), income taxes and equity earnings of unconsolidated subsidiaries increased $11.1 million, or 8.6%, to $140.3 million from $129.2 million for the nine months ended September 30, 2011 and 2010, respectively.  The increase from 2010 to 2011 resulted primarily from higher net earned premium and increased service and fee income offset, partially, by higher loss and loss adjustment expenses and other insurance general and administrative expense.
 
Interest Expense. Interest expense for the nine months ended September 30, 2011 was $12.0 million, compared to $10.0 million for the same period in 2010.  The increase was attributable to higher outstanding debt balances on the revolving credit facility we entered into during January 2011 and the secured loan agreement we entered into in February 2011 compared to outstanding debt balances on our now terminated $40 million term loan and $30 million promissory note during the comparative 2010 period.
 
Bargain Purchase on Majestic transaction.  We recorded a gain of $2.7 million in 2011 related to the acquisition of Majestic’s workers’ compensation renewal rights in July 2011.
 
Gain on Investment in Life Settlement Contracts.    Gain on investment in life settlement contracts increased $36.4 million, or 308%, to $48.3 million from $11.9 million for the nine months ended September 30, 2011 and 2010, respectively, and resulted from the gain realized upon a mortality event and the acquisition of a higher number of life settlement contracts that were purchased by or surrendered to us in satisfaction of premium finance loans during the nine months ended September 30, 2011 as compared to the nine months ended September 30, 2010.  The life settlement contracts were acquired by Tiger Capital, LLC, and AMT Alpha, a company we formed in 2011 with ACAC.
 
Income Tax Expense. Income tax expense for the nine months ended September 30, 2011 was $29.5 million, which resulted in an effective tax rate of 18.4%. Income tax expense for the nine months ended September 30, 2010 was $37.9 million, which resulted in an effective tax rate of 26.1%.  The decrease in our effective rate for the nine months ended September 30, 2011 resulted primarily from earning a higher percentage of pretax income in countries of domicile with lower effective rates.
 
Equity in Earnings of Unconsolidated Subsidiaries - Related Party . Equity in earnings of unconsolidated subsidiaries - related parties decreased by $15.0 million for the nine months ended September 30, 2011 to $6.8 million compared to $21.8 million for the nine months ended September 30, 2010.  The majority of the decrease related to the initial acquisition gain on ACAC of $10.4 million we recognized during the nine months ended September 30, 2010 that was adjusted downward during the nine months ended September 30, 2011 by $3.6 million.

 
41

 

Small Commercial Business Segment Results of Operations (Unaudited)

   
Three Months Ended
September 30,
   
Nine Months Ended
September 30,
 
(Amounts in Thousands)
 
2011
   
2010
   
2011
   
2010
 
Gross written premium
  $ 145,418     $ 107,838     $ 460,741     $ 338,140  
                                 
Net written premium
    79,070       56,386       269,942       173,875  
Change in unearned premium
    10,808       8,029       (44,170 )     15,404  
Net earned premium
    89,877       64,415       225,772       189,279  
Ceding commission – primarily related party
    16,312       16,400       48,207       50,580  
                                 
Loss and loss adjustment expense
    55,721       39,245       142,411       113,680  
Acquisition costs and other underwriting expenses
    42,074       32,899       108,483       97,621  
Total expenses
    97,795       72,144       250,894       211,301  
Underwriting income
  $ 8,394     $ 8,671     $ 23,085     $ 28,558  
                                 
Key measures:
                               
Net loss ratio
    62.0 %     60.9 %     63.1 %     60.1 %
Net expense ratio
    28.7 %     25.6 %     26.7 %     24.9 %
Net combined ratio
    90.7 %     86.5 %     89.8 %     85.0 %
                                 
Reconciliation of net expense ratio:
                               
Acquisition costs and other underwriting expenses
  $ 42,074     $ 32,899     $ 108,483     $ 97,621  
Less: ceding commission revenue – primarily related party
    16,312       16,400       48,207       50,580  
      25,762       16,499       60,276       47,041  
Net earned premium
  $ 89,879     $ 64,415     $ 225,772     $ 189,279  
Net expense ratio
    28.7 %     25.6 %     26.7 %     24.9 %

Small Commercial Business Segment Results of Operations for the Three Months Ended September 30, 2011 and 2010
 
Gross Written Premium.   Gross written premium increased $37.6 million, or 34.9%, to $145.4 million from $107.8 million for the three months ended September 30, 2011 and 2010, respectively.  The increase resulted primarily from new business associated with additional product offerings, higher overall policy counts and an increase in California workers ’ compensation production of approximately $23 million, the majority of which related to the Majestic renewal rights acquisition .
 
Net Written Premium.   Net written premium increased $22.7 million, or 40.2%, to $79.1 million from $56.4 million for the three months ended September 30, 2011 and 2010, respectively. The increase in net premium resulted from an increase in gross written premium for the three months ended September 30, 2011 compared to the three months ended September 30, 2010.
 
Net Earned Premium.   Net earned premium increased $25.5 million, or 39.6%, to $89.9 million from $64.4 million for the three months ended September 30, 2011 and 2010, respectively. As premiums written earn ratably over a twelve month period, the increase in net premium earned resulted from higher net premium written for the twelve months ended September 30, 2011 compared to the twelve months ended September 30, 2010 as well as the assumption of $26 million of unearned premium from Majestic in the second quarter of 2011, for which we earned approximately $10.7 million during the three months ended September 30, 2011.
 
Ceding Commission.   The ceding commission earned during the three months ended September 30, 2011 and 2010 was $16.3 million and $16.4 million, respectively. The ceding commission was flat period over period caused by an increase in the allocation to this segment of its proportionate share of our overall policy acquisition expense offset by a reduction in the Maiden ceding commission percentage resulting from our amended quota share agreement, which became effective April 1, 2011.
 
Loss and Loss Adjustment Expenses; Loss Ratio.   Loss and loss adjustment expenses increased $16.5 million, or 42.1%, to $55.7 million from $39.2 million for the three months ended September 30, 2011 and 2010, respectively. Our loss ratio for the segment for the three months ended September 30, 2011 increased to 62.0% from 60.9% for the three months ended September 30, 2010. The increase in the loss ratio in the three months ended September 30, 2011 resulted primarily from higher current accident year selected ultimate losses as compared to selected ultimate losses from the prior accident years.

 
42

 
 
Acquisition Costs and Other Underwriting Expenses.   Acquisition costs and other underwriting expenses increased $9.2 million, or 28.0%, to $42.1 million from $32.9 million for the three months ended September 30, 2011 and 2010, respectively. The expense ratio increased to 28.7% for the three months ended September 30, 2011 from 25.6% for the three months ended September 30, 2010.   The expense ratio increased as a result of receiving a lower Maiden ceding commission percentage on this business as a result of our amended quota share agreement, which became effective April 1, 2011, and the allocation to this segment of a higher portion of our unallocated expenses.
 
Net Earned Premiums less Expenses Included in Combined Ratio (Underwriting Income).   Net premiums earned less expenses included in combined ratio decreased to $8.4 million for the three months ended September 30, 2011 compared to $8.7 million for the three months ended September 30, 2010 due to a higher combined ratio.
 
Small Commercial Business Segment Results of Operations for the Nine Months Ended September 30, 2011 and 2010
 
Gross Written Premium . Gross written premium increased $122.6 million, or 36.3%, to $460.7 million from $338.1 million for the nine months ended September 30, 2011 and 2010, respectively. The increase resulted primarily from new business associated with additional product offerings, higher overall policy counts and $57 million of additional premium related to an increase in California ’s workers ’ compensation production, which included $31 million of additional premium as well as $26 million from t he assumption of unearned premium from Majestic.
 
Net Written Premium . Net written premium increased $96.0 million, or 55.2%, to $269.9 million from $173.9 million for the nine months ended September 30, 2011 and 2010, respectively. The increase in net premium resulted from an increase in gross written premium for the nine months ended September 30, 2011 compared to the nine months ended September 30, 2010 as well as the assumption of $26 million of unearned premium from Majestic.
 
Net Earned Premium . Net earned premium increased $36.5 million, or 19.3%, to $225.8 million from $189.3 million for the nine months ended September 30, 2011 and 2010, respectively. As premiums written earn ratably over a twelve month period, the increase in net premium earned resulted from higher net premium written for the twelve months ended September 30, 2011 compared to the twelve months ended September 30, 2010, as well as the assumption of $26 million of unearned premium from Majestic in the second quarter of 2011, for which we earned approximately $15.2 million during the nine months ended September 30, 2011.
 
Ceding Commission. The ceding commission earned during the nine months ended September 30, 2011 and 2010 was $48.2 million and $50.6 million, respectively. The decrease related to a decline in the allocation to this segment of its proportionate share of our overall policy acquisition expense and from a reduction in the Maiden ceding commission percentage resulting from our amended quota share agreement, which became effective April 1, 2011.
 
Loss and Loss Adjustment Expenses; Loss Ratio. Loss and loss adjustment expenses increased $28.7 million, or 25.2%, to $142.4 million from $113.7 million for the nine months ended September 30, 2011 and 2010, respectively. Our loss ratio for the segment for the nine months ended September 30, 2011 increased to 63.1% from 60.1% for the nine months ended September 30, 2010. The increase in the loss ratio in the nine months ended September 30, 2011 resulted primarily from higher current accident year selected ultimate losses as compared to selected ultimate losses from the prior accident years, and was also impacted by U.S. storms in the nine months ended September 30, 2011 that contributed an additional 2.8% to the loss ratio.
 
Acquisition Costs and Other Underwriting Expenses.   Acquisition costs and other underwriting expenses increased $10.9 million, or 11.2%, to $108.5 million from $97.6 million for the nine months ended September 30, 2011 and 2010, respectively. The expense ratio increased to 26.7% for the nine months ended September 30, 2011 from 24.9% for the nine months ended September 30, 2010.  The increase in the expense ratio resulted primarily from a lower allocation of Maiden ceding commission to the segment during the nine months ended September 30, 2011 compared to the same period in 2010 and an increase in premium for this segment, resulting in a higher allocation of expenses to this segment.
 
Net Earned Premiums less Expenses Included in Combined Ratio (Underwriting Income).   Net premiums earned less expenses included in combined ratio decreased $5.5 million, or 19.2%, to $23.1 million from $28.6 million for the nine months ended September 30, 2011 and 2010, respectively. This decrease resulted primarily from higher loss and loss adjustment expenses during the nine months ended September 30, 2010 as compared to the nine months ended September 30, 2011.

 
43

 

Specialty Risk and Extended Warranty Segment Results of Operations (Unaudited)

   
Three Months Ended
September 30,
   
Nine Months Ended
September 30,
 
(Amounts in Thousands)
 
2011
   
2010
   
2011
   
2010
 
Gross written premium
  $ 256,493     $ 146,155     $ 749,743     $ 495,799  
                                 
Net written premium
    149,238       78,377       438,963       238,642  
Change in unearned premium
    (22,454 )     2,524       (117,971 )     (19,390 )
Net earned premium
    126,784       80,901       320,992       219,252  
Ceding commission – primarily related party
    14,928       14,578       41,614       35,408  
                                 
Loss and loss adjustment expense
    83,102       50,584       216,579       135,808  
Acquisition costs and other underwriting expenses
    39,187       29,482       97,493       73,531  
Total expenses
    122,289       80,066       314,072       209,339  
Underwriting income
  $ 19,423     $ 15,413     $ 48,534     $ 45,321  
                                 
Key measures:
                               
Net loss ratio
    65.5 %     62.5 %     67.5 %     61.9 %
Net expense ratio
    19.1 %     18.4 %     17.4 %     17.4 %
Net combined ratio
    84.7 %     80.9 %     84.9 %     79.3 %
                                 
Reconciliation of net expense ratio:
                               
Acquisition costs and other underwriting expenses
  $ 39,187     $ 29,482     $ 97,493     $ 73,531  
Less: ceding commission revenue – primarily related party
    14,928       14,578       41,614       35,408  
      24,259       14,904       55,879       38,123  
Net earned premium
  $ 126,784     $ 80,901     $ 320,992     $ 219,252  
Net expense ratio
    19.1 %     18.4 %     17.4 %     17.4 %

Specialty Risk and Extended Warranty Segment Results of Operations for the Three Months Ended September 30, 2011 and 2010
 
Gross Written Premium . Gross written premium increased $110.3 million, or 75.4%, to $256.5 million from $146.2 million for the three months ended September 30, 2011 and 2010, respectively. The increase related primarily to growth in our existing European business from general liability, medical liability and warranty coverage and in our U.S. business from growth in our existing client base and new programs.
 
Net Written Premium . Net written premium increased $70.9 million, or 90.0%, to $149.2 million from $78.4 million for the three months ended September 30, 2011 and 2010, respectively. The increase in net written premium resulted from an increase of gross written premium for the three months ended September 30, 2011 compared to gross written premium for the three months ended September 30, 2010, as well as our entry into a reinsurance agreement with Maiden Insurance commencing in the second quarter of 2011 to cede 40% of our European medical liability business.  In 2010, we ceded 80% of this business under another reinsurance agreement.
 
Net Earned Premium . Net earned premium increased $45.9 million, or 56.7%, to $126.8 million from $80.9 million for the three months ended September 30, 2011 and 2010, respectively.  As net premiums written are earned ratably over the term of a policy, which on average is 25 months, the increase resulted from growth in net written premium between 2009 and 2011 and the changes to our reinsurance arrangements.
 
Ceding Commission.   The ceding commission earned during the three months ended September 30, 2011 and 2010 was $14.9 million and $14.6 million, respectively. The slight increase related to the allocation to this segment of its proportionate share of our overall policy acquisition expense, which was lower than in previous quarters due to the increased growth of our other business segments. Additionally, we began ceding our European medical liability business to Maiden during the second quarter of 2011 and receiving a five percent commission.  In 2010, this business was ceded to another reinsurer.
 
 
44

 
 
Loss and Loss Adjustment Expenses; Loss Ratio. Loss and loss adjustment expenses increased $32.5 million, or 64.2%, to $83.1 million from $50.6 million for the three months ended September 30, 2011 and 2010, respectively. Our loss ratio for the segment for the three months ended September 30, 2011 increased to 65.5% from 62.5% for the three months ended September 30, 2010.  The increase in the loss ratio for the three months ended September 30, 2011 resulted primarily from higher current accident year selected ultimate losses as compared to selected ultimate losses from the prior accident years, as well as a shift in business mix within the segment.
 
Acquisition Costs and Other Underwriting Expenses.   Acquisition costs and other underwriting expenses increased $9.7 million, or 32.9%, to $39.2 million from $29.5 million for the three months ended September 30, 2011 and 2010, respectively. The expense ratio increased to 19.1% for the three months ended September 30, 2011 from 18.4% for the three months ended September 30, 2010.  The increase is primarily attributable to a proportional increase in overall acquisition cost based on a change in business mix, which was partially offset by the amendment to the Maiden Quota Share, effective April 1, 2011, which lowered the ceding commission.
 
Net Earned Premiums less Expenses Included in Combined Ratio (Underwriting Income).   Net earned premiums less expenses included in combined ratio increased $4.0 million, or 26.0%, to $19.4 million from $15.4 million for the three months ended September 30, 2011 and 2010, respectively.  The increase was attributable to higher earned premium that was partially offset by a higher loss ratio.
 
Specialty Risk and Extended Warranty Segment Results of Operations for the Nine Months Ended September 30, 2011 and 2010
 
Gross Written Premium . Gross written premium increased $253.9 million, or 51.2%, to $749.7 million from $495.8 million for the nine months ended September 30, 2011 and 2010, respectively. The increase related primarily to growth in our existing European business from general liability, medical liability and warranty coverage.  Additionally, the segment benefited from the underwriting of new programs in Europe and the U.S., as well as a $19 million assumption of unearned premium from a new U.S. customer.
 
Net Written Premium . Net written premium increased $200.4 million, or 84.0%, to $439.0 million from $238.6 million for the nine months ended September 30, 2011 and 2010, respectively. The increase in net written premium resulted from an increase of gross written premium for the nine months ended September 30, 2011 compared to gross written premium for the nine months ended September 30, 2010, as well as our entry into a reinsurance agreement with Maiden Insurance to cede 40% of our European medical liability business commencing in the second quarter of 2011. In 2010, we ceded 80% of this business under another reinsurance agreement.
 
Net Earned Premium . Net earned premium increased $101.7 million, or 46.4%, to $321.0 million from $219.3 million for the nine months ended September 30, 2011 and 2010, respectively.  As net premiums written are earned ratably over the term of a policy, which on average is 25 months, the increase resulted from growth in net written premium between 2009 and 2011.  In addition, net earned premium increased as a result of our new reinsurance program for our European medical liability business.
 
Ceding Commission.   The ceding commission earned during the nine months ended September 30, 2011 and 2010 was $41.6 million and $35.4 million, respectively. The increase related to the allocation to this segment of its proportionate share of our overall policy acquisition expense, which achieved proportionately more growth than our other segments on a year-to-date basis.  Additionally, beginning on April 1, 2011, we ceded our European medical liability business to Maiden for which we received a five percent commission.  Prior to April 1, 2011, this business was ceded to another reinsurer.
 
Loss and Loss Adjustment Expenses; Loss Ratio. Loss and loss adjustment expenses increased $80.8 million, or 59.5%, to $216.6 million from $135.8 million for the nine months ended September 30, 2011 and 2010, respectively. Our loss ratio for the segment for the nine months ended September 30, 2011 increased to 67.5% from 61.9% for the nine months ended September 30, 2010.  The increase in the loss ratio for the nine months ended September 30, 2011 resulted primarily from higher current year accident selected ultimate losses as compared to selected ultimate losses from the prior year, as well as a shift in business mix within the segment.
 
Acquisition Costs and Other Underwriting Expenses.   Acquisition costs and other underwriting expenses increased $24.0 million, or 32.7%, to $97.5 million from $73.5 million for the nine months ended September 30, 2011 and 2010, respectively. The expense ratio was 17.4% for the nine months ended September 30, 2011 and 2010.  The expense ratio remained flat as an increase in acquisition costs due to a change in business mix was partially offset by a higher allocation of Maiden ceding commission to the segment during the nine months ended September 30, 2011 compared to the same period in 2010.
 
 
45

 
 
Net Earned Premiums less Expense Included in Combined Ratio (Underwriting Income).   Net earned premiums less expenses included in combined ratio increased $3.2 million, or 7.1%, to $48.5 million from $45.3 million for the nine months ended September 30, 2011 and 2010, respectively.  The slight increase was attributable to higher earned premium that was offset, primarily, by higher loss and loss adjustment expense.
 
Specialty Program Segment Results of Operations (Unaudited)

   
Three Months Ended
September 30,
   
Nine Months Ended
September 30,
 
(Amounts in Thousands)
 
2011
   
2010
   
2011
   
2010
 
Gross written premium
  $ 132,621     $ 60,568     $ 275,951     $ 192,935  
                                 
Net written premium
    66,905       23,551       145,422       97,044  
Change in unearned premium
    (19,958 )     3,828       (27,567 )     2,128  
Net earned premium
    46,947       27,379       117,855       99,172  
Ceding commission – primarily related party
    9,492       6,925       22,009       17,121  
                                 
Loss and loss adjustment expense
    30,376       19,235       78,443       65,061  
Acquisition costs and other underwriting expenses
    23,806       13,860       54,432       42,974  
Total expenses
    54,182       33,095       132,875       108,035  
Underwriting income
  $ 2,257     $ 1,209     $ 6,989     $ 8,258  
                                 
Key measures:
                               
Net loss ratio
    64.7 %     70.3 %     66.6 %     65.6 %
Net expense ratio
    30.5 %     25.3 %     27.5 %     26.1 %
Net combined ratio
    95.2 %     95.6 %     94.1 %     91.7 %
                                 
Reconciliation of net expense ratio:
                               
Acquisition costs and other underwriting expenses
  $ 23,806     $ 13,860     $ 54,432     $ 42,974  
Less: ceding commission revenue – primarily related party
    9,492       6,925       22,009       17,121  
      14,314       6,935       32,023       25,853  
Net earned premium
  $ 46,947     $ 27,379     $ 117,855     $ 99,172  
Net expense ratio
    30.5 %     25.3 %     27.5 %     26.1 %

Specialty Program Segment Results of Operations for the Three Months Ended September 30, 2011 and 2010
 
Gross Written Premium . Gross premium increased $72.0 million, or 118.8%, to $132.6 million from $60.6 million for the three months ended September 30, 2011 and 2010, respectively. The increase in gross written premium related primarily to an increase in new and existing programs of approximately $89 million, including commercial auto and general liability programs, excess and surplus lines programs and public entity programs. The increases were offset by declines in other programs as a result of our maintenance of our pricing and administrative discipline, which resulted in the termination of certain programs representing approximately $15 million, of which three programs represented approximately 88% of this decrease.  Additionally, we experienced a decrease of approximately $2 million in business we wrote on behalf of HSBC Insurance Company of Delaware pursuant to a 100% fronting arrangement we entered into in connection with our acquisition of WIC, which is now in run-off.
 
Net Written Premium .  Net premium increased $43.3 million, or 183%, to $66.9 million from $23.6 million for the three months ended September 30, 2011 and 2010, respectively. The increase in net written premium resulted from an increase in gross written premium for the three months ended September 30, 2011 compared to the three months ended September 30, 2010.
 
Net Earned Premium .  Net earned premium increased $19.6 million, or 71.2%, to $46.9 million from $27.4 million for the three months ended September 30, 2011 and 2010, respectively. As premiums written earn ratably over a twelve month period, the increase in net premium earned resulted from higher net premium written for the twelve months ended September 30, 2011 compared to the twelve months ended September 30, 2010.
 
 
46

 
 
Ceding Commission.  The ceding commission earned during the three months ended September 30, 2011 and 2010 was $9.5 million and $6.9 million, respectively.  The increase related primarily to an increase in earned premium and a shift in the mix of the programs written during the periods.  For the three months ended September 30, 2011, we wrote certain programs that have a higher percentage of policy acquisition costs to earned premium than in the three months ended September 30, 2010 and, therefore, we allocated more ceding commission to the segment. In addition, there was an increase in earned premium based on the larger allocation to this segment of its proportionate share of our indirect policy acquisition expense as compared to the year-ago quarter .
 
Loss and Loss Adjustment Expenses; Loss Ratio. Loss and loss adjustment expenses increased $11.2 million, or 58.3%, to $30.4 million from $19.2 million for the three months ended September 30, 2011 and 2010, respectively. Our loss ratio for the segment for the three months ended September 30, 2011 decreased to 64.7% from 70.3% for the three months ended September 30, 2010. The decrease in the loss ratio for the three months ended September 30, 2011 resulted primarily from the non-renewal of under-performing programs.
 
Acquisition Costs and Other Underwriting Expenses . Acquisition costs and other underwriting expenses increased $9.9 million, or 71.2%, to $23.8 million from $13.9 million for the three months ended September 30, 2011 and 2010, respectively. The expense ratio was 30.5% for the three months ended September 30, 2011 compared to 25.3% for the three months ended September 30, 2010.  The increase in the expense ratio was attributable to the allocation to this segment of a higher portion of our unallocated expenses as a result of this segment’s increase in premium for the quarter.
 
Net Earned Premiums less Expenses Included in Combined Ratio (Underwriting Income).   Net earned premiums less expenses included in combined ratio increased $1.1 million, or 91.6%, to $2.3 million from $1.2 million for the three months ended September 30, 2011 and 2010, respectively. The increase of $1.1 million resulted primarily from a lower loss ratio partially offset by an increase in the expense ratio.
 
Specialty Program Segment Results of Operations for the Nine Months Ended September 30, 2011 and 2010
 
Gross Written Premium .  Gross premium increased $83.1 million, or 43.1%, to $276.0 million from $192.9 million for the nine months ended September 30, 2011 and 2010, respectively. The increase in gross written premium related primarily to an increase in new and existing programs of approximately $136 million, including commercial auto and general liability programs, excess and surplus lines programs and public entity programs. The increases were offset by declines in other programs as a result of our maintenance of our pricing and administrative discipline, which resulted in the termination of certain programs representing approximately $50 million, of which three programs represented approximately 92% of this decrease.  Additionally, we experienced a decrease of approximately $3 million in business we wrote on behalf of HSBC Insurance Company of Delaware pursuant to a 100% fronting arrangement we entered into in connection with our acquisition of WIC, which is now in run-off.
 
Net Written Premium .  Net premium increased $48.4 million, or 49.9%, to $145.4 million from $97.0 million for the nine months ended September 30, 2011 and 2010, respectively. The increase in net written premium result from an increase in gross written premium for the nine months ended September 30, 2011 compared to the nine months ended September 30, 2010.
 
Net Earned Premium .  Net earned premium increased $18.7 million, or 18.9%, to $117.9 million from $99.2 million for the nine months ended September 30, 2011 and 2010, respectively.  As premiums written earn ratably over a twelve month period, the increase in net premium earned resulted from higher net premium written for the twelve months ended September 30, 2011 compared to the twelve months ended September 30, 2010.
 
Ceding Commission.  The ceding commission earned during the nine months ended September 30, 2011 and 2010 was $22.0 million and $17.1 million, respectively.  The increase related primarily to an increase in earned premium and a shift in the mix of the programs written during the periods.  For the nine months ended September 30, 2011, we wrote certain programs that have a higher percentage of policy acquisition costs to earned premium than in the nine months ended September 30, 2010 and, therefore, we allocated more ceding commission to the segment.  The increase was partially offset by a decline in earned premium based on the smaller allocation to this segment of its proportionate share of our indirect policy acquisition expense as compared to the nine months ended September 30, 2010.
 
Loss and Loss Adjustment Expenses; Loss Ratio. Loss and loss adjustment expenses increased $13.3 million, or 20.4%, to $78.4 million from $65.1 million for the nine months ended September 30, 2011 and 2010, respectively. Our loss ratio for the segment for the nine months ended September 30, 2011 increased to 66.6% from 65.6% for the nine months ended September 30, 2010.  Current accident year selected ultimate losses are higher than selected ultimate losses from the prior accident years, resulting in the increase in the loss ratio for the nine months ended September 30, 2011 as compared to the nine months ended September 30, 2010.
 
Acquisition Costs and Other Underwriting Expenses . Acquisition costs and other underwriting expenses increased $11.4 million, or 26.5%, to $54.4 million from $43.0 million for the nine months ended September 30, 2011 and 2010, respectively. The expense ratio was 27.5% and 26.1% for the nine months ended September 30, 2011 and 2010, respectively.   The increase in the expense ratio was attributable to the allocation to this segment of a higher portion of our unallocated expenses as a result of the segment’s increase in premium compared to the nine months ended September 30, 2010, but was partially offset by a decline in acquisition costs resulting from the assumption of certain business from an arrangement we fronted in 2010.

 
47

 
 
Net Earned Premiums less Expenses Included in Combined Ratio (Underwriting Income).   Net earned premiums less expenses included in combined ratio decreased $1.3 million, or 15.7%, to $7.0 million from $8.3 million for the nine months ended September 30, 2011 and 2010, respectively. The majority of the decrease of $1.3 million resulted from an increase in the loss ratio.

Personal Lines Reinsurance Segment Results of Operations (Unaudited)

   
Three Months Ended
September 30,
   
Nine Months Ended
September 30,
 
(Amounts in Thousands)
 
2011
   
2010
   
2011
   
2010
 
Gross written premium
  $ 26,690     $ 24,523     $ 77,276     $ 59,083  
                                 
Net written premium
    26,690       24,523       77,276       59,083  
Change in unearned premium
    (1,450 )     (6,333 )     (4,427 )     (31,540 )
Net earned premium
    25,240       18,190       72,849       27,543  
                                 
Loss and loss adjustment expense
    16,153       11,368       46,623       17,214  
Acquisition costs and other underwriting expenses
    8,203       5,911       23,676       8,951  
Total expenses
    24,356       17,279       70,299       26,165  
Underwriting income
  $ 884     $ 911     $ 2,550     $ 1,378  
                                 
Key measures:
                               
Net loss ratio
    64.0 %     62.5 %     64.0 %     62.5 %
Net expense ratio
    32.5 %     32.5 %     32.5 %     32.5 %
Net combined ratio
    96.5 %     95.0 %     96.5 %     95.0 %

Personal Lines Reinsurance Segment Results of Operations for the Three and Nine Months Ended September 30, 2011 and 2010
 
We began assuming commercial auto business from the GMACI Insurers effective March 1, 2010 pursuant to the Personal Lines Quota Share with the GMACI Insurers. We assumed $26.7 million and $24.5 million of premium from the GMACI Insurers for the three months ended September 30, 2011 and 2010, respectively and $77.3 and $59.1 million for the nine months ended September 30, 2011.  The increase in the nine month period related primarily to assuming business for the entire nine-month period in 2011 compared to seven months in 2010.  Net earned premium increased in 2011 in both periods compared to the equivalent periods in 2010 due to the earning cycle of assumed premium written in 2010.  Loss and loss adjustment expense as well as acquisition costs and other underwriting expenses increased proportionately with earned premiums.

Liquidity and Capital Resources
 
Our principal sources of operating funds are premiums, investment income and proceeds from sales and maturities of investments. Our primary uses of operating funds include payments of claims and operating expenses. Currently, we pay claims using cash flow from operations and invest our excess cash primarily in fixed maturity and equity securities. We forecast claim payments based on our historical trends. We seek to manage the funding of claim payments by actively managing available cash and forecasting cash flows on short-term and long-term bases. Cash payments for claims were $436.2 million and $302.0 million in the nine months ended September 30, 2011 and 2010, respectively. We expect cash flow from operations should be sufficient to meet our anticipated claim obligations. We further expect that projected cash flow from operations should provide us sufficient liquidity to fund our current operations and service our debt instruments and anticipated growth for at least the next twelve months. However, if our growth attributable to acquisitions, internally generated growth or a combination of both exceeds our projections, we may have to raise additional capital sooner to support our growth. If we cannot obtain adequate capital on favorable terms or at all, we may be unable to support future growth or operating requirements and, as a result, our business, financial condition and results of operations could be adversely affected.

 
48

 
 
The following table is a summary of our statement of cash flows:

   
Nine Months Ended September 30,
 
(Amounts in Thousands)
 
2011
   
2010
 
Cash and cash equivalents provided by (used in):
           
Operating activities
  $ 232,323     $ (3,666 )
Investing activities
    (151,438 )     32,432  
Financing activities
    37,326       43,682  

Net cash provided by operating activities for the nine months ended September 30, 2011 increased compared to cash provided by operating activities in the nine months ended September 30, 2010. The increase in cash flow resulted from a shift in business mix to business that has a longer average claim payment cycle and an increase in reinsurance payables, which are typically paid in arrears, thus providing us with a timing benefit on the related cash that we collected.
 
Cash used in investing activities during the nine months ended September 30, 2011 was approximately $151 million and primarily consisted of approximately $108 million for the purchase of fixed and equity securities, approximately $44 million related to acquisition of and capitalized premiums for life settlement contracts, approximately $33 million for purchases of property and equipment (which included $13 million for an aircraft and $7.5 million for an office building), partially offset by the receipt of approximately $27 million of cash related to the Majestic loss portfolio transfer and $10.5 million from the proceeds on a life settlement contract.  Cash provided by investing activities during the nine months ended September 30, 2010 was approximately $33 million and consisted primarily of net sales of fixed securities of $96 million, net sales of equity securities of $24 million offset, partially, by investments in ACAC and other subsidiaries of approximately $64 million.
 
Cash provided by financing activities for the nine months ended September 30, 2011 was approximately $37 million and consisted primarily of debt proceeds of approximately $134 million and minority interest capital contributions to two of our subsidiaries of approximately $24 million partially offset by the repayment on repurchase agreements in the amount of approximately $4 million, debt principal payments of approximately $104 million and dividend payments of approximately $14 million.  Cash provided by financing activities for the nine months ended September 30, 2010 was $44 million and consisted primarily of $66 million received from entering repurchase agreements offset, partially, by $18 million of principal payments on existing debt and $13 million of dividend payments.

Other Material Changes in Financial Position
   
September 30,
   
December 31,
 
   
2011
   
2010
 
   
(Amounts in Thousands)
 
Selected Assets:
           
Cash
  $ 320,863     $ 201,949  
Investments
    1,716,467       1,357,012  
Prepaid and other assets
    289,707       163,905  
Goodwill and intangible assets
    292,730       197,826  
Selected Liabilities:
               
Loss and loss expense reserves
  $ 1,782,953     $ 1,263,537  
Deferred income taxes
    85,106       9,883  
 
In 2011, cash increased by $119 million from December 31, 2010 as a result of increase premium writings and the loss portfolio transfer from Majestic.  Investments increased to $1.7 billion from $1.4 billion from December 31, 2010 primarily from investments received from the Majestic loss portfolio transfer.  Prepaid expenses and other assets increased $126 million from the year end December 31, 2010.  The increase related to an increase in value of our life settlement contract portfolio.  In 2011, intangible assets and goodwill increased by $95 million, which related to acquisition activities in 2011 primarily from ICM Re and Cardinal Comp as well as a purchase price adjustment to goodwill related to Warrantech.
 
In 2011, loss and loss expense reserves increased by $519 million from December 31, 2011, the majority of which was from the loss portfolio transfer with Majestic.  In 2011, deferred income taxes increased due primarily to the acquisitions of ICM Re and Warrantech.

 
49

 

Revolving Credit Agreement
 
On January 28, 2011, we entered into a three-year, $150 million credit agreement (the “Credit Agreement”), among JPMorgan Chase Bank, N.A., as Administrative Agent, The Bank of Nova Scotia, as Syndication Agent, SunTrust Bank, as Documentation Agent, and the various lending institutions party thereto. The credit facility is a revolving credit facility with a letter of credit sublimit of $50 million and an expansion feature not to exceed $50 million. Proceeds of borrowings under the Credit Agreement may be used for working capital, acquisitions and general corporate purposes. In connection with entering into the Credit Agreement, we terminated the then existing Term Loan and Uncommitted Line of Credit Letter Agreement with JPMorgan Chase Bank, N.A.  We did not record a gain or loss on the extinguishment of our previous term loan.
 
ABR borrowings (which are borrowings bearing interest at a rate determined by reference to the Alternate Base Rate) under the Credit Agreement will bear interest at (x) the greatest of (a) the Administrative Agent’s prime rate, (b) the federal funds effective rate plus 0.5 percent or (c) the adjusted LIBO rate for a one month interest period on such day plus 1 percent, plus (y) a margin that is adjusted on the basis of our consolidated leverage ratio. Eurodollar borrowings under the credit agreement will bear interest at the adjusted LIBO rate for the interest period in effect plus a margin that is adjusted on the basis of our consolidated leverage ratio.
 
The Credit Agreement contains certain restrictive covenants customary for facilities of this type (subject to negotiated exceptions and baskets), including restrictions on indebtedness, liens, acquisitions and investments, restricted payments and dispositions. There are also financial covenants that require us to maintain a minimum consolidated net worth, a maximum consolidated leverage ratio, a minimum fixed charge coverage ratio, a minimum risk-based capital and a minimum statutory surplus.  We were in compliance with all covenants as of September 30, 2011.
 
As of September 30, 2011, we had outstanding borrowings of $33.2 million under this Credit Agreement. We had outstanding letters of credit in place under this Credit Agreement at September 30, 2011 for $50.6 million, which reduced the availability under the facility to $66.2 million as of September 30, 2011.  Our outstanding letters of credit of $50.6 million exceeded the availability for letters of credit by $0.6 million as of September 30, 2011. We corrected this on October 27, 2011, bringing the Company’s outstanding letters of credit in place under this Credit Agreement to $50.0 million.  This did not require an amendment or waiver to the Credit Agreement, nor did the Company incur any fees as a result.
 
We recorded approximately $1.0 million of deferred financing costs related to the Credit Agreement.  Fees payable by us under the Credit Agreement include a letter of credit participation fee (which is the margin applicable to Eurodollar borrowings and was 2.25% at September 30, 2011), a letter of credit fronting fee with respect to each letter of credit (.125%) and a commitment fee on the available commitments of the lenders (a range of .35% to .45% based on our consolidated leverage ratio was 0.40% at September 30, 2011).
 
The interest rate on the credit facility as of September 30, 2011 was 2.5%. We recorded interest expense of approximately $2.0 million for the nine months ended September 30, 2011 under the Credit Agreement.  We recorded $0.1 million and $0.6 million for the nine months ended September 30, 2011 and 2010, respectively, related to the term loan.
 
Secured Loan Agreement
 
During February 2011, we, through a wholly-owned subsidiary, entered into a seven-year secured loan agreement with Bank of America Leasing & Capital, LLC in the aggregate amount of $10.8 million to finance the purchase of an aircraft. The loan bears interest at a fixed rate of 4.45%, requires monthly installment payments of approximately $0.1 million, commencing on March 25, 2011 and ending on February 25, 2018, and a balloon payment of $3.2 million at the maturity date. We recorded approximately $0.1 million of deferred financing costs related this agreement.  We recorded interest expense of approximately $0.3 million for the nine months ended September 30, 2011 related to this agreement. The loan is secured by an aircraft that the subsidiary acquired in February 2011.
 
The agreement contains certain covenants that are similar to our revolving credit facility. Additionally, subsequent to February 25, 2012, but prior to payment in full, if the outstanding balance of this loan exceeds 90% of the fair value of the aircraft, we are required to pay the lender the entire amount necessary to reduce the outstanding principal balance to be equal or less than 90% of the fair value of the aircraft.  The agreement allows us, under certain conditions, to repay the entire outstanding principal balance of this loan without penalty.
 
Note Payable — Collateral for Proportionate Share of Reinsurance Obligation
 
In conjunction with the Reinsurance Agreement between AII and Maiden Insurance (see Note 11. “Related Party Transactions”), AII entered into a loan agreement with Maiden Insurance during the fourth quarter of 2007, whereby Maiden Insurance loaned to AII the amount equal to its quota share of the obligations of the AmTrust Ceding Insurers that AII was then obligated to secure.  The loan agreement provides for interest at a rate of LIBOR plus 90 basis points and is payable on a quarterly basis. Each advance under the loan is secured by a promissory note. Advances totaled $168 million as of September 30, 2011.  In addition,  AII and Maiden Insurance are parties to a Reinsurer Trust Assets Collateral agreement whereby Maiden Insurance is required to provide AII the assets required to secure Maiden’s proportionate share of the Company’s obligations to its insurance company subsidiaries.  The amount of this collateral as of September 30, 2011 was approximately $434 million.  Maiden retains ownership of the collateral in the trust account.

 
50

 
 
Promissory Note
 
In connection with the stock and asset purchase agreement with a subsidiary of Unitrin, Inc. (now called Kemper Corporation), we, on June 1, 2008, issued a promissory note to Unitrin, Inc. in the amount of $30 million. The note is non-interest bearing and requires four annual principal payments of $7.5 million.  We paid the first three annual principal payments between 2009 and 2011, and the remaining principal payment is due on June 1, 2012. Upon entering into the promissory note, we calculated imputed interest of approximately $3.2 million based on interest rates available to us, which was 4.5%. Accordingly, the note’s carrying balance was adjusted to approximately $26.8 million at the acquisition. The note is required to be paid in full, immediately, under certain circumstances including a default of payment or change of control of the Company. We included approximately $0.4 million and $0.6 million of amortized discount on the note in our results of operations for the nine months ended September 30, 2011 and 2010, respectively. The note’s carrying value at September 30, 2011 was $7.3 million.
 
Securities Sold Under Agreements to Repurchase, at Contract Value
 
We enter into repurchase agreements. The agreements are accounted for as collateralized borrowing transactions and are recorded at contract amounts. We receive cash or securities, which we invest or hold in short term or fixed income securities. As of September 30, 2011, there were $343.9 million principal amount outstanding at interest rates between .30% and .35%. Interest expense associated with these repurchase agreements for the nine months ended September 30, 2011 was $0.8 million, of which $0 million was accrued as of September 30, 2011. We have approximately $356.0 million of collateral pledged in support of these agreements.
 
Reinsurance
 
Third Party Excess of Loss Reinsurance
 
We purchase excess of loss reinsurance from third party insurers for our workers’ compensation, commercial property and casualty business attributable to both the Small Commercial Business segment and the Specialty Program segment. Under excess of loss reinsurance, covered losses above a specified amount up to the limit of the reinsurance coverage are paid by the reinsurer. In return for this coverage, we pay our reinsurers a percentage of our insurance premiums subject to certain minimum reinsurance premium requirements. Our excess of loss reinsurance program includes contracts that are scheduled to renew at various times during the year.
 
Workers’ Compensation Excess of Loss
 
We have coverage for our workers’ compensation line of business under excess of loss reinsurance agreements. In addition to insuring employers for their statutory workers’ compensation liabilities, our workers’ compensation policies provide insurance for the employers’ tort liability (if any) for bodily injury or disease sustained by employees in the course of their employment. Certain layers of our workers’ compensation reinsurance provide coverage for such employers’ liability insurance at lower limits than the applicable limits for workers’ compensation insurance. The agreements have annual limits of coverage of twice the occurrence limit. As the scale of our workers’ compensation business has increased, we have also increased the amount of risk we retain. The agreements cover, per occurrence, losses in excess of $0.5 million through December 31, 2004, $0.6 million effective January 1, 2005, $1.0 million effective July 1, 2006 through July 1, 2009, $1.0 million plus 55% of $9.0 million in excess of $1.0 million effective July 1, 2009 through January 1, 2010, and $10.0 million effective January 1, 2010 up to a maximum $130 million ($50 million prior to December 1, 2003) in losses. For losses occurring on or after January 1, 2010, we purchased a “third and fourth event cover” that covers losses between $5.0 million and $10.0 million per occurrence, after an aggregate deductible equal to the first $10.0 million per annum on such losses.  For losses occurring on or after January 1, 2011, we replaced this “third and fourth event cover” with a “second and third event cover” that applies after an aggregate deductible equal to the first $5.0 million per annum on such losses.  Effective August 19, 2011, we purchased a new layer of coverage providing $100.0 million in excess of $130.0 million per occurrence, providing us with total protection of $220.0 million for losses in excess of $10.0 million.
 
Our reinsurance for workers’ compensation losses caused by acts of terrorism is more limited than our reinsurance for other types of workers’ compensation losses and, effective August 19, 2011, provides coverage, per contract year, of $220.0 million in the aggregate, in excess of an aggregate retention of $10.0 million, but excludes acts of nuclear, biological or chemical terrorism (which are covered by the Terrorism Risk Insurance Act, as amended (“TRIA”)). Any terrorism losses occurring during 2011 would count toward the annual aggregate limits listed above. The reinsurance for worker’s compensation losses caused by acts of terrorism is provided net of any recovery we receive from the federal government pursuant to TRIA.

 
51

 
 
A limited amount of workers’ compensation and excess workers’ compensation exposures are written as reinsurance and are not protected by the excess reinsurance program listed above.  The total limit exposed to a single workers’ compensation occurrence loss for such exposures is $11.0 million as of September 30, 2011.
 
Specialty Risk Excess of Loss
 
We have excess of loss reinsurance coverage for international general liability and professional business underwritten by our English and Irish insurers. The agreements cover losses in excess of £1.0 million per occurrence up to a maximum of £10.0 million per occurrence, subject to annual aggregate limits that vary by layer. Through December 31, 2010, we had excess of loss reinsurance under the same terms for our European medical liability business. In 2010, we purchased an 80% quota share reinsurance agreement from National Indemnity Company for our European medical liability business. This contract was effective for claims made through March 31, 2011.  Effective April 1, 2011, we replaced this quota share reinsurance agreement with a 40% cession to Maiden Insurance, as more fully described below under “Reinsurance Agreements with Maiden Holdings, Ltd.”  In addition, we purchase various pro-rata and excess reinsurance relating to specific foreign insurance programs and/or specialty lines of business.
 
Casualty Reinsurance
 
We have coverage for our U.S. casualty lines of business under an excess of loss reinsurance agreement. The agreement covers losses in excess of $2.0 million per occurrence (in certain cases the retention can rise to $2.5 million) up to a maximum $30.0 million. We purchase quota share reinsurance for a portion of our umbrella business, whereby we cede 70% of the first $5.0 million of loss per policy and 100% of the next $5.0 million loss per policy. In addition, we also purchase various pro-rata and excess reinsurance relating to specific insurance programs and/or specialty lines of business, including casualty, public entity, and professional errors and omissions insurance.
 
Property Per Risk Excess Coverage
 
We have coverage for our U.S. property lines of business under an excess of loss reinsurance agreement. The agreement covers losses in excess of $2.0 million per location up to a maximum $20 million, subject to per occurrence and annual limits that vary by layer.
 
Property Catastrophe Reinsurance
 
For our U.S. business, we have a property catastrophe excess of loss agreement that covers losses in excess of $5.0 million per occurrence up to a maximum $65.0 million, subject to annual limits that vary by layer. We also have coverage for our U.K. property lines of business under an excess of loss reinsurance agreement. The agreement covers losses in excess of £0.5 million per risk (or in certain instances £1 million per risk) up to a maximum £3.0 million. In addition, we have a property catastrophe excess of loss agreement that covers losses in excess of £2.0 million per occurrence up to a maximum £45.0 million.  Under this program, we cede 75% of losses in excess of £2.0 million per occurrence up to £20.0 million.  We cede 100% of any losses in excess of £20.0 million up to £45.0 million.
 
TRIA requires that commercial property and casualty insurance companies offer coverage for U.S. risks (with certain exceptions, such as with respect to commercial auto insurance) for certain acts of terrorism and has established a federal assistance program through the end of 2014 to help such insurers cover claims for terrorism-related losses. TRIA covers certified acts of terrorism, and the U.S. Secretary of the Treasury must declare the act to be a “certified act of terrorism” for it to be covered under this federal program. In addition, no certified act of terrorism will be covered by the TRIA program unless the aggregate insurance industry losses from the act exceed $100.0 million for each year. Under the TRIA program, the federal government covers 85% of the losses from covered certified acts of terrorism on commercial risks in the United States only, in excess of a deductible amount. This deductible is calculated as a percentage of an affiliated insurance group’s prior year premiums on commercial lines policies (with certain exceptions, such as commercial auto insurance policies) covering risks in the United States. This deductible amount is 20% of such premiums.
 
TRIA will expire at the end of 2014 and no assurance can be given that it will be renewed or that any such renewal will not be on materially less favorable terms.
 
Specialty Risk and Extended Warranty Reinsurance
 
We purchase quota share and/or excess of loss and/or facultative reinsurance for specific programs, specialty lines of business, or individual policies to limit our loss exposure and/or allow our program managers to share the risks and rewards of the business they produce.

 
52

 
 
Reinsurance Agreements with Maiden Holdings, Ltd.
 
During the third quarter of 2007, we entered into a master agreement with Maiden, as amended, by which our Bermuda subsidiary, AII, and Maiden Insurance entered into a quota share reinsurance agreement (the “Maiden Quota Share”), as amended. Under this agreement, AII retrocedes to Maiden Insurance an amount equal to 40% of the premium written by our U.S., Irish and U.K. insurance companies (the “AmTrust Ceding Insurers”), net of the cost of unaffiliated inuring reinsurance (and in the case of our U.K. insurance subsidiary, AEL, net of commissions) and 40% of losses, excluding certain specialty risk programs that we commenced writing after the effective date and risks, other than workers’ compensation risks and certain business written by our Irish subsidiary, AIUL, for which the AmTrust Ceding Insurers’ net retention exceeds $5.0 million, which Maiden has not expressly agreed to assume (“Covered Business”). Effective January 1, 2010, Maiden agreed to assume its proportionate share of our workers’ compensation exposure in excess of $5.0 million, and will share the benefit of our excess of loss reinsurance protection.
 
The Maiden Quota Share, which had an initial term of three years, was renewed through June 30, 2014 and will automatically renew for successive three-year terms unless either AII or Maiden Insurance notifies the other of its election not to renew not less than nine months prior to the end of any such three-year term. In addition, either party is entitled to terminate on thirty days’ notice or less upon the occurrence of certain early termination events, which include a default in payment, insolvency, change in control of AII or Maiden Insurance, run-off, or a reduction of 50% or more of the shareholders’ equity of Maiden Insurance or the combined shareholders’ equity of AII and the AmTrust Ceding Insurers.
 
Effective April 1, 2011, the Maiden Quota Share, as amended, further provides that AII receives a ceding commission of 30% of ceded written premiums with respect to all Covered Business, except retail commercial package business, for which the ceding commission is 34.375%. Commencing January 1, 2012, the ceding commission, excluding the retail package business ceding commission (which remains at 34.375%), will be adjusted to (a) 30% of ceded premium, if the Specialty Risk and Extended Warranty subject premium, excluding ceded premium related to our medical liability business discussed below, is greater than or equal to 42% of the total subject premium,  (b) 30.5% of ceded premium, if the Specialty Risk and Extended Warranty subject premium is less than 42% but greater than or equal to 38%, or (c) 31% of ceded premium, if the Specialty Risk and Extended Warranty subject premium is less than 38% of the total subject premium.  Prior to April 1, 2011, AII received a ceding commission of 31% of ceded premiums with respect to all Covered Business, except retail commercial package business, for which the ceding commission was 34.375%.
 
Effective September 1, 2010, we, through our wholly-owned subsidiary, TIC, entered into a quota share reinsurance agreement with Maiden Specialty Insurance Company (“Maiden Specialty”) by which TIC assumes a portion (generally 90%) of premiums and losses with respect to certain surplus lines programs written by Maiden Specialty on our behalf (the “Surplus Lines Facility”). The Surplus Lines Facility enables us to write business on a surplus lines basis throughout the United States in states in which we are unauthorized to write such business through our own insurance company subsidiaries. Currently, we are utilizing the Surplus Lines Facility for two programs for which Maiden Specialty receives a five percent ceding commission on all premiums ceded by Maiden Specialty to TIC. The Surplus Lines Facility shall remain continuously in force until terminated. We are actively pursuing surplus lines authority for two of our insurance company subsidiaries, which would remove the need for the Surplus Lines Facility.  As a result of this agreement the Company assumed approximately $12.8 million of written premium for which it earned approximately $6.3 million and incurred losses of approximately $3.9 million for the nine months ended September 30, 2011.
 
Effective September 1, 2010, we, through our subsidiary, SNIC, entered into a reinsurance agreement with Maiden Reinsurance Company and an unrelated third party. Under the agreement, which has a term of one year, SNIC cedes 80% of the gross liabilities produced under the Southern General Agency program to Maiden Reinsurance Company and 20% of the gross liabilities produced to the unrelated third party. SNIC receives a five percent commission on ceded written premiums. We ceded written premium of $0.3 million and $0.4 million for the three and nine months ended September 30, 2011 related to this agreement, for which we earned ceding commission of $0.1 million and $0.1 million for the three and nine months ended September 30, 2011.
 
Effective April 1, 2011, we, through our subsidiaries AEL and AIU, entered into a reinsurance agreement with Maiden Insurance by which we cede 40% of our European medical liability business, including business in force at April 1, 2011. The quota share has an initial term of one year and can be terminated at April 1, 2012 or any April 1 thereafter by either party on four months’ notice.  Maiden Insurance pays us a 5% ceding commission, and we will earn a profit commission of 50% of the amount by which the ceded loss ratio is lower than 65%. In addition, Maiden Insurance pays our subsidiary, AII Reinsurance Broker, Ltd., brokerage fees in the amount of 1.25% of net premiums ceded.

 
53

 
 
Reinsurance Agreement with ACAC
 
In conjunction with our strategic investment in ACAC and ACAC’s acquisition from GMAC Insurance Holdings, Inc. and MIC of GMAC’s U.S. consumer property and casualty insurance business, which was completed on March 1, 2010, our subsidiary, TIC, has entered into a quota share reinsurance agreement (the “Personal Lines Quota Share”) with the acquired GMACI personal lines insurance companies (“GMACI Insurers”) by which TIC assumes an amount equal to 10% of the premium written by the GMACI Insurers, net of the cost of unaffiliated inuring reinsurance. The Personal Lines Quota Share further provides that the GMACI Insurers receive a provisional ceding commission of 32.5% of ceded written premiums.
 
The provisional premium is subject to adjustment based on results for the period March 1, 2010 through December 31, 2010 and for each 12 month period thereafter based on the ratio of ceded losses to ceded premium, with a maximum commission of 34.5% at loss ratios at or below 60.5% decreasing dollar for dollar to a minimum commission of 30.5% at a loss ratio at or above 64.5%. The Personal Lines Quota Share has an initial term of three years and will automatically renew for successive three-year terms thereafter unless either TIC or the GMACI Insurers notifies the other of its election not to renew not less than nine months prior to the end of any such three-year term. In addition, either party is entitled to terminate on 60 days’ notice or less upon the occurrence of certain early termination events, which include a default in payment, insolvency, change in control of TIC or GMACI Insurers, run-off, or a reduction of 50% or more of the shareholders’ equity. The GMACI Insurers also may terminate on nine months written notice following the effective date of an initial public offering or private placement of stock by ACAC or a subsidiary. The Personal Lines Quota Share is subject to a premium cap that limits the premium that could be ceded by the GMACI Insurers to TIC to $121.0 million during calendar year 2011 to the extent TIC was to determine, in good faith, that it could not assume additional premium. The premium cap increases by 10% per annum thereafter.
 
Other Reinsurance
 
As part of the acquisition of AIIC, we acquired reinsurance recoverables as of the date of closing. The most significant reinsurance recoverable is from American Home Assurance Co. (“American Home”). AIIC’s reinsurance relationship with American Home incepted January 1, 1998 on a loss occurring basis. From January 1, 1998 through March 31, 1999, the American Home reinsurance covered losses in excess of $0.25 million per occurrence up to statutory coverage limits. Effective April 1, 1999, American Home provided coverage in the amount of $0.15 million in excess of $0.1 million. This additional coverage terminated on December 31, 2001 on a run-off basis. Therefore, for losses occurring in 2002 that attached to a 2001 policy, the retention was $0.1 million per occurrence. Effective January 1, 2002, American Home increased its attachment to $0.25 million per occurrence. The excess of loss treaty that had an attachment of $0.25 million was terminated on a run-off basis on December 31, 2002. Therefore, losses occurring in 2003 that attached to a 2002 policy were ceded to American Home at an attachment point of $0.25 million per occurrence.
 
We reevaluate our reinsurance programs annually or more frequently, as needed, and consider a number of factors, including cost of reinsurance, quality of reinsurers, our liquidity requirements, operating leverage and coverage terms. Even if we maintain our existing retention levels, if the cost of reinsurance increases, our cash flow from operations would decrease as we would cede a greater portion of our premiums written to our reinsurers. Conversely, our cash flow from operations would increase if the cost of reinsurance declined relative to our retention.

 
54

 
 
Investment Portfolio
 
Our investment portfolio, including cash and cash equivalents, increased $469.7 million, or 32.2%, to $1,930.0 million for the nine months ended September 30, 2011 from $1,460.3 million as of December 31, 2010 (excluding $21.2 million and $21.5 million of other investments, respectively).  The increase resulted from obtaining  $218 million of cash and investments from the  Majestic transaction as well as an increase to premium writings.  Our investment portfolio is classified as available-for-sale, as defined by ASC 320, Investments — Debt and Equity Securities . Our fixed maturity securities, gross, had a fair value of $1,412.2 million and an amortized cost of $1,391.1 million as of September 30, 2011. Our equity securities are reported at fair value and totaled $32.1 million with a cost of $38.4 million as of September 30, 2011. Securities sold but not yet purchased, which was $55.6 million as of September 30, 2011, represent our obligations to deliver the specified security at the contracted price and thereby create a liability to purchase the security in the market at prevailing rates. Sales of securities under repurchase agreements, which were $343.9 million as of September 30, 2011, are accounted for as collateralized borrowing transactions and are recorded at their contracted amounts. Our investment portfolio is summarized in the table below by type of investment:

   
September 30, 2011
   
December 31, 2010
 
(Amounts in Thousands)
 
Carrying
Value
   
Percentage of
Portfolio
   
Carrying
Value
   
Percentage of
Portfolio
 
Cash and cash equivalents
  $ 320,863       16.6 %   $ 201,949       13.8 %
Time and short-term deposits
    164,815       8.5       32,137       2.2  
U.S. treasury securities
    40,414       2.1       82,447       5.6  
U.S. government agencies
    29,840       1.5       7,162       0.5  
Municipals
    278,359       14.4       66,676       4.6  
Commercial mortgage back securities
    1,639       0.1       2,076       0.1  
Residential mortgage backed securities:
                               
Agency backed
    432,679       22.4       546,098       37.4  
Non-agency backed
    12,062       0.6       8,591       0.6  
Asset backed securities
    727       0.1       2,687       0.2  
Corporate bonds
    616,444       32.0       493,076       33.8  
Preferred stocks
    4,424       0.2       7,037       0.5  
Common stocks
    27,695       1.5       10,375       0.7  
    $ 1,929,961       100.0 %   $ 1,460,311       100.0 %
 
As of September 30, 2011, the weighted average duration of our fixed income securities was 3.9 years and had a yield of 4.0%.
 
Quarterly, our Investment Committee (“Committee”) evaluates each security that has an unrealized loss as of the end of the subject reporting period for OTTI. We generally consider an investment to be impaired when it has been in a significant unrealized loss position (in excess of 35% of cost if the issuer has a market capitalization of under $1 billion and in excess of 25% of cost if the issuer has a market capitalization of $1 billion or more) for over 24 months. In addition, the Committee uses a set of quantitative and qualitative criteria to review our investment portfolio to evaluate the necessity of recording impairment losses for other-than-temporary declines in the fair value of our investments. The criteria the Committee primarily considers include:

 
the current fair value compared to amortized cost;
 
the length of time the security’s fair value has been below its amortized cost;
 
specific credit issues related to the issuer such as changes in credit rating, reduction or elimination of dividends or non-payment of scheduled interest payments;
 
whether management intends to sell the security and, if not, whether it is not more than likely than not that the Company will be required to sell the security before recovery of its amortized cost basis;
 
the financial condition and near-term prospects of the issuer of the security, including any specific events that may affect its operations or earnings;
 
the occurrence of a discrete credit event resulting in the issuer defaulting on material outstanding obligations or the issuer seeking protection under bankruptcy laws; and
 
other items, including company management, media exposure, sponsors, marketing and advertising agreements, debt restructurings, regulatory changes, acquisitions and dispositions, pending litigation, distribution agreements and general industry trends.
 
Impairment of investment securities results in a charge to operations when a market decline below cost is deemed to be other-than-temporary. We write down investments immediately that we consider to be impaired based on the above criteria collectively.

 
55

 
 
Based on guidance in FASB ASC 320-10-65, in the event of the decline in fair value of a debt security, a holder of that security that does not intend to sell the debt security and for whom it is not more than likely than not that such holder will be required to sell the debt security before recovery of its amortized cost basis, is required to separate the decline in fair value into (a) the amount representing the credit loss and (b) the amount related to other factors. The amount of total decline in fair value related to the credit loss shall be recognized in earnings as an OTTI with the amount related to other factors recognized in accumulated other comprehensive loss net loss, net of tax. OTTI credit losses result in a permanent reduction of the cost basis of the underlying investment. The determination of OTTI is a subjective process, and different judgments and assumptions could affect the timing of the loss realization.
 
The impairment charges of our fixed and equity securities for the nine months ended September 30, 2011 and 2010 are presented in the table below:

(Amounts in thousands)
 
2011
   
2010
 
Equity securities
  $ 345     $ 10,656  
Fixed maturity securities
    -       10,540  
    $ 345     $ 21,196  
 
In addition to the other-than-temporary impairment of $0.3 million recorded during the nine months ended September 30, 2011, we had $37.0 million of gross unrealized losses, of which $7.3 million related to marketable equity securities and $29.7 million related to fixed maturity securities as of September 30, 2011.
 
Corporate bonds represent 44% of the fair value of our fixed maturities and 97% of the total unrealized losses of our fixed maturities. We own 343 corporate bonds in the industrial, bank and financial and other sectors, which have a fair value of approximately 7%, 34% and 3%, respectively, and 8%, 86% and 4% of total unrealized losses, respectively, of our fixed maturities. We believe that the unrealized losses in these securities are the result, primarily, of general economic conditions and not the condition of the issuers, which we believe are solvent and have the ability to meet their obligations. Therefore, we expect that the market price for these securities should recover within a reasonable time.  Additionally, we do not intend to sell the investments and it is not more likely than not that we will be required to sell the investments before recovery of their amortized cost basis.
 
Our investment in marketable equity securities consist of investments in preferred and common stock across a wide range of sectors. We evaluated the near-term prospects for recovery of fair value in relation to the severity and duration of the impairment and have determined in each case that the probability of recovery is reasonable and we have the ability and intent to hold these investments until a recovery of fair value. Within our portfolio of equity securities, eight common stocks comprised $4.5 million, or 62 percent of the unrealized loss.  We own two securities in the financial sector that represent 52% of the fair market value and 43% of our unrealized losses.  We own two securities each in the industrial and healthcare sectors that represent approximately 6% and 2% of the fair market value, respectively, and approximately 13% and 1% of our unrealized losses, respectively.  We also own two positions in the consumer products sector that have approximately 3% of the fair value and approximately 5% of the unrealized losses.  The duration of these impairments ranges from 2 to 17 months.  The remaining securities in a loss position are not considered individually significant and accounted for 38 percent of our unrealized losses.  We believe these securities will recover and that we have the ability and intent to hold them to recovery.

Item 3. Quantitative and Qualitative Disclosures About Market Risk
 
Market Risk.  Market risk is the risk of potential economic loss principally arising from adverse changes in the fair value of financial instruments. The major components of market risk affecting us are liquidity risk, credit risk, interest rate risk, foreign currency risk and equity price risk.
 
Liquidity Risk.   Liquidity risk represents our potential inability to meet all payment obligations when they become due. We maintain sufficient cash and marketable securities to fund claim payments and operations. We purchase reinsurance coverage to mitigate the liquidity risk of an unexpected rise in claims severity or frequency from catastrophic events or a single large loss. The availability, amount and cost of reinsurance depend on market conditions and may vary significantly.
 
Credit Risk. Credit risk is the potential loss arising principally from adverse changes in the financial condition of the issuers of our fixed maturity securities and the financial condition of our third party reinsurers. We address the credit risk related to the issuers of our fixed maturity securities by investing primarily in fixed maturity securities that are rated “BBB-” or higher by Standard & Poor’s. We also independently monitor the financial condition of all issuers of our fixed maturity securities. To limit our risk exposure, we employ diversification policies that limit the credit exposure to any single issuer or business sector.

 
56

 
 
We are subject to credit risk with respect to our third party reinsurers. Although our third party reinsurers are obligated to reimburse us to the extent we cede risk to them, we are ultimately liable to our policyholders on all risks that have ceded. As a result, reinsurance contracts do not limit our ultimate obligations to pay claims covered under the insurance policies we issue and we might not collect amounts recoverable from our reinsurers. We address this credit risk by selecting reinsurers that have an A.M. Best rating of “A” (Excellent) or better at the time we enter into the agreement and by performing, along with our reinsurance brokers, periodic credit reviews of our reinsurers. If one of our reinsurers suffers a credit downgrade, we may consider various options to lessen the risk of asset impairment, including commutation, novation and letters of credit.  See “—Reinsurance.”
 
Interest Rate Risk. We had fixed maturity securities (excluding $164.8 million of time and short-term deposits) with a fair value and carry value of $1,412.2 million as of September 30, 2011 that are subject to interest rate risk. Interest rate risk is the risk that we may incur losses due to adverse changes in interest rates. Fluctuations in interest rates have a direct impact on the market valuation of our fixed maturity securities. We manage our exposure to interest rate risk through a disciplined asset and liability matching and capital management process. In the management of this risk, the characteristics of duration, credit and variability of cash flows are critical elements. These risks are assessed regularly and balanced within the context of our liability and capital position.
 
The table below summarizes the interest rate risk associated with our fixed maturity securities by illustrating the sensitivity of the fair value and carrying value of our fixed maturity securities as of September 30, 2011 to selected hypothetical changes in interest rates, and the associated impact on our shareholders’ equity. All fixed income securities are classified as available-for-sale and carried on our balance sheet at fair value. Temporary changes in the fair value of our fixed maturity securities do impact the carrying value of these securities and are reported in our shareholders’ equity as a component of other comprehensive income, net of deferred taxes. The selected scenarios in the table below are not predictions of future events, but rather are intended to illustrate the effect such events may have on the fair value and carrying value of our fixed maturity securities and on our shareholders’ equity, each as of September 30, 2011.

Hypothetical Change in Interest Rates
 
Fair Value
   
Estimated
Change in
Fair Value
   
Hypothetical Percentage
Increase (Decrease) in
Shareholders’ Equity
 
(Amounts in Thousands)
 
200 basis point increase
  $ 1,279,369     $ (132,795 )     (10.3 )%
100 basis point increase
    1,344,873       (67,291 )     (5.2 )
No change
    1,412,164              
100 basis point decrease
    1,476,072       63,908       7.6  
200 basis point decrease
    1,544,279       132,115       10.2  
 
Foreign Currency Risk. We write insurance in the United Kingdom and certain other European Union member countries through AIU and AEL. While the functional currency of AIU and AEL are, respectively, the Euro and the British Pound, we write coverages that are settled in local currencies, including, primarily, the Euro and British Pound. We attempt to maintain sufficient local currency assets on deposit to minimize our exposure to realized currency losses. Assuming a 5% increase in the exchange rate of the local currency in which the claims will be paid and in the event that we do not hold that local currency, we would recognize a $10.3 million after tax realized currency loss based on our outstanding foreign denominated reserves of $317.1 million at September 30, 2011.
 
Equity Price Risk. Equity price risk is the risk that we may incur losses due to adverse changes in the market prices of the equity securities we hold in our investment portfolio, which include common stocks, non-redeemable preferred stocks and master limited partnerships. We classify our portfolio of equity securities as available-for-sale and carry these securities on our balance sheet at fair value. Accordingly, adverse changes in the market prices of our equity securities result in a decrease in the value of our total assets and a decrease in our shareholders’ equity. As of September 30, 2011, the equity securities in our investment portfolio had a fair value of $32.1 million, representing approximately 1.6 percent of our total invested assets on that date. We are fundamental long buyers and short sellers, with a focus on value oriented stocks. The table below illustrates the impact on our equity portfolio and financial position given a hypothetical movement in the broader equity markets. The selected scenarios in the table below are not predictions of future events, but rather are intended to illustrate the effect such events may have on the carrying value of our equity portfolio and on shareholders’ equity as of September 30, 2011.

 
57

 
 
The hypothetical scenarios below assume that our Beta is 1 when compared to the S&P 500 index.

Hypothetical Change in Interest Rates
 
Fair Value
   
Estimated
Change in
Fair Value
   
Hypothetical
Percentage
Increase
( Decrease) in
Shareholders’
Equity
 
(Amounts in Thousands)
 
5% increase
  $ 33,725     $ 1,606       0.1 %
No change
    32,119              
5 % decrease
    30,513       (1,606 )     (0.1 )

Off Balance Sheet Risk . We have exposure or risk related to securities sold but not yet purchased.

         Item 4. Controls and Procedures
 
Our management, with the participation and under the supervision of our principal executive officer and principal financial officer, has evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended (the "Exchange Act")) and has concluded that, as of the end of the period covered by this report, such disclosure controls and procedures were effective in ensuring that information required to be disclosed by us in the reports we file or submit under the Exchange Act is timely recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure. During the most recent fiscal quarter, there have been no changes in our internal controls over financial reporting (as defined in Exchange Act Rule 13a-15(f) and 15d-15(f)) that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
 
PART II - OTHER INFORMATION
 
Item 1.  Legal Proceedings
 
Vehicle service contract industry inquiry and related proceedings
 
As disclosed in Part I, Item 3 of our Annual Report on Form 10-K, the states of Texas, Washington and Ohio, by and through the offices of their respective Attorneys General, are acting as the Executive Committee of a multi-state Attorneys General task force (the “Multi-State Task Force”) that is making inquiries into the vehicle service contract industry focusing on former third party administrators of U.S. Fidelis, a direct marketer of vehicle service contracts that filed a petition for Chapter 11 bankruptcy protection in February 2010 in the United States Bankruptcy Court for the Eastern District of Missouri (the “Bankruptcy Proceeding”).  The inquiries relate to the handling of payment of customer refunds in the absence of U.S. Fidelis fulfilling such obligations. In connection with such inquiry, on or about January 14, 2011, our subsidiary, Warrantech, received an inquiry from the Texas Attorney General’s office because Warrantech is a former third party administrator of U.S. Fidelis.
 
On March 10, 2011, Warrantech received a demand letter from Mepco Finance Corporation (“Mepco”) related to certain damages Mepco allegedly incurred in connection with vehicle service contracts marketed and sold by U.S. Fidelis, financed by Mepco, and administered by Warrantech.  Mepco claims that under the terms of an agreement between Warrantech and Mepco, Warrantech is obligated to indemnify Mepco for damages incurred resulting from the failure of U.S. Fidelis to repay certain amounts to Mepco on cancelled vehicle service contracts that were marketed and sold by U.S. Fidelis, financed by Mepco, and administered by Warrantech.
 
Warrantech disputes that it owes Mepco any amounts resulting from the failure of U.S. Fidelis to repay Mepco for certain cancelled vehicle service contracts.  On September 13, 2011, Warrantech commenced an adversary proceeding against Mepco in the Bankruptcy Proceeding, Case Number 11-04313 (the “Adversary Proceeding”).  In the Adversary Proceeding, Warrantech is seeking a judicial determination that Mepco breached the agreement between the parties and, as result, Warrantech has incurred damages in connection with the marketing and sales of vehicle service contracts by U.S. Fidelis and Mepco’s financing of those vehicle service contracts.  In addition, Warrantech is seeking a declaratory judgment that any contractual obligation it may have had to indemnify or reimburse Mepco for unpaid amounts due from U.S. Fidelis is unenforceable due to Mepco’s own conduct.
 
In a related proceeding, the Official Committee of the Unsecured Creditors (the “Creditors Committee”) also commenced an adversary proceeding against Mepco in the Bankruptcy Proceeding, Case Number 10-41902-705.  In that proceeding, the Creditors Committee asserts, among other things, that Mepco’s pre and post-petition bankruptcy claims should be subordinated due to Mepco’s inequitable conduct.

 
58

 
 
On September 28, 2011, the Multi-State Task Force, acting through the Executive Committee, filed a motion in the Bankruptcy Proceeding requesting that the Bankruptcy Court issue an order compelling Mepco, Warrantech, the Creditors Committee and the Executive Committee to mediate the claims asserted in the two adversary proceedings and the issues raised by the Multi-State Task Force.  Warrantech did not oppose the motion to compel mediation.
 
At this point, it is not possible to predict the outcome of the mediation or the inquiries by the Multi-State Task Force.  We do not, however, currently believe that the outcomes will have a material adverse effect on our financial position or liquidity.
 
Item 1A.  Risk Factors
 
There are no material changes to the risk factors previously reported in our Annual Report on Form 10-K for the year ended December 31, 2010.  For more information regarding such risk factors, refer to Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2010.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

None.

Item 3. Defaults Upon Senior Securities

None.

Item 4.  (Removed and Reserved)

Item 5. Other Information

None.

 
59

 

Item 6. Exhibits

Exhibit
Number
 
Description
     
10.1
 
Form of Incentive Stock Option Agreement, amended and restated effective November 1, 2011.
     
10.2
 
Form of Non-qualified Stock Option Agreement for Non-Employee Directors, amended and restated effective November 1, 2011.
     
10.3
 
Form of Restricted Stock Agreement, amended and restated effective November 1, 2011.
     
10.4
 
Form of Restricted Stock Unit Agreement, amended and restated effective November 1, 2011.
     
31.1
 
Certification of the Chief Executive Officer, pursuant to Rule 13a-14(a) or 15d-14(a), for the quarter ended September 30, 2011.
     
31.2
 
Certification of the Chief Financial Officer, pursuant to Rule 13a-14(a) or 15d-14(a), for the quarter ended September 30, 2011.
     
32.1
 
Certification of the Chief Executive Officer, pursuant to 18 U.S.C. Section 1350, for the quarter ended September 30, 2011.
     
32.2
 
Certification of the Chief Financial Officer, pursuant to 18 U.S.C. Section 1350, for the quarter ended September 30, 2011.
     
101.1
 
The following materials from the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2011, formatted in XBRL (Extensible Business Reporting Language): (i) the Condensed Consolidated Balance Sheets at September 30, 2011 and December 31, 2010; (ii) the Condensed Consolidated Statements of Income for the three and nine months ended September 30, 2011 and 2010; (iii) the Consolidated Statements of Cash Flows for the nine months ended September 30, 2011 and 2010; and (iv) the Notes to Unaudited Condensed Consolidated Financial Statements, tagged as blocks of text (submitted electronically herewith).
     
   
In accordance with Rule 406T of Regulation S-T, the XBRL related information in Exhibit 101.1 to this Quarterly Report on Form 10-Q shall not be deemed to be “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liability of that section, and shall not be part of any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
 
 
60

 

 
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 
AmTrust Financial Services, Inc.
 
(Registrant)
     
Date: November 9, 2011
 
/s/ Barry D. Zyskind
   
Barry D. Zyskind
   
President and Chief Executive Officer
     
   
/s/ Ronald E. Pipoly, Jr.
   
Ronald E. Pipoly, Jr.
   
Chief Financial Officer

 
61

 
Exhibit 10.1
 
 
AMTRUST FINANCIAL SERVICES, INC.
2010 OMNIBUS INCENTIVE PLAN
 

 
INCENTIVE STOCK OPTION AGREEMENT
 



     Your stock option grant by AmTrust Financial Services, Inc. (the “ Company ”) is subject to the terms and conditions set forth in (i) this Award Agreement, and (ii) the AmTrust Financial Services, Inc. 2010 Omnibus Incentive Plan (the “ Plan ”) Unless otherwise defined herein, capitalized terms used in this Agreement are defined in the Plan, and have the meaning set forth in the Plan.

Award of Stock Options
 
 
 
You have been granted an Option (the “ Option ”), subject to the terms and conditions of this Agreement and the Plan, to purchase ____________ shares of the Company’s Stock.
 
     
Exercise Price
 
 
 
The exercise price with respect to your Option is $xx.xx per share, such exercise price payable on terms and conditions and in a form as determined by the Compensation Committee in its sole discretion consistent with the terms of the Plan and this Award Agreement.
     
Grant Date
 
The effective date of this grant is ________ ____, 20__.
 
Term
 
The term of your Option will expire at the close of business on the 10th anniversary of the Grant Date. Your Option will expire earlier if your Employment with the Company terminates, as described below.
 
Vesting
 
Your Option shall vest as follows: (i) 25% on the first anniversary of the Grant Date, and (ii) the remaining 75% will vest in 12 equal quarterly installments of 6.25% each every 3 months thereafter, until fully vested 48 months after the Grant Date.
 
This Option is only exercisable before it expires and then only with respect to the vested portion of the Option. You may exercise this Option, in whole or in part, to purchase a whole number of vested shares in accordance with the Plan and this Agreement.
 
Except as provided in this Agreement, or in any other agreement between you and the Company, no additional Options will vest after your Employment has terminated.
 
Tax Matters (Incentive Stock Option)
 
The Option granted hereby is intended to qualify as an “incentive stock option” under Section 422 of the Internal Revenue Code of 1986, as amended (the “ Code ”). Notwithstanding the foregoing, the Option will not qualify as an “incentive stock option,” among other events, (i) if you dispose of the Stock acquired pursuant to the Option at any time during either of the two year period following the date of this Agreement or the one year period following the date on which the Option is exercised; (ii) except in the event of the Participant’s death or disability, as defined in Section 22(e)(3) of the Code, if the Participant is not employed by the Company (or any affiliate) at all times during the period beginning on the date of this Agreement and ending on the day three (3) months before the date of exercise of the Option; or (iii) to the extent the aggregate fair market value (determined as of the time the Option is granted) of the Common Stock subject to “incentive stock options” which become exercisable for the first time in any calendar year exceeds $100,000. To the extent that the Option does not qualify as an “incentive stock option,” it shall not affect the validity of the Option and shall constitute a separate non-qualified stock option.
 
 
 
1

 
 
 
Termination of Employment
 
 
If your Employment (as defined below) terminates for any reason, other than retirement, death, Disability or Cause, then your Option will expire at the close of business at Company headquarters on the 90th day after your termination date (or the next business day if the 90th day after your termination date falls on a weekend or holiday).
 
Employment ” means that you are currently (i) an employee of the Company, (ii) are a member of the Company’s Board of Directors, or (iii) are otherwise providing services to the Company.
 
Termination for
Cause
 
If your Employment is terminated for Cause (as defined below), then you shall immediately forfeit all rights to your Option and the Option shall expire immediately upon your termination.
 
For purposes of this Agreement, “ Caus e” shall mean
(a) willful misconduct or gross negligence;
(b) conviction of a felony or conviction of a crime involving moral turpitude;
(c) any act constituting fraud or the misappropriation or embezzlement of money or other property of the Company; and
(d) any willful act or course of conduct constituting an abuse of office or authority which has a material adverse impact on the Company’s reputation or financial condition.
 
Retirement
 
If you have been employed by the Company for at least five years and your Employment terminates due to your: (i) retirement on or after your sixty-fifth birthday; or (ii) retirement on or after your fifty-fifth birthday with the consent of the Company, your Option will automatically vest as to the number of Options that would have vested had you remained in Employment for the 12-month period immediately following your retirement and your Option will expire at the close of business at Company headquarters on the date 12 months after the date of your retirement (or the next business day if the date 12 months after the date of your retirement falls on a weekend or holiday).
 
Death
 
If your Employment terminates because of your death, your Option will automatically vest as to the number of Options that would have vested had you remained in Employment for the 12-month period immediately following your death and your Option will expire at the close of business at Company headquarters on the date 12 months after the date of death (or the next business day if the date 12 months after the date of death falls on a weekend or holiday).
 
If you die during the 90-day period in connection with a regular termination of Employment described above, and a vested portion of your Option has not yet been exercised, then your Option will instead expire on the date 12 months after your termination date.
 
During the 12-month period above, your estate or heirs may exercise the vested portion of your Option.
 
 
 
2

 
 
Disability
 
If your Employment terminates because of your Disability (defined below), your Option will automatically vest as to the number of Options that would have vested had you remained in Employment for the 12-month period immediately following your Disability and your Option will expire at the close of business at Company headquarters on the date 12 months after the date of termination (or the next business day if the date 12 months after the date of termination falls on a weekend or holiday).
 
For purposes of this Agreement, “ Disability ” shall mean the award holder is unable to perform the duties of their service (or other services) (i) for a period of 90 consecutive days, or (ii) any 120 days during any consecutive 12-month period.
 
Termination without Cause within 12 Months of Change in Control
 
 
Notwithstanding anything contained in this Agreement to the contrary, if your Employment with the Company (or any affiliate) is terminated by the Company without Cause within 12 months following the effective date of a “Change of Control,” the Board of Directors may accelerate the vesting of all or any portion of your Option that is unvested.
 
For purposes of this Agreement: “ Change in Control ” shall mean:
(i) any “person” (as such term is used in Section 13(d) and 14(d)(2) of the Securities Exchange Act of 1934, as amended (the “ Exchange Act ”), including any syndicate or group deemed to be a “person” under Section 13(d)(3) of the Exchange Act) other than Barry Zyskind, George Karfunkel, Michael Karfunkel, any of their lineal descendants, any trust or charitable foundation controlled by any of them or their lineal descendants, any subsidiary or any employee benefit plan of the Company or a subsidiary or former subsidiary, is or becomes a beneficial owner, directly or indirectly, of stock of the Company representing 50% of more of the total voting power of the Company’s then outstanding stock;
 
(ii) a tender offer (for which a filing has been made with the Securities and Exchange Commission (the “ SEC ”) that purports to comply with the requirements of Section 14(d) of the Exchange Act, and the corresponding SEC rules) is made for the stock of the Company. In case of a tender offer described in this paragraph (ii), the “Change of Control” will be deemed to have occurred any time during the offer when the person (using the definition in (i) above) making the offer owns or has accepted for payment stock of the Company with 50% or more of the total voting power of the Company's outstanding stock; or
 
(iii)  individuals who were the Board’s nominees for election as directors of the Company immediately prior to a meeting of the stockholders of the Company involving a contest for the election of directors shall not constitute a majority of the Board following the election.
 
 
 
3

 
 
Notice of Exercise
 
When you wish to exercise this Option, you must notify the Company in writing. Such exercise will only become effective upon the Company’s receipt of such written instructions.
 
Recapture Rights
 
In the event that you violate any of your obligations pursuant to the Confidentiality, Non-Competition, or Non-Solicitation provisions of this Agreement, you agree to return, within five days of receipt of written demand from the Company, any gains you realize from the exercise of all or any portion of the Option within the 12 months immediately preceding such violation, and any remaining portion of your Option shall be immediately forfeited, whether vested or unvested.
 
Confidentiality
 
During your Employment, you will have access to confidential or proprietary data or information of the Company (and its affiliates) and its operations.  You agree that you will not at any time divulge or communicate the Confidential Information (defined below) to any person, nor shall you direct any employee to divulge or communicate to any person (other than to a person bound by confidentiality obligations similar to those contained herein and other than as necessary in performing your duties hereunder), or use to the detriment of the Company (or any of its affiliates) or for the benefit of any other person, any Confidential Information.  This restriction shall survive your Employment hereunder, whether by the normal expiration thereof or otherwise.
 
The term “Confidential Information” shall mean all information, whether or not reduced to written or recorded form, that is related to the Company and that is not generally known or accessible to members of the public and/or competitors of the Company nor intended for general dissemination, whether furnished by the Company or compiled by the employee, including, without limitation, relating to the Company’s (or any affiliate’s) financial performance, customers, existing or proposed future projects, prospects, or business strategies, personnel information, financial information, customer lists, supplier lists, trade secrets, information regarding operations, systems, services, know-how, computer and any other processed or collated data, computer programs, pricing, marketing and advertising data.
 
You understand the Company intends to maintain the confidentiality of the Confidential Information notwithstanding that employees of the Company may have free access to the information for the purpose of performing their duties with the Company, and notwithstanding that employees not expressly bound by agreements similar to this agreement may have access to such information for job purposes. You acknowledge that Confidential Information need not be marked as such to preserve the confidential nature of the information.
 
 
 
4

 
 
Non-Competition
 
You acknowledge that (a) in the course of your Employment with the Company and its affiliates, you have, and will continue to, become familiar with the Company’s and its affiliates’ trade secrets, methods of doing business, business plans and other valuable confidential and proprietary information concerning the Company, its affiliates, their customers and business partners and that your services have been and will be of special, unique and extraordinary value to the Company and its affiliates.  In consideration thereof and of this Award, during your Employment with the Company or an affiliate and for a period of one (1) year thereafter, you shall not, without the Company’s prior written approval, become engaged, directly or indirectly, as a director, officer, employee or 5% or more stockholder or equity interest owner in, partner in, or consultant to, any business that is directly competitive with the business of the Company (or any affiliate) in any area or region where the Company (or any affiliate) conducts business (“ Competition ”).  Notwithstanding the foregoing, you shall not be deemed to be in Competition with the Company if you provide evidence satisfactory to the Company, in its sole and absolute discretion, that you: (i) work in a separate division, department or unit that does not compete with the business of the Company (or any affiliate); and (ii) will not have contact with the division, department or unit that does compete with the business of the Company (or any affiliate).  If you received your Option grant as a non-employee member of the Company’s Board of Directors, this provision will not apply to you unless your Employment is terminated for Cause (as defined above) or for cause pursuant to the Company’s Certificate of Incorporation.
 
Non-Solicitation
 
During Employment and for a period of two (2) years thereafter, you shall not, without the prior written consent of the Company, directly or indirectly, on your own behalf or on behalf of any other person, firm, corporation or business entity: (a) induce or attempt to induce any agent, broker, affinity group or policyholder of the Company (or any affiliate), or any prior agent, affinity group or policyholder that was an agent, affinity group or policyholder within twelve (12) months of such contact, to withdraw, decrease or cancel its business with the Company (or any affiliate) or otherwise terminate any written or oral agreement or understanding or other relationship with the Company (or any affiliate); (b) solicit or attempt to solicit, service or attempt to service, or for the purpose of obtaining the business of any agent, broker, affinity group or policyholder of the Company (or any affiliate), or any prior agent, affinity group or policyholder that was an agent, broker, affinity group or policyholder within twelve (12) months of such contact, to the extent the business solicited is similar to, or competitive with, the business of the Company (or any affiliate), engage in discussions or other communications with (regardless of who initiates such discussions or communications) any person, firm or entity that was an actual or prospective agent, broker, affinity group or policyholder of the Company during any part of the twelve (12) month period immediately preceding termination of Employment if you participated, directly or indirectly, in the solicitation or servicing of that agent, broker, affinity group or policyholder or prospective agent, broker, affinity group or policyholder, or supervised or managed those who did, during your Employment with the Company at any time during such twelve (12) month period immediately preceding your termination of Employment; (c) solicit or attempt to solicit, hire or attempt to hire, or communicate with, any person who is an employee, individual consultant or independent contractor of the Company (or any affiliate), or any prior employee, individual consultant or independent contractor that was an employee, consultant or independent contractor within twelve (12) months of such contact, with the purpose or intent of attracting such person from the employ of the Company (or any affiliate); or (d) induce or attempt to induce any person who is an employee, individual consultant or independent contractor of the Company (or any affiliate) to terminate or limit his or her Employment or other relationship with the Company (or any affiliate), or any prior employee, individual consultant or independent contractor that was an employee, individual consultant or independent contractor within twelve (12) months of such contact.
 
 
 
5

 
 
Form of Payment
 
Upon exercise of your Option, you must submit payment of the Option price for the shares you are purchasing. Payment may be made via (i) cash; (ii) a “cashless” exercise, by which you deliver an irrevocable direction to a licensed securities broker to sell Stock and to deliver all or part of the sale proceeds to the Company in payment of the aggregate Option price and any applicable withholding taxes; or (iii) as otherwise permitted by the Administrator.
 
Administrator ” shall mean one or more officers or employees of the Company to whom the Committee may delegate the authority execute and distribute Award Agreements or other documents evidencing or relating to Awards granted by the Committee under the Plan, to maintain records relating to Awards, to process or oversee the issuance of Stock under Awards, to interpret and administer the terms of Awards and to take such other actions as may be necessary or appropriate for the administration of the Plan and of Awards under the Plan, other that those specified in Section 3(b)(i) – (iii) of the Plan.
 
Withholding Taxes
 
In the event that the Company determines that any federal, state, local or foreign tax or withholding payment is required relating to the exercise or sale of shares arising from this grant, the Company shall have the right to require such payments from you, or withhold such minimum statutory amounts from other payments due to you from the Company. Payment of your withholding or other taxes may be made via one of the forms of payment for exercise set forth above, or as otherwise determined by the Administrator.
 
Transfer of Option
 
The Option is non-transferable by you. Any attempt by you to transfer this Option will result in the Option becoming invalid, except upon your death by the laws of descent and distribution.
 
No Employment Rights
 
Neither your Option nor this Agreement give you the right to be retained by the Company in any capacity and your Employment may be terminated at any time and for any reason.
 
Shareholder Rights
 
You have no rights as a shareholder of the Company unless and until the Stock relating to your exercise has been issued (or an appropriate book entry has been made). Except as described in the Plan, no adjustments are made for dividends or other rights if the applicable record date occurs before your Stock is issued (or an appropriate book entry has been made).
 
Applicable Law
 
 
 
This Agreement shall be governed by the laws of the State of Delaware, with consent to jurisdiction by you in the State of New York.
 
Data Privacy
 
To administer the Plan, the Company may process personal data about you. Such data includes the information provided in this Agreement, other appropriate personal and financial data about you such as home address and business addresses and other contact information, payroll information and any other information deemed appropriate by the Company to facilitate the administration of the Plan.
 
By accepting this award, you consent to the Company’s processing of such personal data and the transfer of such data outside the country in which you work or are employed, including, with respect to non-U.S. residents, to the United States, to transferees who shall include the Company and other persons designated by the Company to administer the Plan.
 
Consent to Electronic Delivery
 
Certain statutory materials relating to the Plan may be delivered to you in electronic form. By accepting this grant, you consent to electronic delivery and acknowledge receipt of these materials, including the Plan and the Plan prospectus.
 
This Agreement is not a stock certificate or a negotiable instrument.
 
 
6

 

By accepting your grant, you agree to the terms and conditions in this Agreement and in the Plan, and agree that the Plan will control in the event any provision of this Agreement should appear to be inconsistent with the terms and conditions in the Plan.

          IN WITNESS WHEREOF, the parties have executed this Agreement on the date and year below.

AMTRUST FINANCIAL SERVICES, INC.


______________________________________                                                                                                           Date: _____________________
By:
Its:


EMPLOYEE



______________________________________                                                                                                           Date: _____________________
Name:
 
 
 
7

 
Exhibit 10.2
 
 

 
 
AMTRUST FINANCIAL SERVICES, INC.
2010 OMNIBUS INCENTIVE PLAN
 

 
NON-QUALIFIED STOCK OPTION AGREEMENT
 

 
     Your stock option grant by AmTrust Financial Services, Inc. (the “ Company ”) is subject to the terms and conditions set forth in (i) this Award Agreement, and (ii) the AmTrust Financial Services, Inc. 2010 Omnibus Incentive Plan (the “ Plan ”) Unless otherwise defined herein, capitalized terms used in this Agreement are defined in the Plan, and have the meaning set forth in the Plan.

Award of Stock Options
 
You have been granted an Option (the “ Option ”), subject to the terms and conditions of this Agreement and the Plan, to purchase ____________ shares of the Company’s Stock.
     
Exercise Price
 
The exercise price with respect to your Option is $xx.xx per share, such exercise price payable on terms and conditions and in a form as determined by the Compensation Committee in its sole discretion consistent with the terms of the Plan and this Award Agreement.
     
Grant Date
 
The effective date of this grant is ________ ____, 20__.
 
Term
 
The term of your Option will expire at the close of business on the 10th anniversary of the Grant Date. Your Option will expire earlier if your Employment with the Company terminates, as described below.
 
Vesting
 
Your Option shall vest 100% on the first anniversary of the Grant Date.
 
This Option is only exercisable before it expires and then only with respect to the vested portion of the Option. You may exercise this Option, in whole or in part, to purchase a whole number of vested shares in accordance with the Plan and this Agreement.
 
Except as provided in this Agreement, or in any other agreement between you and the Company, no additional Options will vest after your Employment has terminated.
 
Termination of Employment
 
 
If your Employment (as defined below) terminates for any reason, other than retirement, death, Disability or Cause, then your Option will expire at the close of business at Company headquarters on the 90th day after your termination date (or the next business day if the 90th day after your termination date falls on a weekend or holiday).
 
Employment ” means that you are currently (i) an employee of the Company, (ii) are a member of the Company’s Board of Directors, or (iii) are otherwise providing services to the Company.
 
 
 
1

 
 
Termination for
Cause
 
If your Employment is terminated for Cause (as defined below), then you shall immediately forfeit all rights to your Option and the Option shall expire immediately upon your termination.
 
For purposes of this Agreement, “ Caus e” shall mean
(a) willful misconduct or gross negligence;
(b) conviction of a felony or conviction of a crime involving moral turpitude;
(c) any act constituting fraud or the misappropriation or embezzlement of money or other property of the Company; and
(d) any willful act or course of conduct constituting an abuse of office or authority which has a material adverse impact on the Company’s reputation or financial condition.
 
Retirement
 
If you have been a member of the Company’s Board of Directors for at least five years and your Employment terminates due to your: (i) retirement on or after your sixty-fifth birthday; or (ii) retirement on or after your fifty-fifth birthday with the consent of the Company, your Option will automatically vest as to the number of Options that would have vested had you remained in Employment for the 12-month period immediately following your retirement and your Option will expire at the close of business at Company headquarters on the date 12 months after the date of your retirement (or the next business day if the date 12 months after the date of your retirement falls on a weekend or holiday).
 
Death
 
If your Employment terminates because of your death, your Option will automatically vest as to the number of Options that would have vested had you remained in Employment for the 12-month period immediately following your death and your Option will expire at the close of business at Company headquarters on the date 12 months after the date of death (or the next business day if the date 12 months after the date of death falls on a weekend or holiday).
 
If you die during the 90-day period in connection with a regular termination of Employment described above, and a vested portion of your Option has not yet been exercised, then your Option will instead expire on the date 12 months after your termination date.
 
During the 12 month period above, your estate or heirs may exercise the vested portion of your Option.
 
Disability
 
If your Employment terminates because of your Disability (defined below), your Option will automatically vest as to the number of Options that would have vested had you remained in Employment for the 12 month period immediately following your Disability and your Option will expire at the close of business at Company headquarters on the date 12 months after the date of termination (or the next business day if the date 12 months after the date of termination falls on a weekend or holiday).
 
For purposes of this Agreement, “ Disability ” shall mean the award holder is unable to perform the duties of their service (or other services) (i) for a period of 90 consecutive days, or (ii) any 120 days during any consecutive 12 month period.
 
 
 
2

 
 
Termination without Cause within 12 Months of Change in Control
 
 
If your Employment with the Company (or any affiliate) is terminated by the Company without Cause within 12 months following the effective date of a “Change of Control”, the Board of Directors may accelerate the vesting all or any portion of your Option.
 
For purposes of this Agreement: “ Change in Control ” shall mean:
(i) any “person” (as such term is used in Section 13(d) and 14(d)(2) of the Securities Exchange Act of 1934, as amended (the “ Exchange Act ”), including any syndicate or group deemed to be a “person” under Section 13(d)(3) of the Exchange Act) other than Barry Zyskind, George Karfunkel, Michael Karfunkel, any of their lineal descendants, any trust or charitable foundation controlled by any of them or their lineal descendants, any subsidiary or any employee benefit plan of the Company or a subsidiary or former subsidiary, is or becomes a beneficial owner, directly or indirectly, of stock of the Company representing 50% of more of the total voting power of the Company’s then outstanding stock;
 
(ii) a tender offer (for which a filing has been made with the Securities and Exchange Commission (the “ SEC ”) that purports to comply with the requirements of Section 14(d) of the Exchange Act, and the corresponding SEC rules) is made for the stock of the Company. In case of a tender offer described in this paragraph (ii), the “Change of Control” will be deemed to have occurred any time during the offer when the person (using the definition in (i) above) making the offer owns or has accepted for payment stock of the Company with 50% or more of the total voting power of the Company's outstanding stock; or
 
(iii)  individuals who were the Board’s nominees for election as directors of the Company immediately prior to a meeting of the stockholders of the Company involving a contest for the election of directors shall not constitute a majority of the Board following the election.
 
Notice of Exercise
 
When you wish to exercise this Option, you must notify the Company in writing. Such exercise will only become effective upon the Company’s receipt of such written instructions.
 
Recapture Rights
 
In the event that you violate any of your obligations pursuant to the Confidentiality, Non-Competition, or Non-Solicitation provisions of this Agreement, you agree to return, within five days of receipt of written demand from the Company, any gains you realize from the exercise of all or any portion of the Option within the 12 months immediately preceding such violation, and any remaining portion of your Option shall be immediately forfeited, whether vested or unvested.
 
 
 
3

 
 
Confidentiality
 
During your Employment, you will have access to confidential or proprietary data or information of the Company (and its affiliates) and its operations.  You agree that you will not at any time divulge or communicate the Confidential Information (defined below) to any person, nor shall you direct any employee to divulge or communicate to any person (other than to a person bound by confidentiality obligations similar to those contained herein and other than as necessary in performing your duties hereunder), or use to the detriment of the Company (or any of its affiliates) or for the benefit of any other person, any Confidential Information.  This restriction shall survive your Employment hereunder, whether by the normal expiration thereof or otherwise.
 
The term “Confidential Information” shall mean all information, whether or not reduced to written or recorded form, that is related to the Company and that is not generally known or accessible to members of the public and/or competitors of the Company nor intended for general dissemination, whether furnished by the Company or compiled by the employee, including, without limitation, relating to the Company’s (or any affiliate’s) financial performance, customers, existing or proposed future projects, prospects, or business strategies, personnel information, financial information, customer lists, supplier lists, trade secrets, information regarding operations, systems, services, know-how, computer and any other processed or collated data, computer programs, pricing, marketing and advertising data.
 
You understand the Company intends to maintain the confidentiality of the Confidential Information notwithstanding that employees of the Company may have free access to the information for the purpose of performing their duties with the Company, and notwithstanding that employees not expressly bound by agreements similar to this agreement may have access to such information for job purposes. You acknowledge that Confidential Information need not be marked as such to preserve the confidential nature of the information.
 
Non-Competition
 
You acknowledge that (a) in the course of your Employment with the Company and its affiliates, you have, and will continue to, become familiar with the Company’s and its affiliates’ trade secrets, methods of doing business, business plans and other valuable confidential and proprietary information concerning the Company, its affiliates, their customers and business partners and that your services have been and will be of special, unique and extraordinary value to the Company and its affiliates.  In consideration thereof and of this Award, during your Employment with the Company or an affiliate and for a period of one (1) year thereafter, you shall not, without the Company’s prior written approval, become engaged, directly or indirectly, as a director, officer, employee or 5% or more stockholder or equity interest owner in, partner in, or consultant to, any business that is directly competitive with the business of the Company (or any affiliate) in any area or region where the Company (or any affiliate) conducts business (“ Competition ”).  Notwithstanding the foregoing, you shall not be deemed to be in Competition with the Company if you provide evidence satisfactory to the Company, in its sole and absolute discretion, that you: (i) work in a separate division, department or unit that does not compete with the business of the Company (or any affiliate); and (ii) will not have contact with the division, department or unit that does compete with the business of the Company (or any affiliate).  If you received your Option grant as a non-employee member of the Company’s Board of Directors, this provision will not apply to you unless your Employment is terminated for Cause (as defined above) or for cause pursuant to the Company’s Certificate of Incorporation.
 
 
 
4

 
 
Non-Solicitation
 
During Employment and for a period of two (2) years thereafter, you shall not, directly or indirectly, on your own behalf or on behalf of any other person: (a) induce or attempt to induce any agent, broker, affinity group or policyholder of the Company (or any affiliate), or any prior agent, affinity group or policyholder that was an agent, affinity group or policyholder within twelve (12) months of such contact, to withdraw, decrease or cancel its business with the Company (or any affiliate) or otherwise terminate any written or oral agreement or understanding or other relationship with the Company (or any affiliate); (b) solicit the business of any agent, broker, affinity group or policyholder of the Company (or any affiliate), or any prior agent, affinity group or policyholder that was an agent, affinity group or policyholder within twelve (12) months of such contact, to the extent the business solicited is similar to, or competitive with, the business of the Company (or any affiliate); (c) solicit or attempt to solicit, or hire or attempt to hire, or communicate with any person who is an employee, individual consultant or independent contractor of the Company (or any affiliate), or any prior employee, individual consultant or independent contractor that was an employee, consultant or independent contractor within twelve (12) months of such contact; or (d) induce or attempt to induce any person who is an employee, individual consultant or independent contractor of the Company (or any affiliate) to terminate or limit his or her employment or other relationship with the Company (or any affiliate), or any prior employee, individual consultant or independent contractor that was an employee, individual consultant or independent contractor within twelve (12) months of such contact.
 
Form of Payment
 
Upon exercise of your Option, you must submit payment of the Option price for the shares you are purchasing. Payment may be made via (i) cash; (ii) a “cashless” exercise, by which you deliver an irrevocable direction to a licensed securities broker to sell Stock and to deliver all or part of the sale proceeds to the Company in payment of the aggregate Option price and any applicable withholding taxes; or (iii) as otherwise permitted by the Administrator.
 
Administrator ” shall mean one or more officers or employees of the Company to whom the Committee may delegate the authority execute and distribute Award Agreements or other documents evidencing or relating to Awards granted by the Committee under the Plan, to maintain records relating to Awards, to process or oversee the issuance of Stock under Awards, to interpret and administer the terms of Awards and to take such other actions as may be necessary or appropriate for the administration of the Plan and of Awards under the Plan, other that those specified in Section 3(b)(i) – (iii) of the Plan.
 
Withholding Taxes
 
In the event that the Company determines that any federal, state, local or foreign tax or withholding payment is required relating to the exercise or sale of shares arising from this grant, the Company shall have the right to require such payments from you, or withhold such minimum statutory amounts from other payments due to you from the Company. Payment of your withholding or other taxes may be made via one of the forms of payment for exercise set forth above, or as otherwise determined by the Administrator.
 
Transfer of Option
 
The Option is non-transferable by you. Any attempt by you to transfer this Option will result in the Option becoming invalid, except upon your death by the laws of descent and distribution.
 
 
 
5

 
 
No Employment Rights
 
Neither your Option nor this Agreement give you the right to be retained by the Company in any capacity and your Employment may be terminated at any time and for any reason.
 
Shareholder Rights
 
You have no rights as a shareholder of the Company unless and until the Stock relating to your exercise has been issued (or an appropriate book entry has been made). Except as described in the Plan, no adjustments are made for dividends or other rights if the applicable record date occurs before your Stock is issued (or an appropriate book entry has been made).
 
Applicable Law
 
 
Data Privacy
 
This Agreement shall be governed by the laws of the State of Delaware, with consent to jurisdiction by you in the State of New York.
 
To administer the Plan, the Company may process personal data about you. Such data includes the information provided in this Agreement, other appropriate personal and financial data about you such as home address and business addresses and other contact information, payroll information and any other information deemed appropriate by the Company to facilitate the administration of the Plan.
 
By accepting this award, you consent to the Company’s processing of such personal data and the transfer of such data outside the country in which you work or are employed, including, with respect to non-U.S. residents, to the United States, to transferees who shall include the Company and other persons designated by the Company to administer the Plan.
 
Consent to Electronic Delivery
 
Certain statutory materials relating to the Plan may be delivered to you in electronic form. By accepting this grant, you consent to electronic delivery and acknowledge receipt of these materials, including the Plan and the Plan prospectus.
 
Non-Qualified Stock Option
 
This Option is not intended to be an “incentive stock option” under Section 422 of the Internal Revenue Code of 1986, as amended, and will be interpreted accordingly.

This Agreement is not a stock certificate or a negotiable instrument.
 
 
6

 
 
By accepting your grant, you agree to the terms and conditions in this Agreement and in the Plan, and agree that the Plan will control in the event any provision of this Agreement should appear to be inconsistent with the terms and conditions in the Plan.

          IN WITNESS WHEREOF, the parties have executed this Agreement on the date and year below.

AMTRUST FINANCIAL SERVICES, INC.


____________________________________                                                                                     Date: ___________________________
By:
Its:


NON-EMPLOYEE DIRECTOR




____________________________________                                                                                     Date:____________________________
Name:




 
7

 
Exhibit 10.3
 
AMTRUST FINANCIAL SERVICES, INC.
  2010 OMNIBUS INCENTIVE PLAN
 

 
RESTRICTED STOCK AGREEMENT
 

 
AmTrust Financial Services, Inc.  a Delaware corporation, (the “ Company ”), hereby grants restricted stock (“ Restricted Stock ”) relating to shares of its common stock, $.01 par value, (the “ Stock ”), to the individual named below as the Grantee, subject to the vesting conditions set forth in this Agreement. This grant is subject to the terms and conditions set forth in (i) this Agreement, and (ii) the 2010 Omnibus Incentive Plan (the “ Plan ”). Unless otherwise defined herein, capitalized terms used in this Agreement are defined in the Plan, and have the meaning set forth in the Plan.

Award of Restricted Stock
 
You have been granted ________ shares of Restricted Stock, subject to the terms and conditions of this Agreement and the Plan.
     
Grant Date
 
The effective date of this grant of Restricted Stock is _______ ____, 20__ (“ Grant Date ”).
     
Vesting
 
Your award of Restricted Stock  shall vest in four equal installments of 25% on each of the first, second, third and fourth anniversaries of the Grant Date, provided you remain in Service (as defined below) on the vesting date.
 
Service ” means that you are currently an employee of the Company, are a member of the Company’s Board of Directors, or are otherwise providing services to the Company.
 
Restricted Stock Ownership and Transferability
 
Subject to the restrictions set forth in the Plan and this Agreement, the Award holder shall possess all incidents of ownership of the Restricted Stock granted hereunder, including the right to receive dividends with respect to such Restricted Stock and the right to vote such Restricted Stock.
 
Restricted Stock may not be transferred, assigned, pledged or hypothecated, whether by operation of law or otherwise (except by the laws of descent and distribution) nor may shares of Restricted Stock be made subject to execution, attachment or similar process.
 
Forfeiture of Unvested
Restricted Stock
 
Except as specifically provided in this Agreement or as may be provided in other agreements between you and the Company, no additional shares of Restricted Stock will vest after your Service has terminated for any reason and you will forfeit to the Company all of the Restricted Stock not yet vested or with respect to which all applicable restrictions and conditions have not lapsed.
 
Retirement
 
If you have been employed by the Company for at least five years and your Service terminates due to your: (i) retirement on or after your sixty-fifth birthday; or (ii) retirement on or after your fifty-fifth birthday with the consent of the Company, the Restricted Stock granted under this Agreement will automatically vest as to the number of Restricted Stock that would have vested had you remained in Service for the 12 month period immediately following your retirement.
 
 
 
1

 
 
Death
 
If your Service terminates because of your death, the Restricted Stock granted under this Agreement will automatically vest as to the number of Restricted Stock that would have vested had you remained in Service for the 12 month period immediately following your death.
 
Disability
 
If your Service terminates because of your Disability (as defined below), the Restricted Stock granted under this Agreement will automatically vest as to the number of Restricted Stock that would have vested had you remained in Service for the 12 month period immediately following your termination for Disability.
 
For purposes of this Agreement, “ Disability ” shall mean the Award holder is unable to perform the duties of their Service (or other services) (i) for a period of 90 consecutive days, or (ii) any 120 days during any consecutive 12 month period.
 
Termination For Cause
 
If your Service is terminated for Cause (as defined below), then you shall immediately forfeit all rights to your vested (but undelivered) and unvested Restricted Stock and this award shall immediately terminate.
 
For purposes of this Agreement, “ Caus e” shall mean (a) willful misconduct or gross negligence; (b) conviction of a felony or conviction of a crime involving moral turpitude; (c) any act constituting fraud or the misappropriation or embezzlement of money or other property of the Company; and (d) any willful act or course of conduct constituting an abuse of office or authority which has a material adverse impact on the Company’s reputation or financial condition.
 
Termination without Cause within 12 Months of Change in Control
 
 
If your Service with the Company (or any affiliate) is terminated by the Company without Cause within 12 months following the effective date of a “Change of Control,” the Board of Directors may accelerate the vesting of any award of Restricted Stock held by you.
 
For purposes of this Agreement: “ Change in Control ” shall mean:
(i) any “person” (as such term is used in Section 13(d) and 14(d)(2) of the Securities Exchange Act of 1934, as amended (the “ Exchange Act ”), including any syndicate or group deemed to be a “person” under Section 13(d)(3) of the Exchange Act) other than Barry Zyskind, George Karfunkel, Michael Karfunkel, any lineal descendants, any trust or charitable foundation controlled by any of them or their lineal descendants, any subsidiary or any employee benefit plan of the Company or a subsidiary or former subsidiary, is or becomes a beneficial owner, directly or indirectly, of stock of the Company representing 50% of more of the total voting power of the Company’s then outstanding stock;
 
(ii) a tender offer (for which a filing has been made with the Securities and Exchange Commission (the “ SEC ”) that purports to comply with the requirements of Section 14(d) of the Exchange Act, and the corresponding SEC rules) is made for the stock of the Company. In case of a tender offer described in this paragraph (ii), the “Change of Control” will be deemed to have occurred any time during the offer when the person (using the definition in (i) above) making the offer owns or has accepted for payment stock of the Company with 50% or more of the total voting power of the Company's outstanding stock; or
 
(iii)  individuals who were the Board’s nominees for election as directors of the Company immediately prior to a meeting of the stockholders of the Company involving a contest for the election of directors shall not constitute a majority of the Board following the election.
 
 
 
2

 
 
Certificate; Book Entry Form; Legend
 
The Company shall issue the shares of Restricted Stock either (i) in certificate form or (ii) in book entry form, registered in the name of the Award holder, with legends, or notations, as applicable, referring to the terms, conditions, and restrictions applicable to the Award.  Any certificate issued for Restricted Stock prior to vesting will be inscribed with the following legend:
 
“The transferability of this certificate and the shares of stock represented hereby are subject to the terms and conditions (including forfeiture) relating to Restricted Stock contained in the AmTrust Financial Services, Inc. 2010 Omnibus Incentive Plan and an Agreement entered into between the registered owner and AmTrust Financial Services, Inc. Copies of such Plan and Agreement are on file at the principal office of AmTrust Financial Services, Inc.”
 
Escrow
 
 
Any Restricted Stock issued pursuant to this Award shall be held by the Company in escrow for the benefit of the Award recipient. Upon vesting, a certificate for the vested shares shall be issued to the Award holder free of the restrictive legend.
 
Vesting: Delivery of Shares
 
Upon vesting, restrictions related to the vested shares of Restricted stock shall lapse and the Company shall, as applicable, either remove the notations on such vested shares issued in book-entry form or deliver to the Award holder or their personal representative a stock certificate representing the number of shares of Stock, free of any restrictive legend, equal to the number of vested shares.  If certificates representing such Restricted Stock had previously been delivered to you, you shall return such certificates to the Company, complete with any necessary signatures or instruments of transfer prior to the issuance by the Company of shares of Stock without the restrictive legend.
 
 
 
3

 
 
Income Taxes
 
(a)  You shall pay to the Company promptly upon request, and in any event at the time you recognize taxable income in respect of the Restricted Stock (whether in connection with the grant or vesting of the Restricted Stock, the making of an election under Section 83(b) of the Code in connection with the Award as described below or otherwise), an amount equal to the taxes the Company determines it is required to withhold under applicable tax laws with respect to the Restricted Stock.  Such payment may be made by any of, or a combination of, the following methods: (i) cash or check; (ii) out of your current compensation; (iii) in the sole discretion of the Company, by surrender of other shares of Common Stock of the Company that (a) in the case of shares initially acquired from the Company (upon exercise of a stock option or otherwise), have been owned by you for such period, if any, as may be required to avoid a charge to the Company’s earnings and (b) have a Fair Market Value on the date of surrender equal to the amount required to be withheld; or (iv) in the sole discretion of the Company, by electing to have the Company withhold or otherwise reacquire from you shares of Restricted Stock that vest pursuant to the terms hereof having a Fair Market Value equal to the minimum statutory amount required to be withheld in connection with the vesting of such shares.  For these purposes, the Fair Market Value of the shares to be withheld or repurchased, as applicable, shall be determined on the date that the amount of the tax to be withheld is to be determined (the “ Tax Date ”).
 
All elections by you to have the shares withheld or repurchased to satisfy tax obligations shall be made in writing in a form acceptable to the Company and shall be subject to the following restrictions:
 
(i)   the election must be made on or prior to the applicable Tax Date;
 
(ii)   once made, the election shall be irrevocable as to the particular shares as to which the election is made and you acknowledge that this irrevocable written instruction is intended to constitute an instruction pursuant to Rule 10b5-1 of the Exchange Act;
 
(iii)   all elections shall be subject to the consent or disapproval of the Company; and
 
(iv)   If you are subject to Section 16 of the Exchange Act, the election must comply with the applicable provisions of Rule 16(b)-3 promulgated under the Exchange Act and shall be subject to such additional conditions or restrictions as may be required thereunder to qualify for the maximum exemption from Section 16 of the Exchange Act with respect to Plan transactions.
 
   
(b)   Section 83(b) Election .  You hereby acknowledge that you may file an election pursuant to Section 83(b) of the Code to be taxed currently on the fair market value of the shares of Restricted Stock (less any purchase price paid for the shares), provided that such election must be filed with the Internal Revenue Service no later than thirty (30) days after the date of the Award.  You will seek the advice of your own tax advisors as to the advisability of making such a Section 83(b) election, the potential consequences of making such an election, and the other tax consequences of the Award under federal, state, and any other laws that may be applicable.  The Company and its affiliates and agents have not and are not providing any tax advice to you.
 
 
 
4

 
 
Recapture Rights
 
 
In the event that you violate any of your obligations pursuant to the Confidentiality, Non-Competition, or Non-Solicitation provisions of this Agreement, you agree to return to the Company, within five days of receipt of written demand from the Company, any gains you realize from the sale of all or any portion of the Restricted Stock during the 12 months immediately preceding such violation, and any remaining unsold portion of your Restricted Stock shall be immediately and totally forfeited.
 
Confidentiality
 
During your Service, you will have access to confidential or proprietary data or information of the Company (and its affiliates) and its operations.  You agree not to at any time divulge or communicate the Confidential Information (defined below) to any person, nor shall you direct any employee to divulge or communicate to any person (other than to a person bound by confidentiality obligations similar to those contained herein and other than as necessary in performing your duties hereunder), or use to the detriment of the Company (or any of its affiliates) or for the benefit of any other person, any Confidential Information.  This restriction shall survive your Service hereunder, whether by the normal expiration thereof or otherwise.
 
The term “Confidential Information” shall mean all information, whether or not reduced to written or recorded form, that is related to the Company and that is not generally known or accessible to members of the public and/or competitors of the Company nor intended for general dissemination, whether furnished by the Company or compiled by the employee, including, without limitation, relating to the Company’s (or any affiliate’s) financial performance, customers, existing or proposed future projects, prospects, or business strategies, personnel information, financial information, customer lists, supplier lists, trade secrets, information regarding operations, systems, services, know-how, computer and any other processed or collated data, computer programs, pricing, marketing and advertising data.
 
You understand the Company intends to maintain the confidentiality of the Confidential Information notwithstanding that employees of the Company may have free access to the information for the purpose of performing their duties with the Company, and notwithstanding that employees not expressly bound by agreements similar to this agreement may have access to such information for job purposes. You  acknowledge that Confidential Information need not be marked as such to preserve the confidential nature of the information.
 
 
 
5

 
 
Non-Competition
 
You acknowledge that (a) in the course of your Service with the Company and its affiliates, you have, and will continue to, become familiar with the Company’s and its affiliates’ trade secrets, methods of doing business, business plans and other valuable confidential and proprietary information concerning the Company, its affiliates, their customers and business partners and that your services have been and will be of special, unique and extraordinary value to the Company and its affiliates.  In consideration thereof and of this Award, during your Service with the Company or an affiliate and for a period of one (1) year thereafter, you shall not, without the Company’s prior written approval, become engaged, directly or indirectly, as a director, officer, employee or 5% or more stockholder or equity interest owner in, partner in, or consultant to, any business that is directly competitive with the business of the Company (or any affiliate) in any area or region where the Company (or any affiliate) conducts business (“ Competition ”).  Notwithstanding the foregoing, you shall not be deemed to be in Competition with the Company if you provide evidence satisfactory to the Company, in its sole and absolute discretion, that you: (i) work in a separate division, department or unit that does not compete with the business of the Company (or any affiliate); and (ii) will not have contact with the division, department or unit that does compete with the business of the Company (or any affiliate).  If you received your Restricted Stock grant as a non-employee member of the Company’s Board of Directors, this provision will not apply to you unless your Service is terminated for Cause (as defined above) or for cause pursuant to the Company’s Certificate of Incorporation.
 
Non-Solicitation
 
During Service and for a period of two (2) years thereafter, you shall not, without the prior written consent of the Company, directly or indirectly, on your own behalf or on behalf of any other person, firm, corporation or business entity: (a) induce or attempt to induce any agent, affinity group or policyholder of the Company (or any affiliate), or any prior agent, affinity group or policyholder that was an agent, broker, affinity group or policyholder within twelve (12) months of such contact, to withdraw, decrease or cancel its business with the Company (or any affiliate) or otherwise terminate any written or oral agreement or understanding or other relationship with the Company (or any affiliate); (b) solicit or attempt to solicit, service or attempt to service, or for the purpose of obtaining the business of any customer of the Company (or any affiliate), or any prior agent, affinity group or policyholder that was an agent, broker, affinity group or policyholder within twelve (12) months of such contact, to the extent the business solicited is similar to, or competitive with, the business of the Company (or any affiliate), engage in discussions or other communications with (regardless of who initiates such discussions or communications) any person, firm or entity that was an actual or prospective agent, broker, affinity group or policyholder of the Company during any part of the twelve (12) month period immediately preceding termination of Service if you participated, directly or indirectly, in the solicitation or servicing of that agent, broker, affinity group or policyholder or prospective agent, broker, affinity group or policyholder , or supervised or managed those who did, during your Service with the Company at any time during such twelve (12) month period immediately preceding your termination of Service; (c) solicit or attempt to solicit, hire or attempt to hire, or communicate with, any person who is an employee, individual consultant or independent contractor of the Company (or any affiliate), or any prior employee, individual consultant or independent contractor that was an employee, consultant or independent contractor within twelve (12) months of such contact, with the purpose or intent of attracting such person from the employ of the Company (or any affiliate ) ; or (d) induce or attempt to induce any person who is an employee, individual consultant or independent contractor of the Company (or any affiliate) to terminate or limit his or her Service or other relationship with the Company (or any affiliate), or any prior employee, individual consultant or independent contractor that was an employee, individual consultant or independent contractor within twelve (12) months of such contact.
 
 
 
6

 
 
No Right to Employment
 
Neither your Restricted Stock nor this Agreement give you the right to be retained by the Company in any capacity and your Service may be terminated at any time and for any reason.
 
Shareholder Rights
 
You have no rights as a shareholder unless and until the Stock relating to the Restricted Stock has been issued to you (or an appropriate book entry has been made). Except as described in the Plan or herein, no adjustments are made for dividends or other rights if the applicable record date occurs before your Stock is issued (or an appropriate book entry has been made). If the Company pays a dividend on its Stock, you will, however, be entitled to receive a cash payment equal to the per-share dividend paid on the Stock times the number of Restricted Stock that you hold as of the record date for the dividend.
 
Applicable Law
 
This Agreement shall be governed by the laws of the State of Delaware, with consent to jurisdiction by you in the State of New York.
 
Data Privacy
 
To administer the Plan, the Company may process personal data about you. Such data includes the information provided in this Agreement, other appropriate personal and financial data about you such as home address and business addresses and other contact information, payroll information and any other information deemed appropriate by the Company to facilitate the administration of the Plan.
 
By accepting this award, you consent to the Company’s processing of such personal data and the transfer of such data outside the country in which you work or are employed, including, with respect to non-U.S. residents, to the United States, to transferees who shall include the Company and other persons designated by the Company to administer the Plan.
 
Consent to Electronic Delivery
 
Certain statutory materials relating to the Plan may be delivered to you in electronic form. By accepting this grant, you consent to electronic delivery and acknowledge receipt of these materials, including the Plan and the Plan prospectus.
 
     
     
     

           This Agreement is not a not a stock certificate or a negotiable instrument .
 
 
7

 
 
By accepting your grant, you agree to the terms and conditions in this Agreement and in the Plan, and agree that the Plan will control in the event any provision of this Agreement should appear to be inconsistent with the terms and conditions of the Plan.

IN WITNESS WHEREOF, the parties have executed this Agreement on the date and year below .

AMTRUST FINANCIAL SERVICES, INC.



____________________________________                                                                                     Date: ___________________________
By:
Its:



EMPLOYEE




____________________________________                                                                                     Date:____________________________
Name:


 
8

 

Exhibit 10.4
 
AMTRUST FINANCIAL SERVICES, INC.
2010 OMNIBUS INCENTIVE PLAN
 

 
RESTRICTED STOCK UNIT AGREEMENT
 

 
AmTrust Financial Services, Inc.  a Delaware corporation, (the “ Company ”), hereby grants restricted stock units (“ RSUs ”) relating to shares of its common stock, $.01 par value, (the “ Stock ”), to the individual named below as the Grantee, subject to the vesting conditions set forth in this Agreement. This grant is subject to the terms and conditions set forth in (i) this Agreement, and (ii) the 2010 Omnibus Incentive Plan (the “ Plan ”). Unless otherwise, defined herein, capitalized terms used in this Agreement are defined in the Plan, and have the meaning set forth in the Plan.

Award of RSUs
 
 You have been granted ________ RSUs, subject to the terms and conditions of this Agreement and the Plan.
     
Grant Date
 
The effective date of this grant of RSUs is _______ ____, 20__ (“ Grant Date ”).
     
Vesting
 
 
RSUs shall vest in four equal installments of 25% on each of the first, second, third and fourth anniversaries of the Grant Date, provided you remain in Service (as defined below) on the vesting date.
 
Service ” means that you are currently an employee of the Company, are a member of the Company’s Board of Directors, or are otherwise providing services to the Company.
 
RSU Transferability
 
RSUs may not be transferred, assigned, pledged or hypothecated, whether by operation of law or otherwise, nor may the RSUs be made subject to execution, attachment or similar process.
 
Forfeiture of Unvested
RSUS
 
Except as specifically provided in this Agreement or as may be provided in other agreements between you and the Company, no additional RSUs will vest after your Service has terminated for any reason and you will forfeit to the Company all of the RSUs that have not yet vested or with respect to which all applicable restrictions and conditions have not lapsed.
 
Retirement
 
If you have been employed by the Company for at least five years and your Service terminates due to your: (i) retirement on or after your sixty-fifth birthday; or (ii) retirement on or after your fifty-fifth birthday with the consent of the Company, the RSUs granted under this Agreement will automatically vest as to the number of RSUs that would have vested had you remained in Service for the 12 month period immediately following your retirement.
 
Death
 
If your Service terminates because of your death, the RSUs granted under this Agreement will automatically vest as to the number of RSUs that would have vested had you remained in Service for the 12 month period immediately following your death.
 
 
 
 

 
 
Disability
 
If your Service terminates because of your Disability (as defined below), the RSUs granted under this Agreement will automatically vest as to the number of RSUs that would have vested had you remained in Service for the 12 month period immediately following your termination for Disability.
 
For purposes of this Agreement, “ Disability ” shall mean the Award holder is unable to perform the duties of their Service (or other services) (i) for a period of 90 consecutive days, or (ii) any 120 days during any consecutive 12 month period.
 
Termination For Cause
 
If your Service is terminated for Cause (as defined below), then you shall immediately forfeit all rights to your vested (but undelivered) and unvested RSUs and this award shall immediately terminate.
 
For purposes of this Agreement, “ Caus e” shall mean (a) willful misconduct or gross negligence; (b) conviction of a felony or conviction of a crime involving moral turpitude; (c) any act constituting fraud or the misappropriation or embezzlement of money or other property of the Company; and (d) any willful act or course of conduct constituting an abuse of office or authority which has a material adverse impact on the Company’s reputation or financial condition.
 
Termination without
Cause within 12 Months of
Change in Control
 
 
If your Service with the Company (or any affiliate) is terminated by the Company without Cause within 12 months following the effective date of a “Change of Control,” the Board of Directors may accelerate the vesting of all or any portion of this RSUs award.
 
For purposes of this Agreement: “ Change in Control ” shall mean:
(i) any “person” (as such term is used in Section 13(d) and 14(d)(2) of the Securities Exchange Act of 1934, as amended (the “ Exchange Act ”), including any syndicate or group deemed to be a “person” under Section 13(d)(3) of the Exchange Act) other than Barry Zyskind, George Karfunkel, Michael Karfunkel, any of their lineal descendants, any trust or charitable foundation controlled by any of them or their lineal descendants, any subsidiary or any employee benefit plan of the Company or a subsidiary or former subsidiary, is or becomes a beneficial owner, directly or indirectly, of stock of the Company representing 50% of more of the total voting power of the Company’s then outstanding stock;
 
(ii) a tender offer (for which a filing has been made with the Securities and Exchange Commission (the “ SEC ”) that purports to comply with the requirements of Section 14(d) of the Exchange Act, and the corresponding SEC rules) is made for the stock of the Company. In case of a tender offer described in this paragraph (ii), the “Change of Control” will be deemed to have occurred any time during the offer when the person (using the definition in (i) above) making the offer owns or has accepted for payment stock of the Company with 50% or more of the total voting power of the Company's outstanding stock; or
 
(iii)  individuals who were the Board’s nominees for election as directors of the Company immediately prior to a meeting of the stockholders of the Company involving a contest for the election of directors shall not constitute a majority of the Board following the election.
 
 
 
 

 
 
Share Delivery Pursuant to Vested Units; Withholding Tax
 
On the vesting date (or as soon as practicable thereafter but in no event beyond 2½ months after the end of the calendar year in which the shares vest), at the Company’s option, (i) a brokerage account in your name will be credited with Stock representing the number of shares that vested under this grant (the “ Vesting Shares ”), or (ii) the Company shall physically deliver the Vesting Shares. If the vesting date is not a trading day, the Stock will be delivered on the next trading day. The Company will determine the number of the Vesting Shares necessary to cover the statutory minimum amount of federal, state, local, and foreign taxes that the Company is required to withhold with respect to the RSU vesting, rounding up   to the nearest whole Share of Stock (the “ Withholding Shares ”).
 
   
By accepting this award of RSUs, you irrevocably (i) instruct the Company to deliver the Vesting Shares to your account; and (ii) authorize and direct the Company to withhold or otherwise reacquire from you the Withholding Shares at the time of vesting to be used to fund the payment of the withholding taxes. You further acknowledge that this irrevocable written instruction is intended to constitute an instruction pursuant to Rule 10b5-1 of the Exchange Act.
 
   
The purchase price for the vested Stock is deemed paid by your prior services to the Company.
 
Withholding shall only be applicable to employees of the Company.
 
Recapture Rights
 
In the event that you violate any of your obligations pursuant to the Confidentiality, Non-Competition, or Non-Solicitation provisions of this Agreement, you agree to return to the Company, within five days of receipt of written demand from the Company, any gains you realize from the sale of all or any portion of the RSUs during the 12 months immediately preceding such violation, and any remaining unsold portion of your RSUs shall be immediately and totally forfeited.
 
 
 
 

 
 
Confidentiality
 
During your Service, you will have access to confidential or proprietary data or information of the Company (and its affiliates) and its operations.  You agree that you will not at any time divulge or communicate the Confidential Information (defined below) to any person, nor shall you direct any employee to divulge or communicate to any person (other than to a person bound by confidentiality obligations similar to those contained herein and other than as necessary in performing your duties hereunder), or use to the detriment of the Company (or any of its affiliates) or for the benefit of any other person, any Confidential Information.  This restriction shall survive your Service hereunder, whether by the normal expiration thereof or otherwise.
 
The term “Confidential Information” shall mean all information, whether or not reduced to written or recorded form, that is related to the Company and that is not generally known or accessible to members of the public and/or competitors of the Company nor intended for general dissemination, whether furnished by the Company or compiled by the employee, including, without limitation, relating to the Company’s (or any affiliate’s) financial performance, customers, existing or proposed future projects, prospects, or business strategies, personnel information, financial information, customer lists, supplier lists, trade secrets, information regarding operations, systems, services, know-how, computer and any other processed or collated data, computer programs, pricing, marketing and advertising data.
 
You understand the Company intends to maintain the confidentiality of the Confidential Information notwithstanding that employees of the Company may have free access to the information for the purpose of performing their duties with the Company, and notwithstanding that employees not expressly bound by agreements similar to this agreement may have access to such information for job purposes. You  acknowledge that Confidential Information need not be marked as such to preserve the confidential nature of the information.
 
  Non-Competition
 
You acknowledge that (a) in the course of your Service with the Company and its affiliates, you have, and will continue to, become familiar with the Company’s and its affiliates’ trade secrets, methods of doing business, business plans and other valuable confidential and proprietary information concerning the Company, its affiliates, their customers and business partners and that your services have been and will be of special, unique and extraordinary value to the Company and its affiliates.  In consideration thereof and of this Award, during your Service with the Company or an affiliate and for a period of one (1) year thereafter, you shall not, without the Company’s prior written approval, become engaged, directly or indirectly, as a director, officer, employee or 5% or more stockholder or equity interest owner in, partner in, or consultant to, any business that is directly competitive with the business of the Company (or any affiliate) in any area or region where the Company (or any affiliate) conducts business (“ Competition ”).  Notwithstanding the foregoing, you shall not be deemed to be in Competition with the Company if you provide evidence satisfactory to the Company, in its sole and absolute discretion, that you: (i) work in a separate division, department or unit that does not compete with the business of the Company (or any affiliate); and (ii) will not have contact with the division, department or unit that does compete with the business of the Company (or any affiliate).  If you received your RSU grant as a non-employee member of the Company’s Board of Directors, this provision will not apply to you unless your Service is terminated for Cause (as defined above) or for cause pursuant to the Company’s Certificate of Incorporation.
 
 
 
 

 
 
Non-Solicitation
 
During Service and for a period of two (2) years thereafter, you shall not, without the prior written consent of the Company, directly or indirectly, on your own behalf or on behalf of any other person, firm, corporation or business entity: (a) induce or attempt to induce any agent, affinity group or policyholder of the Company (or any affiliate), or any prior agent, broker, affinity group or policyholder that was an agent, affinity group or policyholder within twelve (12) months of such contact, to withdraw, decrease or cancel its business with the Company (or any affiliate) or otherwise terminate any written or oral agreement or understanding or other relationship with the Company (or any affiliate); (b) solicit or attempt to solicit, service or attempt to service, or for the purpose of obtaining the business of any agent, broker, affinity group or policyholder of the Company (or any affiliate), or any prior agent, affinity group or policyholder that was an agent, affinity group or policyholder within twelve (12) months of such contact, to the extent the business solicited is similar to, or competitive with, the business of the Company (or any affiliate), engage in discussions or other communications with (regardless of who initiates such discussions or communications) any person, firm or entity that was an actual or prospective agent, broker, affinity group or policyholder of the Company during any part of the twelve (12) month period immediately preceding termination of Service if you participated, directly or indirectly, in the solicitation or servicing of that agent, broker, affinity group or policyholder or prospective agent, broker, affinity group or policyholder, or supervised or managed those who did, during your Service with the Company at any time during such twelve (12) month period immediately preceding your termination of Service; (c) solicit or attempt to solicit, hire or attempt to hire, or communicate with, any person who is an employee, individual consultant or independent contractor of the Company (or any affiliate), or any prior employee, individual consultant or independent contractor that was an employee, consultant or independent contractor within twelve (12) months of such contact, with the purpose or intent of attracting such person from the employ of the Company (or any affiliate); or (d) induce or attempt to induce any person who is an employee, individual consultant or independent contractor of the Company (or any affiliate) to terminate or limit his or her Service or other relationship with the Company (or any affiliate), or any prior employee, individual consultant or independent contractor that was an employee, individual consultant or independent contractor within twelve (12) months of such contact.
 
No Right to Employment
 
Neither your RSUs nor this Agreement give you the right to be retained by the Company in any capacity and your Service may be terminated at any time and for any reason.
 
 
 
 

 
 
Shareholder Rights
 
You have no rights as a shareholder unless and until the Stock relating to the RSUs has been issued to you (or an appropriate book entry has been made). Except as described in the Plan or herein, no adjustments are made for dividends or other rights if the applicable record date occurs before your Stock is issued (or an appropriate book entry has been made).
 
You will not be entitled to any dividends on any unvested RSUs.
 
Applicable Law
 
This Agreement shall be governed by the laws of the State of Delaware, with consent to jurisdiction by you in the State of New York.
 
Data Privacy
 
To administer the Plan, the Company may process personal data about you. Such data includes the information provided in this Agreement, other appropriate personal and financial data about you such as home address and business addresses and other contact information, payroll information and any other information deemed appropriate by the Company to facilitate the administration of the Plan.
 
By accepting this award, you consent to the Company’s processing of such personal data and the transfer of such data outside the country in which you work or are employed, including, with respect to non-U.S. residents, to the United States, to transferees who shall include the Company and other persons designated by the Company to administer the Plan and the Plan prospectus.
 
Consent to Electronic Delivery
 
Certain statutory materials relating to the Plan may be delivered to you in electronic form. By accepting this grant, you consent to electronic delivery and acknowledge receipt of these materials, including the Plan.
 
 
 This Agreement is not a stock certificate or a negotiable instrument.
 
 
 

 
          
By accepting your grant, you agree to the terms and conditions in this Agreement and in the Plan, and agree that the Plan will control in the event any provision of this Agreement should appear to be inconsistent with the terms and conditions of the Plan.

IN WITNESS WHEREOF, the parties have executed this Agreement on the date and year below .

AMTRUST FINANCIAL SERVICES, INC.



____________________________________                                                                                     Date: ___________________________
By:
Its:



EMPLOYEE




____________________________________                                                                                     Date:____________________________
Name:



 
 

 
 

EXHIBIT 31.1

CERTIFICATION

I, Barry Zyskind, certify that:

 
1.
I have reviewed this Quarterly Report on Form 10-Q of AmTrust Financial Services, Inc.;

 
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 
4.
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 
(a)
designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 
(b)
designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 
(c)
evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 
(d)
disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 
5.
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 
(a)
all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 
(b)
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Dated: November 9, 2011
By:
/s/ Barry Zyskind
   
Barry Zyskind
   
President and Chief Executive Officer
   
(Principal Executive Officer)
 
 
 

 

EXHIBIT 31.2

CERTIFICATION

I, Ronald Pipoly, certify that:

 
1.
I have reviewed this Quarterly Report on Form 10-Q of AmTrust Financial Services, Inc.;

 
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 
4.
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 
(a)
designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 
(b)
designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 
(c)
evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 
(d)
disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of the annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 
5.
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 
(a)
all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 
(b)
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Dated: November 9, 2011
By:
/s/ Ronald Pipoly
   
Ronald Pipoly
   
Chief Financial Officer
   
(Principal Financial and Accounting Officer)
 
 
 

 

EXHIBIT 32.1

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, I Barry Zyskind, President and Chief Executive Officer (Principal Executive Officer) of AmTrust Financial Services, Inc. (the “Company”), hereby certify, that, to my knowledge:

 
1.
The Quarterly Report on Form 10-Q for the quarter ended September 30, 2011 (the “Report”) fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 
2.
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date:  November 9, 2011
By:
/s/ Barry Zyskind
   
Barry Zyskind
   
President and Chief Executive Officer
   
(Principal Executive Officer)

 
 

 
 
EXHIBIT 32.2

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, I Ronald Pipoly, Chief Financial Officer (Principal Financial and Accounting Officer) of AmTrust Financial Services, Inc. (the “Company”), hereby certify, that, to my knowledge:

 
1.
The Quarterly Report on Form 10-Q for the quarter ended September 30, 2011 (the “Report”) fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 
2.
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: November  9, 2011
By:
/s/ Ronald Pipoly
   
Ronald Pipoly
   
Chief Financial Officer
   
(Principal Financial and Accounting Officer)